No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 1p4tA, 0.6000, 2.95, 0.111, 155, 63, CRYSTAL STRUCTURE OF NEISSERIAL SURFACE PROTEIN A (NSPA)
2, 4mvlD, 0.5962, 2.77, 0.066, 171, 61, CRYSTAL STRUCTURE OF AN ENGINEERED LIPOCALIN (ANTICALIN H1GA) IN COMPLEX WITH THE ALZHEIMER AMYLOID PEPTIDE ABETA1-40
3, 3s26A, 0.5947, 2.80, 0.049, 169, 61, CRYSTAL STRUCTURE OF MURINE SIDEROCALIN (LIPOCALIN 2 24P3)
4, 3u9pC, 0.5932, 2.79, 0.049, 169, 61, CRYSTAL STRUCTURE OF MURINE SIDEROCALIN IN COMPLEX WITH AN FAB FRAGMENT
5, 5n47C, 0.5926, 2.89, 0.066, 176, 61, STRUCTURE OF ANTICALIN N7E IN COMPLEX WITH THE THREE-DOMAIN FRAGMENT FN7B8 OF HUMAN ONCOFETAL FIBRONECTIN
6, 3hwgA, 0.5922, 3.09, 0.048, 175, 63, CRYSTAL STRUCTURE OF SIDEROCALIN (NGAL LIPOCALIN 2) COMPLEXED WITH FE-TRENCAM-HOPO2
7, 3dszB, 0.5901, 3.16, 0.031, 173, 64, ENGINEERED HUMAN LIPOCALIN 2 IN COMPLEX WITH Y-DTPA
8, 3hwgC, 0.5894, 3.09, 0.048, 174, 63, CRYSTAL STRUCTURE OF SIDEROCALIN (NGAL LIPOCALIN 2) COMPLEXED WITH FE-TRENCAM-HOPO2
9, 2r56B, 0.5894, 2.84, 0.082, 159, 61, CRYSTAL STRUCTURE OF A RECOMBINANT IGE FAB FRAGMENT IN COMPLEX WITH BOVINE BETA-LACTOGLOBULIN ALLERGEN
10, 4iaxA, 0.5892, 3.02, 0.032, 172, 62, ENGINEERED HUMAN LIPOCALIN 2 (CL31) IN COMPLEX WITH Y-DTPA
11, 2r56A, 0.5892, 2.84, 0.082, 159, 61, CRYSTAL STRUCTURE OF A RECOMBINANT IGE FAB FRAGMENT IN COMPLEX WITH BOVINE BETA-LACTOGLOBULIN ALLERGEN
12, 4qaeE, 0.5890, 2.78, 0.049, 166, 61, CRYSTAL STRUCTURE OF AN ENGINEERED LIPOCALIN (ANTICALIN) IN COMPLEX WITH HUMAN HEPCIDIN
13, 4mviA, 0.5888, 3.23, 0.062, 172, 64, CRYSTAL STRUCTURE OF AN ENGINEERED LIPOCALIN (ANTICALIN US7) IN COMPLEX WITH THE ALZHEIMER AMYLOID PEPTIDE ABETA(1-40)
14, 3t1dA, 0.5882, 3.10, 0.063, 175, 63, THE MUTANT STRUCTURE OF HUMAN SIDEROCALIN W79A R81A Y106F BOUND TO ENTEROBACTIN
15, 4qaeB, 0.5881, 2.76, 0.049, 175, 61, CRYSTAL STRUCTURE OF AN ENGINEERED LIPOCALIN (ANTICALIN) IN COMPLEX WITH HUMAN HEPCIDIN
16, 3dszA, 0.5880, 3.12, 0.032, 172, 63, ENGINEERED HUMAN LIPOCALIN 2 IN COMPLEX WITH Y-DTPA
17, 5kidB, 0.5879, 3.10, 0.048, 169, 63, TIGHTENING THE RECOGNITION OF TETRAVALENT ZR AND TH COMPLEXES BY THE SIDEROPHORE-BINDING MAMMALIAN PROTEIN SIDEROCALIN FOR THERANOSTIC APPLICATIONS
18, 2q4iC, 0.5879, 3.05, 0.062, 173, 64, ENSEMBLE REFINEMENT OF THE PROTEIN CRYSTAL STRUCTURE OF ALLENE OXIDE CYCLASE FROM ARABIDOPSIS THALIANA AT3G25770
19, 1x89A, 0.5878, 3.10, 0.048, 174, 63, CRYSTAL STRUCTURE OF SIDEROCALIN (NGAL LIPOCALIN 2) COMPLEXED WITH CARBOXYMYCOBACTIN S
20, 5khpC, 0.5873, 3.11, 0.048, 173, 63, TIGHTENING THE RECOGNITION OF TETRAVALENT ZR AND TH COMPLEXES BY THE SIDEROPHORE-BINDING MAMMALIAN PROTEIN SIDEROCALIN FOR THERANOSTIC APPLICATIONS
21, 3hwfB, 0.5872, 3.00, 0.048, 169, 63, CRYSTAL STRUCTURE OF SIDEROCALIN (NGAL LIPOCALIN 2) COMPLEXED WITH FE-TRENCAM2-HOPO
22, 5khpB, 0.5870, 3.11, 0.048, 171, 63, TIGHTENING THE RECOGNITION OF TETRAVALENT ZR AND TH COMPLEXES BY THE SIDEROPHORE-BINDING MAMMALIAN PROTEIN SIDEROCALIN FOR THERANOSTIC APPLICATIONS
23, 3by0A, 0.5868, 3.11, 0.063, 174, 63, CRYSTAL STRUCTURE OF SIDEROCALIN (NGAL LIPOCALIN 2) W79A-R81A COMPLEXED WITH FERRIC ENTEROBACTIN
24, 4zhdA, 0.5867, 3.15, 0.047, 174, 64, SIDEROCALIN-MEDIATED RECOGNITION AND CELLULAR UPTAKE OF ACTINIDES
25, 6gqzA, 0.5864, 3.14, 0.062, 174, 64, PETROBACTIN-BINDING ENGINEERED LIPOCALIN WITHOUT LIGAND 
26, 5kidC, 0.5864, 3.23, 0.047, 174, 64, TIGHTENING THE RECOGNITION OF TETRAVALENT ZR AND TH COMPLEXES BY THE SIDEROPHORE-BINDING MAMMALIAN PROTEIN SIDEROCALIN FOR THERANOSTIC APPLICATIONS
27, 5f6zC, 0.5864, 2.65, 0.066, 166, 61, SANDERCYANIN FLUORESCENT PROTEIN PURIFIED FROM SANDER VITREUS
28, 3i0aA, 0.5863, 3.23, 0.047, 174, 64, CRYSTAL STRUCTURE OF SIDEROCALIN (NGAL LIPOCALIN 2) K134A MUTANT COMPLEXED WITH FERRIC ENTEROBACTIN
29, 3fw5C, 0.5863, 3.12, 0.048, 174, 63, CRYSTAL STRUCTURE OF SIDEROCALIN (NGAL LIPOCALIN 2) COMPLEXED WITH FERRIC 4-METHYL-CATECHOL
30, 4h6bG, 0.5862, 3.06, 0.078, 180, 64, STRUCTURAL BASIS FOR ALLENE OXIDE CYCLIZATION IN MOSS
31, 3pedB, 0.5862, 3.11, 0.048, 172, 63, SIDEROCALIN RECOGNITIN OF CARBOXYMYCOBACTINS: INTERFERENCE BY THE IMMUNE SYSTEM IN INTRACELLULAR IRON ACQUISITION BY MYCOBACTERIA TUBERCULOSIS
32, 5dyvC, 0.5861, 2.87, 0.097, 134, 62, ABYU - WILDTYPE
33, 4h6bF, 0.5861, 3.05, 0.078, 180, 64, STRUCTURAL BASIS FOR ALLENE OXIDE CYCLIZATION IN MOSS
34, 3dtqA, 0.5861, 3.08, 0.048, 171, 63, ENGINEERED HUMAN LIPOCALIN 2 WITH SPECIFICITY FOR Y-DTPA APO-FORM
35, 3u03C, 0.5860, 3.12, 0.048, 173, 63, THE STRUCTURE OF HUMAN SIDEROCALIN BOUND TO THE BACTERIAL SIDEROPHORE PYOCHELIN
36, 6gqzB, 0.5858, 3.16, 0.062, 174, 64, PETROBACTIN-BINDING ENGINEERED LIPOCALIN WITHOUT LIGAND 
37, 3pecA, 0.5857, 3.11, 0.048, 176, 63, SIDEROCALIN RECOGNITIN OF CARBOXYMYCOBACTINS: INTERFERENCE BY THE IMMUNE SYSTEM IN INTRACELLULAR IRON ACQUISITION BY MYCOBACTERIA TUBERCULOSIS
38, 3tf6C, 0.5855, 3.10, 0.048, 173, 63, CRYSTAL STRUCTURE OF NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (C87S MUTANT) IN COMPLEX WITH EUROPIUM AND THE SIDEROPHORE ANALOG TREN(CAM)(12-HOPO)2
39, 6rytA, 0.5854, 2.85, 0.082, 145, 61, ENGINEERED BETA-LACTOGLOBULIN: VARIANT M107L 
40, 4h6bB, 0.5854, 3.06, 0.078, 180, 64, STRUCTURAL BASIS FOR ALLENE OXIDE CYCLIZATION IN MOSS
41, 6gr0A, 0.5853, 2.96, 0.048, 173, 63, PETROBACTIN-BINDING ENGINEERED LIPOCALIN IN COMPLEX WITH GALLIUM- PETROBACTIN 
42, 3pecC, 0.5853, 3.11, 0.048, 175, 63, SIDEROCALIN RECOGNITIN OF CARBOXYMYCOBACTINS: INTERFERENCE BY THE IMMUNE SYSTEM IN INTRACELLULAR IRON ACQUISITION BY MYCOBACTERIA TUBERCULOSIS
43, 1z8kC, 0.5853, 3.07, 0.062, 173, 64, X-RAY STRUCTURE OF ALLENE OXIDE CYCLASE FROM ARABIDOPSIS THALIANA AT3G25770
44, 4h6cB, 0.5851, 3.06, 0.078, 177, 64, CRYSTAL STRUCTURE OF THE ALLENE OXIDE CYCLASE 1 FROM PHYSCOMITRELLA PATENS
45, 1z8kB, 0.5848, 3.04, 0.062, 173, 64, X-RAY STRUCTURE OF ALLENE OXIDE CYCLASE FROM ARABIDOPSIS THALIANA AT3G25770
46, 2dioC, 0.5847, 3.05, 0.062, 173, 64, CRYSTAL STRUCTURE OF THE ALLENE OXIDE CYCLASE 2 WITH BOUND INHIBITOR VERNOLIC ACID
47, 4h6cG, 0.5846, 3.06, 0.078, 175, 64, CRYSTAL STRUCTURE OF THE ALLENE OXIDE CYCLASE 1 FROM PHYSCOMITRELLA PATENS
48, 1dfvB, 0.5844, 3.24, 0.047, 174, 64, CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN MONOMER
49, 4zhhA, 0.5843, 3.11, 0.048, 177, 63, SIDEROCALIN-MEDIATED RECOGNITION AND CELLULAR UPTAKE OF ACTINIDES
50, 2brjB, 0.5841, 3.06, 0.062, 173, 64, X-RAY STRUCTURE OF THE ALLENE OXIDE CYCLASE FROM ARABIDOPSIS THALIANA
51, 4h6bH, 0.5840, 2.93, 0.095, 180, 63, STRUCTURAL BASIS FOR ALLENE OXIDE CYCLIZATION IN MOSS
52, 4zhfA, 0.5838, 3.11, 0.048, 177, 63, SIDEROCALIN-MEDIATED RECOGNITION AND CELLULAR UPTAKE OF ACTINIDES
53, 1zvcA, 0.5837, 3.03, 0.062, 171, 64, X-RAY STRUCTURE OF ALLENE OXIDE CYCLASE FROM ARABIDOPSIS THALIANA AT3G25760
54, 4zhcC, 0.5836, 3.10, 0.048, 174, 63, SIDEROCALIN-MEDIATED RECOGNITION AND CELLULAR UPTAKE OF ACTINIDES
55, 4h6aC, 0.5836, 3.06, 0.078, 181, 64, CRYSTAL STRUCTURE OF THE ALLENE OXIDE CYCLASE 2 FROM PHYSCOMITRELLA PATENS
56, 4cq7C, 0.5836, 3.04, 0.062, 173, 64, THE CRYSTAL STRUCTURE OF THE ALLENE OXIDE CYCLASE 2 FROM ARABIDOPSIS THALIANA WITH BOUND PRODUCT - OPDA
57, 2xstA, 0.5836, 2.70, 0.067, 149, 60, CRYSTAL STRUCTURE OF THE HUMAN LIPOCALIN 15
58, 1l6mB, 0.5836, 2.92, 0.063, 169, 63, NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN IS A NOVEL BACTERIOSTATIC AGENT THAT INTERFERES WITH SIDEROPHORE- MEDIATED IRON ACQUISITION
59, 6gr0C, 0.5835, 3.15, 0.062, 166, 64, PETROBACTIN-BINDING ENGINEERED LIPOCALIN IN COMPLEX WITH GALLIUM- PETROBACTIN 
60, 5dyvD, 0.5835, 2.88, 0.097, 134, 62, ABYU - WILDTYPE
61, 5dyvA, 0.5835, 2.87, 0.097, 135, 62, ABYU - WILDTYPE
62, 4h6bL, 0.5835, 3.07, 0.078, 180, 64, STRUCTURAL BASIS FOR ALLENE OXIDE CYCLIZATION IN MOSS
63, 4cq6C, 0.5835, 3.06, 0.062, 174, 64, THE CRYSTAL STRUCTURE OF THE ALLENE OXIDE CYCLASE 2 FROM ARABIDOPSIS THALIANA WITH BOUND INHIBITOR - VERNOLIC ACID
64, 3u0dB, 0.5835, 3.16, 0.048, 175, 63, THE STRUCTURE OF HUMAN SIDEROCALIN BOUND TO THE BACTERIAL SIDEROPHORE 23-DHBA
65, 3tzsC, 0.5835, 3.13, 0.048, 173, 63, CRYSTAL STRUCTURE OF NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN NGAL (C87S MUTANT) IN COMPLEX WITH FRAGMENT 1026 PHENYLUREA
66, 3fw4A, 0.5835, 3.14, 0.048, 174, 63, CRYSTAL STRUCTURE OF SIDEROCALIN (NGAL LIPOCALIN 2) COMPLEXED WITH FERRIC CATECHOL
67, 4zhfD, 0.5834, 3.12, 0.048, 177, 63, SIDEROCALIN-MEDIATED RECOGNITION AND CELLULAR UPTAKE OF ACTINIDES
68, 4zhfB, 0.5834, 3.11, 0.048, 175, 63, SIDEROCALIN-MEDIATED RECOGNITION AND CELLULAR UPTAKE OF ACTINIDES
69, 2brjC, 0.5834, 3.05, 0.062, 173, 64, X-RAY STRUCTURE OF THE ALLENE OXIDE CYCLASE FROM ARABIDOPSIS THALIANA
70, 1x89C, 0.5834, 3.11, 0.048, 173, 63, CRYSTAL STRUCTURE OF SIDEROCALIN (NGAL LIPOCALIN 2) COMPLEXED WITH CARBOXYMYCOBACTIN S
71, 4h69F, 0.5833, 3.03, 0.078, 184, 64, CRYSTAL STRUCTURE OF THE ALLENE OXIDE CYCLASE 2 FROM PHYSCOMITRELLA PATENS COMPLEXED WITH SUBSTRATE ANALOG
72, 4h69E, 0.5833, 3.07, 0.078, 193, 64, CRYSTAL STRUCTURE OF THE ALLENE OXIDE CYCLASE 2 FROM PHYSCOMITRELLA PATENS COMPLEXED WITH SUBSTRATE ANALOG
73, 3dtqC, 0.5833, 3.02, 0.048, 172, 63, ENGINEERED HUMAN LIPOCALIN 2 WITH SPECIFICITY FOR Y-DTPA APO-FORM
74, 2dioB, 0.5833, 3.08, 0.062, 173, 64, CRYSTAL STRUCTURE OF THE ALLENE OXIDE CYCLASE 2 WITH BOUND INHIBITOR VERNOLIC ACID
75, 1z8kA, 0.5833, 3.03, 0.062, 173, 64, X-RAY STRUCTURE OF ALLENE OXIDE CYCLASE FROM ARABIDOPSIS THALIANA AT3G25770
76, 1x8uB, 0.5833, 3.16, 0.047, 169, 64, CRYSTAL STRUCTURE OF SIDEROCALIN (NGAL LIPOCALIN 2) COMPLEXED WITH CARBOXYMYCOBACTIN T
77, 4h6cK, 0.5831, 3.07, 0.078, 180, 64, CRYSTAL STRUCTURE OF THE ALLENE OXIDE CYCLASE 1 FROM PHYSCOMITRELLA PATENS
78, 3hweA, 0.5831, 3.17, 0.047, 174, 64, CRYSTAL STRUCTURE OF SIDEROCALIN (NGAL LIPOCALIN 2) COMPLEXED WITH FE-BISHACAM
79, 3hwdA, 0.5829, 3.11, 0.048, 176, 63, CRYSTAL STRUCTURE OF SIDEROCALIN (NGAL LIPOCALIN 2) K125A-K134A MUTANT COMPLEXED WITH FERRIC ENTEROBACTIN
80, 3cbcC, 0.5829, 3.13, 0.048, 175, 63, CRYSTAL STRUCTURE OF SIDEROCALIN (NGAL LIPOCALIN 2) Y106F COMPLEXED WITH FERRIC ENTEROBACTIN
81, 4h69C, 0.5828, 3.07, 0.078, 180, 64, CRYSTAL STRUCTURE OF THE ALLENE OXIDE CYCLASE 2 FROM PHYSCOMITRELLA PATENS COMPLEXED WITH SUBSTRATE ANALOG
82, 3bx8G, 0.5827, 2.79, 0.067, 161, 60, ENGINEERED HUMAN LIPOCALIN 2 (LCN2) APO-FORM
83, 1qqsA, 0.5827, 3.04, 0.063, 174, 63, NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN HOMODIMER
84, 4zfxB, 0.5826, 3.12, 0.048, 169, 63, SIDEROCALIN-MEDIATED RECOGNITION AND CELLULAR UPTAKE OF ACTINIDES
85, 1x71B, 0.5826, 3.16, 0.047, 171, 64, CRYSTAL STRUCTURE OF SIDEROCALIN (NGAL LIPOCALIN 2) COMPLEXED WITH TRENCAM-32-HOPO A CEPABACTIN ANALOGUE
86, 3pedC, 0.5825, 3.12, 0.048, 172, 63, SIDEROCALIN RECOGNITIN OF CARBOXYMYCOBACTINS: INTERFERENCE BY THE IMMUNE SYSTEM IN INTRACELLULAR IRON ACQUISITION BY MYCOBACTERIA TUBERCULOSIS
87, 3hwdC, 0.5825, 3.11, 0.048, 173, 63, CRYSTAL STRUCTURE OF SIDEROCALIN (NGAL LIPOCALIN 2) K125A-K134A MUTANT COMPLEXED WITH FERRIC ENTEROBACTIN
88, 4cq6B, 0.5824, 3.08, 0.062, 174, 64, THE CRYSTAL STRUCTURE OF THE ALLENE OXIDE CYCLASE 2 FROM ARABIDOPSIS THALIANA WITH BOUND INHIBITOR - VERNOLIC ACID
89, 4cq6A, 0.5824, 3.05, 0.062, 174, 64, THE CRYSTAL STRUCTURE OF THE ALLENE OXIDE CYCLASE 2 FROM ARABIDOPSIS THALIANA WITH BOUND INHIBITOR - VERNOLIC ACID
90, 2brjA, 0.5823, 3.05, 0.062, 173, 64, X-RAY STRUCTURE OF THE ALLENE OXIDE CYCLASE FROM ARABIDOPSIS THALIANA
91, 4h6bJ, 0.5821, 2.91, 0.079, 180, 63, STRUCTURAL BASIS FOR ALLENE OXIDE CYCLIZATION IN MOSS
92, 4h6aE, 0.5821, 3.07, 0.078, 193, 64, CRYSTAL STRUCTURE OF THE ALLENE OXIDE CYCLASE 2 FROM PHYSCOMITRELLA PATENS
93, 2acoB, 0.5821, 3.05, 0.095, 166, 63, XRAY STRUCTURE OF BLC DIMER IN COMPLEX WITH VACCENIC ACID
94, 4zhgD, 0.5820, 3.13, 0.048, 177, 63, SIDEROCALIN-MEDIATED RECOGNITION AND CELLULAR UPTAKE OF ACTINIDES
95, 4h6aF, 0.5820, 2.91, 0.079, 180, 63, CRYSTAL STRUCTURE OF THE ALLENE OXIDE CYCLASE 2 FROM PHYSCOMITRELLA PATENS
96, 1x8uC, 0.5819, 3.11, 0.048, 173, 63, CRYSTAL STRUCTURE OF SIDEROCALIN (NGAL LIPOCALIN 2) COMPLEXED WITH CARBOXYMYCOBACTIN T
97, 3cmpC, 0.5818, 3.28, 0.047, 174, 64, CRYSTAL STRUCTURE OF SIDEROCALIN (NGAL LIPOCALIN 2) K125A MUTANT COMPLEXED WITH FERRIC ENTEROBACTIN
98, 4h6cF, 0.5817, 2.94, 0.095, 175, 63, CRYSTAL STRUCTURE OF THE ALLENE OXIDE CYCLASE 1 FROM PHYSCOMITRELLA PATENS
99, 4h6cC, 0.5817, 3.02, 0.078, 175, 64, CRYSTAL STRUCTURE OF THE ALLENE OXIDE CYCLASE 1 FROM PHYSCOMITRELLA PATENS
100, 4h69D, 0.5817, 3.07, 0.078, 180, 64, CRYSTAL STRUCTURE OF THE ALLENE OXIDE CYCLASE 2 FROM PHYSCOMITRELLA PATENS COMPLEXED WITH SUBSTRATE ANALOG
101, 2q4iB, 0.5817, 3.07, 0.062, 173, 64, ENSEMBLE REFINEMENT OF THE PROTEIN CRYSTAL STRUCTURE OF ALLENE OXIDE CYCLASE FROM ARABIDOPSIS THALIANA AT3G25770
102, 4h6aD, 0.5816, 3.07, 0.078, 179, 64, CRYSTAL STRUCTURE OF THE ALLENE OXIDE CYCLASE 2 FROM PHYSCOMITRELLA PATENS
103, 4zhgB, 0.5815, 3.12, 0.048, 175, 63, SIDEROCALIN-MEDIATED RECOGNITION AND CELLULAR UPTAKE OF ACTINIDES
104, 4mvlC, 0.5815, 2.98, 0.048, 174, 63, CRYSTAL STRUCTURE OF AN ENGINEERED LIPOCALIN (ANTICALIN H1GA) IN COMPLEX WITH THE ALZHEIMER AMYLOID PEPTIDE ABETA1-40
105, 4h6cL, 0.5815, 3.07, 0.078, 175, 64, CRYSTAL STRUCTURE OF THE ALLENE OXIDE CYCLASE 1 FROM PHYSCOMITRELLA PATENS
106, 4h6aA, 0.5815, 3.08, 0.078, 194, 64, CRYSTAL STRUCTURE OF THE ALLENE OXIDE CYCLASE 2 FROM PHYSCOMITRELLA PATENS
107, 2dioA, 0.5815, 3.05, 0.062, 173, 64, CRYSTAL STRUCTURE OF THE ALLENE OXIDE CYCLASE 2 WITH BOUND INHIBITOR VERNOLIC ACID
108, 1x89B, 0.5814, 2.92, 0.063, 171, 63, CRYSTAL STRUCTURE OF SIDEROCALIN (NGAL LIPOCALIN 2) COMPLEXED WITH CARBOXYMYCOBACTIN S
109, 4h6bA, 0.5812, 2.91, 0.079, 180, 63, STRUCTURAL BASIS FOR ALLENE OXIDE CYCLIZATION IN MOSS
110, 3tf6B, 0.5812, 3.16, 0.047, 171, 64, CRYSTAL STRUCTURE OF NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (C87S MUTANT) IN COMPLEX WITH EUROPIUM AND THE SIDEROPHORE ANALOG TREN(CAM)(12-HOPO)2
111, 4h6bC, 0.5811, 3.02, 0.078, 180, 64, STRUCTURAL BASIS FOR ALLENE OXIDE CYCLIZATION IN MOSS
112, 2q4iA, 0.5810, 3.07, 0.062, 173, 64, ENSEMBLE REFINEMENT OF THE PROTEIN CRYSTAL STRUCTURE OF ALLENE OXIDE CYCLASE FROM ARABIDOPSIS THALIANA AT3G25770
113, 4iawB, 0.5809, 3.01, 0.032, 176, 62, ENGINEERED HUMAN LIPOCALIN 2 (C26) IN COMPLEX WITH Y-DTPA
114, 4h6cJ, 0.5809, 3.07, 0.078, 175, 64, CRYSTAL STRUCTURE OF THE ALLENE OXIDE CYCLASE 1 FROM PHYSCOMITRELLA PATENS
115, 4h6cI, 0.5809, 2.90, 0.079, 180, 63, CRYSTAL STRUCTURE OF THE ALLENE OXIDE CYCLASE 1 FROM PHYSCOMITRELLA PATENS
116, 4h6bI, 0.5808, 2.91, 0.079, 180, 63, STRUCTURAL BASIS FOR ALLENE OXIDE CYCLIZATION IN MOSS
117, 3bx8H, 0.5808, 2.91, 0.066, 161, 61, ENGINEERED HUMAN LIPOCALIN 2 (LCN2) APO-FORM
118, 3hwfC, 0.5806, 3.24, 0.047, 173, 64, CRYSTAL STRUCTURE OF SIDEROCALIN (NGAL LIPOCALIN 2) COMPLEXED WITH FE-TRENCAM2-HOPO
119, 5dyvE, 0.5804, 2.89, 0.097, 130, 62, ABYU - WILDTYPE
120, 1qwdA, 0.5803, 2.65, 0.033, 167, 61, CRYSTAL STRUCTURE OF A BACTERIAL LIPOCALIN THE BLC GENE PRODUCT FROM E. COLI
121, 2ginB, 0.5801, 3.10, 0.062, 173, 64, X-RAY STRUCTURE OF THE WT ALLENE OXIDE CYCLASE 2 FROM ARABIDOPSIS THALIANA
122, 6gr0B, 0.5800, 3.15, 0.062, 167, 64, PETROBACTIN-BINDING ENGINEERED LIPOCALIN IN COMPLEX WITH GALLIUM- PETROBACTIN 
123, 4h6bK, 0.5800, 2.91, 0.079, 180, 63, STRUCTURAL BASIS FOR ALLENE OXIDE CYCLIZATION IN MOSS
124, 3by0C, 0.5800, 3.19, 0.063, 174, 63, CRYSTAL STRUCTURE OF SIDEROCALIN (NGAL LIPOCALIN 2) W79A-R81A COMPLEXED WITH FERRIC ENTEROBACTIN
125, 4ck4A, 0.5798, 2.84, 0.082, 160, 61, OVINE BETA-LACTOGLOBULIN AT ATOMIC RESOLUTION
126, 4h6cE, 0.5796, 2.91, 0.079, 180, 63, CRYSTAL STRUCTURE OF THE ALLENE OXIDE CYCLASE 1 FROM PHYSCOMITRELLA PATENS
127, 4h6cH, 0.5795, 3.07, 0.078, 175, 64, CRYSTAL STRUCTURE OF THE ALLENE OXIDE CYCLASE 1 FROM PHYSCOMITRELLA PATENS
128, 4h69A, 0.5795, 3.09, 0.078, 190, 64, CRYSTAL STRUCTURE OF THE ALLENE OXIDE CYCLASE 2 FROM PHYSCOMITRELLA PATENS COMPLEXED WITH SUBSTRATE ANALOG
129, 3cmpB, 0.5795, 3.17, 0.047, 168, 64, CRYSTAL STRUCTURE OF SIDEROCALIN (NGAL LIPOCALIN 2) K125A MUTANT COMPLEXED WITH FERRIC ENTEROBACTIN
130, 1x71C, 0.5795, 3.11, 0.048, 174, 63, CRYSTAL STRUCTURE OF SIDEROCALIN (NGAL LIPOCALIN 2) COMPLEXED WITH TRENCAM-32-HOPO A CEPABACTIN ANALOGUE
131, 2ginD, 0.5794, 3.09, 0.062, 173, 64, X-RAY STRUCTURE OF THE WT ALLENE OXIDE CYCLASE 2 FROM ARABIDOPSIS THALIANA
132, 5dyvG, 0.5793, 2.92, 0.097, 130, 62, ABYU - WILDTYPE
133, 4h6bD, 0.5793, 2.92, 0.079, 180, 63, STRUCTURAL BASIS FOR ALLENE OXIDE CYCLIZATION IN MOSS
134, 3u9pD, 0.5792, 3.13, 0.032, 166, 63, CRYSTAL STRUCTURE OF MURINE SIDEROCALIN IN COMPLEX WITH AN FAB FRAGMENT
135, 5dyvH, 0.5791, 2.89, 0.097, 129, 62, ABYU - WILDTYPE
136, 4h6bE, 0.5791, 2.91, 0.079, 180, 63, STRUCTURAL BASIS FOR ALLENE OXIDE CYCLIZATION IN MOSS
137, 4h69B, 0.5791, 2.96, 0.095, 180, 63, CRYSTAL STRUCTURE OF THE ALLENE OXIDE CYCLASE 2 FROM PHYSCOMITRELLA PATENS COMPLEXED WITH SUBSTRATE ANALOG
138, 4gh7A, 0.5791, 3.33, 0.047, 174, 64, CRYSTAL STRUCTURE OF ANTICALIN N7A IN COMPLEX WITH ONCOFETAL FIBRONECTIN FRAGMENT FN7B8
139, 4cq7A, 0.5791, 3.08, 0.062, 173, 64, THE CRYSTAL STRUCTURE OF THE ALLENE OXIDE CYCLASE 2 FROM ARABIDOPSIS THALIANA WITH BOUND PRODUCT - OPDA
140, 4zhcB, 0.5790, 3.18, 0.047, 168, 64, SIDEROCALIN-MEDIATED RECOGNITION AND CELLULAR UPTAKE OF ACTINIDES
141, 3saoA, 0.5790, 2.66, 0.083, 150, 60, THE SIDEROCALIN EX-FABP FUNCTIONS THROUGH DUAL LIGAND SPECIFICITIES
142, 4zhfF, 0.5786, 3.21, 0.047, 175, 64, SIDEROCALIN-MEDIATED RECOGNITION AND CELLULAR UPTAKE OF ACTINIDES
143, 4h6cD, 0.5786, 2.92, 0.079, 180, 63, CRYSTAL STRUCTURE OF THE ALLENE OXIDE CYCLASE 1 FROM PHYSCOMITRELLA PATENS
144, 4h6cA, 0.5785, 3.09, 0.078, 180, 64, CRYSTAL STRUCTURE OF THE ALLENE OXIDE CYCLASE 1 FROM PHYSCOMITRELLA PATENS
145, 5n48C, 0.5784, 3.12, 0.048, 174, 62, STRUCTURE OF ANTICALIN N9B IN COMPLEX WITH EXTRA-DOMAIN B OF HUMAN ONCOFETAL FIBRONECTIN
146, 4h6aB, 0.5783, 3.09, 0.078, 180, 64, CRYSTAL STRUCTURE OF THE ALLENE OXIDE CYCLASE 2 FROM PHYSCOMITRELLA PATENS
147, 4cq7B, 0.5782, 3.06, 0.062, 173, 64, THE CRYSTAL STRUCTURE OF THE ALLENE OXIDE CYCLASE 2 FROM ARABIDOPSIS THALIANA WITH BOUND PRODUCT - OPDA
148, 3dtqB, 0.5782, 3.19, 0.047, 168, 64, ENGINEERED HUMAN LIPOCALIN 2 WITH SPECIFICITY FOR Y-DTPA APO-FORM
149, 4revA, 0.5780, 2.78, 0.049, 128, 61, STRUCTURE OF THE DIRIGENT PROTEIN DRR206
150, 5dyvF, 0.5774, 2.93, 0.097, 130, 62, ABYU - WILDTYPE
151, 3cmpA, 0.5773, 3.15, 0.048, 174, 63, CRYSTAL STRUCTURE OF SIDEROCALIN (NGAL LIPOCALIN 2) K125A MUTANT COMPLEXED WITH FERRIC ENTEROBACTIN
152, 2mhlA, 0.5772, 2.81, 0.031, 192, 64, NMR SOLUTION STRUCTURE OF THE E.COLI OUTER MEMBRANE PROTEIN W
153, 2ginA, 0.5772, 2.92, 0.063, 173, 63, X-RAY STRUCTURE OF THE WT ALLENE OXIDE CYCLASE 2 FROM ARABIDOPSIS THALIANA
154, 4revB, 0.5771, 2.80, 0.049, 127, 61, STRUCTURE OF THE DIRIGENT PROTEIN DRR206
155, 4gh7C, 0.5771, 3.34, 0.047, 174, 64, CRYSTAL STRUCTURE OF ANTICALIN N7A IN COMPLEX WITH ONCOFETAL FIBRONECTIN FRAGMENT FN7B8
156, 3hweC, 0.5769, 3.21, 0.048, 174, 63, CRYSTAL STRUCTURE OF SIDEROCALIN (NGAL LIPOCALIN 2) COMPLEXED WITH FE-BISHACAM
157, 3pecB, 0.5768, 2.92, 0.063, 165, 63, SIDEROCALIN RECOGNITIN OF CARBOXYMYCOBACTINS: INTERFERENCE BY THE IMMUNE SYSTEM IN INTRACELLULAR IRON ACQUISITION BY MYCOBACTERIA TUBERCULOSIS
158, 2ginF, 0.5768, 3.12, 0.062, 173, 64, X-RAY STRUCTURE OF THE WT ALLENE OXIDE CYCLASE 2 FROM ARABIDOPSIS THALIANA
159, 5n48A, 0.5767, 3.18, 0.047, 175, 64, STRUCTURE OF ANTICALIN N9B IN COMPLEX WITH EXTRA-DOMAIN B OF HUMAN ONCOFETAL FIBRONECTIN
160, 3fw4C, 0.5767, 3.12, 0.048, 173, 63, CRYSTAL STRUCTURE OF SIDEROCALIN (NGAL LIPOCALIN 2) COMPLEXED WITH FERRIC CATECHOL
161, 2ginE, 0.5767, 3.10, 0.062, 173, 64, X-RAY STRUCTURE OF THE WT ALLENE OXIDE CYCLASE 2 FROM ARABIDOPSIS THALIANA
162, 3u0dC, 0.5764, 3.34, 0.047, 174, 64, THE STRUCTURE OF HUMAN SIDEROCALIN BOUND TO THE BACTERIAL SIDEROPHORE 23-DHBA
163, 3k3lC, 0.5762, 3.37, 0.062, 175, 64, CRYSTAL STRUCTURE OF SIDEROCALIN (NGAL LIPOCALIN 2) COMPLEXED WITH APO ENTEROBACTIN
164, 4zhhC, 0.5761, 3.18, 0.047, 175, 64, SIDEROCALIN-MEDIATED RECOGNITION AND CELLULAR UPTAKE OF ACTINIDES
165, 2ginC, 0.5757, 3.11, 0.062, 173, 64, X-RAY STRUCTURE OF THE WT ALLENE OXIDE CYCLASE 2 FROM ARABIDOPSIS THALIANA
166, 5kicA, 0.5756, 3.28, 0.047, 173, 64, LONG-SOUGHT STABILIZATION OF BERKELIUM(IV) IN SOLUTION: AN ANOMALY WITHIN THE HEAVY ACTINIDE SERIES
167, 3u0dA, 0.5754, 3.34, 0.047, 175, 64, THE STRUCTURE OF HUMAN SIDEROCALIN BOUND TO THE BACTERIAL SIDEROPHORE 23-DHBA
168, 4mvlA, 0.5753, 3.04, 0.048, 173, 63, CRYSTAL STRUCTURE OF AN ENGINEERED LIPOCALIN (ANTICALIN H1GA) IN COMPLEX WITH THE ALZHEIMER AMYLOID PEPTIDE ABETA1-40
169, 3t1dC, 0.5752, 3.20, 0.062, 172, 64, THE MUTANT STRUCTURE OF HUMAN SIDEROCALIN W79A R81A Y106F BOUND TO ENTEROBACTIN
170, 1qwdB, 0.5751, 3.15, 0.063, 166, 63, CRYSTAL STRUCTURE OF A BACTERIAL LIPOCALIN THE BLC GENE PRODUCT FROM E. COLI
171, 4zhhF, 0.5750, 3.21, 0.047, 175, 64, SIDEROCALIN-MEDIATED RECOGNITION AND CELLULAR UPTAKE OF ACTINIDES
172, 2l5pA, 0.5745, 3.12, 0.063, 175, 63, SOLUTION NMR STRUCTURE OF PROTEIN LIPOCALIN 12 FROM RAT EPIDIDYMIS
173, 4zhgF, 0.5743, 3.22, 0.047, 175, 64, SIDEROCALIN-MEDIATED RECOGNITION AND CELLULAR UPTAKE OF ACTINIDES
174, 4zhgA, 0.5741, 3.17, 0.048, 177, 63, SIDEROCALIN-MEDIATED RECOGNITION AND CELLULAR UPTAKE OF ACTINIDES
175, 4iawA, 0.5740, 3.12, 0.032, 180, 63, ENGINEERED HUMAN LIPOCALIN 2 (C26) IN COMPLEX WITH Y-DTPA
176, 4zhhE, 0.5737, 3.21, 0.047, 176, 64, SIDEROCALIN-MEDIATED RECOGNITION AND CELLULAR UPTAKE OF ACTINIDES
177, 5x7yB, 0.5730, 2.90, 0.033, 161, 61, CRYSTAL STRUCTURE OF THE DOG LIPOCALIN ALLERGEN CAN F 6
178, 4zhhB, 0.5730, 3.28, 0.047, 175, 64, SIDEROCALIN-MEDIATED RECOGNITION AND CELLULAR UPTAKE OF ACTINIDES
179, 5y5cA, 0.5729, 2.86, 0.082, 159, 61, CRYSTAL STRUCTURE OF DHA BIND TO BOVINE BETA-LACTOGLOBULIN 
180, 4qaeA, 0.5727, 3.32, 0.048, 172, 63, CRYSTAL STRUCTURE OF AN ENGINEERED LIPOCALIN (ANTICALIN) IN COMPLEX WITH HUMAN HEPCIDIN
181, 5khpA, 0.5726, 2.96, 0.063, 173, 63, TIGHTENING THE RECOGNITION OF TETRAVALENT ZR AND TH COMPLEXES BY THE SIDEROPHORE-BINDING MAMMALIAN PROTEIN SIDEROCALIN FOR THERANOSTIC APPLICATIONS
182, 5jr8B, 0.5726, 3.14, 0.048, 173, 63, DISPOSAL OF IRON BY A MUTANT FORM OF SIDEROCALIN NGAL
183, 1bebA, 0.5725, 2.88, 0.082, 156, 61, BOVINE BETA-LACTOGLOBULIN LATTICE X
184, 3tf6A, 0.5723, 3.42, 0.077, 176, 65, CRYSTAL STRUCTURE OF NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (C87S MUTANT) IN COMPLEX WITH EUROPIUM AND THE SIDEROPHORE ANALOG TREN(CAM)(12-HOPO)2
185, 1nglA, 0.5722, 3.05, 0.032, 179, 62, HUMAN NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (HNGAL) REGULARISED AVERAGE NMR STRUCTURE
186, 5x7yD, 0.5717, 2.86, 0.033, 157, 61, CRYSTAL STRUCTURE OF THE DOG LIPOCALIN ALLERGEN CAN F 6
187, 4qaeC, 0.5715, 3.02, 0.050, 163, 60, CRYSTAL STRUCTURE OF AN ENGINEERED LIPOCALIN (ANTICALIN) IN COMPLEX WITH HUMAN HEPCIDIN
188, 3l4rA, 0.5714, 2.87, 0.100, 151, 60, CRYSTAL STRUCTURE OF THE DOG LIPOCALIN ALLERGEN CAN F 2 AND IMPLICATIONS FOR CROSS-REACTIVITY TO THE CAT ALLERGEN FEL D 4
189, 4k19C, 0.5711, 3.51, 0.061, 176, 66, THE STRUCTURE OF HUMAN SIDEROCALIN BOUND TO THE BACTERIAL SIDEROPHORE FLUVIBACTIN
190, 6nkqA, 0.5708, 2.87, 0.082, 158, 61, THE STRUCTURE OF BOVINE BETA-LACTOGLOBULIN IN NOVEL CRYSTALS GROWN AT PH 3.8 
191, 3hweB, 0.5708, 3.48, 0.077, 170, 65, CRYSTAL STRUCTURE OF SIDEROCALIN (NGAL LIPOCALIN 2) COMPLEXED WITH FE-BISHACAM
192, 5eedB, 0.5707, 3.04, 0.063, 152, 63, OVINE LACTOGLOBULIN COMPLEX WITH DECANOL
193, 5mhhA, 0.5705, 3.57, 0.046, 181, 65, CRYSTAL STRUCTURE OF ENGINEERED HUMAN LIPOCALIN 2 CARRYING P- BORONOPHENYLALANINE AT POSITION 36
194, 3k3lA, 0.5700, 3.45, 0.077, 175, 65, CRYSTAL STRUCTURE OF SIDEROCALIN (NGAL LIPOCALIN 2) COMPLEXED WITH APO ENTEROBACTIN
195, 3i0aC, 0.5700, 3.39, 0.062, 176, 64, CRYSTAL STRUCTURE OF SIDEROCALIN (NGAL LIPOCALIN 2) K134A MUTANT COMPLEXED WITH FERRIC ENTEROBACTIN
196, 4zhfE, 0.5697, 3.34, 0.062, 176, 64, SIDEROCALIN-MEDIATED RECOGNITION AND CELLULAR UPTAKE OF ACTINIDES
197, 3t1dB, 0.5696, 3.46, 0.092, 174, 65, THE MUTANT STRUCTURE OF HUMAN SIDEROCALIN W79A R81A Y106F BOUND TO ENTEROBACTIN
198, 3hwdB, 0.5696, 2.72, 0.068, 163, 59, CRYSTAL STRUCTURE OF SIDEROCALIN (NGAL LIPOCALIN 2) K125A-K134A MUTANT COMPLEXED WITH FERRIC ENTEROBACTIN
199, 6fxbA, 0.5695, 3.18, 0.063, 162, 63, BOVINE BETA-LACTOGLOBULIN VARIANT A AT PH 4.0 
200, 1l6mA, 0.5694, 3.43, 0.077, 174, 65, NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN IS A NOVEL BACTERIOSTATIC AGENT THAT INTERFERES WITH SIDEROPHORE- MEDIATED IRON ACQUISITION
201, 4k19A, 0.5693, 3.48, 0.061, 174, 66, THE STRUCTURE OF HUMAN SIDEROCALIN BOUND TO THE BACTERIAL SIDEROPHORE FLUVIBACTIN
202, 3u0dD, 0.5693, 3.59, 0.046, 174, 65, THE STRUCTURE OF HUMAN SIDEROCALIN BOUND TO THE BACTERIAL SIDEROPHORE 23-DHBA
203, 3cqnA, 0.5693, 2.76, 0.066, 162, 61, CRYSTAL STRUCTURE OF THE LIPOCALIN DOMAIN OF VIOLAXANTHIN DE-EPOXIDASE (VDE) AT PH7
204, 3cbcB, 0.5693, 3.61, 0.077, 173, 65, CRYSTAL STRUCTURE OF SIDEROCALIN (NGAL LIPOCALIN 2) Y106F COMPLEXED WITH FERRIC ENTEROBACTIN
205, 3hwfA, 0.5689, 3.45, 0.077, 173, 65, CRYSTAL STRUCTURE OF SIDEROCALIN (NGAL LIPOCALIN 2) COMPLEXED WITH FE-TRENCAM2-HOPO
206, 4zhdB, 0.5687, 3.43, 0.046, 172, 65, SIDEROCALIN-MEDIATED RECOGNITION AND CELLULAR UPTAKE OF ACTINIDES
207, 3tzsB, 0.5687, 3.44, 0.062, 173, 64, CRYSTAL STRUCTURE OF NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN NGAL (C87S MUTANT) IN COMPLEX WITH FRAGMENT 1026 PHENYLUREA
208, 4qaeF, 0.5686, 3.01, 0.050, 164, 60, CRYSTAL STRUCTURE OF AN ENGINEERED LIPOCALIN (ANTICALIN) IN COMPLEX WITH HUMAN HEPCIDIN
209, 4mvkA, 0.5686, 3.42, 0.063, 171, 63, CRYSTAL STRUCTURE OF AN ENGINEERED LIPOCALIN (ANTICALIN US7) IN COMPLEX WITH THE ALZHEIMER AMYLOID PEPTIDE FRAGMENT VFFAED
210, 1pbyA, 0.5683, 2.89, 0.113, 489, 62, STRUCTURE OF THE PHENYLHYDRAZINE ADDUCT OF THE QUINOHEMOPROTEIN AMINE DEHYDROGENASE FROM PARACOCCUS DENITRIFICANS AT 1.7 A RESOLUTION
211, 5kidA, 0.5682, 3.52, 0.061, 173, 66, TIGHTENING THE RECOGNITION OF TETRAVALENT ZR AND TH COMPLEXES BY THE SIDEROPHORE-BINDING MAMMALIAN PROTEIN SIDEROCALIN FOR THERANOSTIC APPLICATIONS
212, 5kicB, 0.5682, 3.40, 0.062, 175, 64, LONG-SOUGHT STABILIZATION OF BERKELIUM(IV) IN SOLUTION: AN ANOMALY WITHIN THE HEAVY ACTINIDE SERIES
213, 1jzuA, 0.5679, 2.94, 0.100, 157, 60, CELL TRANSFORMATION BY THE MYC ONCOGENE ACTIVATES EXPRESSION OF A LIPOCALIN: ANALYSIS OF THE GENE (Q83) AND SOLUTION STRUCTURE OF ITS PROTEIN PRODUCT
214, 1x8uA, 0.5678, 3.47, 0.077, 175, 65, CRYSTAL STRUCTURE OF SIDEROCALIN (NGAL LIPOCALIN 2) COMPLEXED WITH CARBOXYMYCOBACTIN T
215, 3cqnB, 0.5677, 2.81, 0.066, 161, 61, CRYSTAL STRUCTURE OF THE LIPOCALIN DOMAIN OF VIOLAXANTHIN DE-EPOXIDASE (VDE) AT PH7
216, 3ph5A, 0.5676, 2.91, 0.082, 159, 61, BOVINE BETA LACTOGLOBULIN CRYSTALLIZED THROUGH LIGANDATION OF YTTRIUM CATIONS
217, 1x71A, 0.5672, 3.51, 0.061, 175, 66, CRYSTAL STRUCTURE OF SIDEROCALIN (NGAL LIPOCALIN 2) COMPLEXED WITH TRENCAM-32-HOPO A CEPABACTIN ANALOGUE
218, 5jr8A, 0.5670, 3.44, 0.077, 172, 65, DISPOSAL OF IRON BY A MUTANT FORM OF SIDEROCALIN NGAL
219, 4zhcA, 0.5668, 3.40, 0.077, 175, 65, SIDEROCALIN-MEDIATED RECOGNITION AND CELLULAR UPTAKE OF ACTINIDES
220, 3u03A, 0.5668, 3.54, 0.061, 174, 66, THE STRUCTURE OF HUMAN SIDEROCALIN BOUND TO THE BACTERIAL SIDEROPHORE PYOCHELIN
221, 3cbcA, 0.5668, 3.43, 0.077, 176, 65, CRYSTAL STRUCTURE OF SIDEROCALIN (NGAL LIPOCALIN 2) Y106F COMPLEXED WITH FERRIC ENTEROBACTIN
222, 3bx8D, 0.5666, 3.22, 0.046, 168, 65, ENGINEERED HUMAN LIPOCALIN 2 (LCN2) APO-FORM
223, 4zhhD, 0.5665, 3.55, 0.061, 176, 66, SIDEROCALIN-MEDIATED RECOGNITION AND CELLULAR UPTAKE OF ACTINIDES
224, 1dfvA, 0.5665, 3.46, 0.077, 173, 65, CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN MONOMER
225, 4zhdC, 0.5663, 3.50, 0.046, 175, 65, SIDEROCALIN-MEDIATED RECOGNITION AND CELLULAR UPTAKE OF ACTINIDES
226, 6rwrA, 0.5661, 2.89, 0.082, 154, 61, ENGINEERED BETA-LACTOGLOBULIN: VARIANT M107L IN COMPLEX WITH MYRISTIC ACID 
227, 3bx7A, 0.5658, 2.96, 0.063, 173, 63, ENGINEERED HUMAN LIPOCALIN 2 (LCN2) IN COMPLEX WITH THE EXTRACELLULAR DOMAIN OF HUMAN CTLA-4
228, 5x7yA, 0.5655, 2.86, 0.033, 159, 61, CRYSTAL STRUCTURE OF THE DOG LIPOCALIN ALLERGEN CAN F 6
229, 4zhgE, 0.5655, 3.33, 0.047, 176, 64, SIDEROCALIN-MEDIATED RECOGNITION AND CELLULAR UPTAKE OF ACTINIDES
230, 4mvlB, 0.5655, 3.25, 0.047, 172, 64, CRYSTAL STRUCTURE OF AN ENGINEERED LIPOCALIN (ANTICALIN H1GA) IN COMPLEX WITH THE ALZHEIMER AMYLOID PEPTIDE ABETA1-40
231, 5kicC, 0.5654, 3.61, 0.061, 175, 66, LONG-SOUGHT STABILIZATION OF BERKELIUM(IV) IN SOLUTION: AN ANOMALY WITHIN THE HEAVY ACTINIDE SERIES
232, 1jjuA, 0.5653, 2.91, 0.113, 489, 62, STRUCTURE OF A QUINOHEMOPROTEIN AMINE DEHYDROGENASE WITH A UNIQUE REDOX COFACTOR AND HIGHLY UNUSUAL CROSSLINKING
233, 3bx8B, 0.5652, 3.14, 0.048, 166, 62, ENGINEERED HUMAN LIPOCALIN 2 (LCN2) APO-FORM
234, 5n47E, 0.5650, 3.23, 0.048, 172, 62, STRUCTURE OF ANTICALIN N7E IN COMPLEX WITH THE THREE-DOMAIN FRAGMENT FN7B8 OF HUMAN ONCOFETAL FIBRONECTIN
235, 5fq3D, 0.5650, 3.22, 0.045, 199, 66, CRYSTAL STRUCTURE OF THE LIPOPROTEIN BT2262 FROM BACTEROIDES THETAIOTAOMICRON
236, 3pedA, 0.5650, 3.48, 0.077, 177, 65, SIDEROCALIN RECOGNITIN OF CARBOXYMYCOBACTINS: INTERFERENCE BY THE IMMUNE SYSTEM IN INTRACELLULAR IRON ACQUISITION BY MYCOBACTERIA TUBERCULOSIS
237, 3fw5A, 0.5649, 3.52, 0.077, 175, 65, CRYSTAL STRUCTURE OF SIDEROCALIN (NGAL LIPOCALIN 2) COMPLEXED WITH FERRIC 4-METHYL-CATECHOL
238, 4nljB, 0.5647, 2.86, 0.082, 158, 61, CRYSTAL STRUCTURE OF SHEEP BETA-LACTOGLOBULIN (SPACE GROUP P1)
239, 1l6mC, 0.5645, 3.52, 0.061, 172, 66, NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN IS A NOVEL BACTERIOSTATIC AGENT THAT INTERFERES WITH SIDEROPHORE- MEDIATED IRON ACQUISITION
240, 6rytB, 0.5644, 3.10, 0.063, 145, 63, ENGINEERED BETA-LACTOGLOBULIN: VARIANT M107L 
241, 6e0yD, 0.5641, 3.11, 0.034, 161, 59, A131Q MUTANT OF CYT P460 OF NITROSOMONAS SP. AL212 WITH BOUND NH2OH 
242, 4zfxA, 0.5641, 3.42, 0.046, 174, 65, SIDEROCALIN-MEDIATED RECOGNITION AND CELLULAR UPTAKE OF ACTINIDES
243, 2ob4A, 0.5640, 3.40, 0.033, 157, 61, HUMAN UBIQUITIN-CONJUGATING ENZYME CDC34
244, 4omwB, 0.5639, 3.22, 0.092, 162, 65, CRYSTAL STRUCTURE OF GOAT BETA-LACTOGLOBULIN (ORTHORHOMBIC FORM)
245, 4zhfC, 0.5638, 3.55, 0.061, 175, 66, SIDEROCALIN-MEDIATED RECOGNITION AND CELLULAR UPTAKE OF ACTINIDES
246, 4lzvA, 0.5637, 2.94, 0.082, 159, 61, BOVINE BETA-LACTOGLOBULIN CRYSTALLIZED IN THE PRESENCE OF 20 MM ZINC CHLORIDE
247, 4iawC, 0.5636, 3.36, 0.031, 172, 64, ENGINEERED HUMAN LIPOCALIN 2 (C26) IN COMPLEX WITH Y-DTPA
248, 5hteA, 0.5634, 2.90, 0.082, 149, 61, RECOMBINANT BOVINE BETA-LACTOGLOBULIN VARIANT L1A/I2S (SBLGB 2)
249, 4nyrA, 0.5632, 2.60, 0.068, 153, 59, IN-VIVO CRYSTALLISATION (MIDGUTS OF A VIVIPAROUS COCKROACH) AND STRUCTURE AT 2.5 A RESOLUTION OF A GLYCOSYLATED LIPID-BINDING LIPOCALIN-LIKE PROTEIN
250, 3mbtA, 0.5632, 3.06, 0.079, 149, 63, STRUCTURE OF MONOMERIC BLC FROM E. COLI
251, 3hwgB, 0.5629, 3.15, 0.032, 167, 62, CRYSTAL STRUCTURE OF SIDEROCALIN (NGAL LIPOCALIN 2) COMPLEXED WITH FE-TRENCAM-HOPO2
252, 4zhgC, 0.5627, 3.56, 0.061, 175, 66, SIDEROCALIN-MEDIATED RECOGNITION AND CELLULAR UPTAKE OF ACTINIDES
253, 3tzsA, 0.5624, 3.50, 0.061, 174, 66, CRYSTAL STRUCTURE OF NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN NGAL (C87S MUTANT) IN COMPLEX WITH FRAGMENT 1026 PHENYLUREA
254, 2akqC, 0.5621, 2.91, 0.082, 156, 61, THE STRUCTURE OF BOVINE B-LACTOGLOBULIN A IN CRYSTALS GROWN AT VERY LOW IONIC STRENGTH
255, 5fq8G, 0.5619, 3.21, 0.045, 212, 66, CRYSTAL STRUCTURE OF THE SUSCD COMPLEX BT2261-2264 FROM BACTEROIDES THETAIOTAOMICRON
256, 5fq3C, 0.5619, 3.18, 0.045, 199, 66, CRYSTAL STRUCTURE OF THE LIPOPROTEIN BT2262 FROM BACTEROIDES THETAIOTAOMICRON
257, 1bsqA, 0.5618, 3.19, 0.063, 162, 63, STRUCTURAL AND FUNCTIONAL CONSEQUENCES OF POINT MUTATIONS OF VARIANTS A AND B OF BOVINE BETA-LACTOGLOBULIN
258, 4es7A, 0.5612, 3.22, 0.065, 166, 62, CRYSTAL STRUCTURE OF PROTEIN HC FROM HOMO SAPIENS AT 2 ANGSTROM
259, 2q39A, 0.5611, 3.17, 0.063, 160, 63, BETA-LACTOGLOBULIN (LOW HUMIDITY)
260, 2jmmA, 0.5611, 3.07, 0.062, 156, 64, NMR SOLUTION STRUCTURE OF A MINIMAL TRANSMEMBRANE BETA- BARREL PLATFORM PROTEIN
261, 1yupD, 0.5607, 3.10, 0.065, 158, 62, REINDEER BETA-LACTOGLOBULIN
262, 4qaeD, 0.5600, 3.18, 0.048, 164, 63, CRYSTAL STRUCTURE OF AN ENGINEERED LIPOCALIN (ANTICALIN) IN COMPLEX WITH HUMAN HEPCIDIN
263, 5f1eB, 0.5599, 3.38, 0.092, 164, 65, APO PROTEIN OF SANDERCYANIN
264, 2akqA, 0.5599, 3.20, 0.063, 156, 63, THE STRUCTURE OF BOVINE B-LACTOGLOBULIN A IN CRYSTALS GROWN AT VERY LOW IONIC STRENGTH
265, 4oddB, 0.5597, 3.18, 0.063, 152, 63, CRYSTAL STRUCTURE OF A DOG LIPOCALIN ALLERGEN
266, 1cj5A, 0.5596, 2.75, 0.083, 162, 60, BOVINE BETA-LACTOGLOBULIN A
267, 4omwA, 0.5594, 3.23, 0.063, 162, 63, CRYSTAL STRUCTURE OF GOAT BETA-LACTOGLOBULIN (ORTHORHOMBIC FORM)
268, 4oddC, 0.5592, 3.18, 0.063, 149, 63, CRYSTAL STRUCTURE OF A DOG LIPOCALIN ALLERGEN
269, 5fq3B, 0.5591, 3.19, 0.045, 199, 66, CRYSTAL STRUCTURE OF THE LIPOPROTEIN BT2262 FROM BACTEROIDES THETAIOTAOMICRON
270, 4zfxC, 0.5591, 3.50, 0.061, 173, 66, SIDEROCALIN-MEDIATED RECOGNITION AND CELLULAR UPTAKE OF ACTINIDES
271, 4oddA, 0.5591, 3.17, 0.063, 149, 63, CRYSTAL STRUCTURE OF A DOG LIPOCALIN ALLERGEN
272, 3pquB, 0.5588, 3.16, 0.097, 540, 62, THE CRYSTAL STRUCTURES OF PORCINE PATHOGEN ASH57_TBPB
273, 3bx8A, 0.5586, 3.35, 0.048, 167, 62, ENGINEERED HUMAN LIPOCALIN 2 (LCN2) APO-FORM
274, 3kzaA, 0.5582, 3.16, 0.063, 149, 63, CRYSTAL STRUCTURE OF GYUBA A PATCHED CHIMERA OF B-LACTGLOBULIN
275, 3bx8C, 0.5581, 3.35, 0.065, 167, 62, ENGINEERED HUMAN LIPOCALIN 2 (LCN2) APO-FORM
276, 3blgA, 0.5580, 3.12, 0.063, 162, 63, STRUCTURAL BASIS OF THE TANFORD TRANSITION OF BOVINE BETA- LACTOGLOBULIN FROM CRYSTAL STRUCTURES AT THREE PH VALUES; PH 6.2
277, 5f6zD, 0.5579, 2.87, 0.113, 166, 62, SANDERCYANIN FLUORESCENT PROTEIN PURIFIED FROM SANDER VITREUS
278, 1qg5A, 0.5577, 3.24, 0.094, 152, 64, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE BOVINE BETA- LACTOGLOBULIN (ISOFORM A)
279, 3kzaB, 0.5575, 3.16, 0.063, 149, 63, CRYSTAL STRUCTURE OF GYUBA A PATCHED CHIMERA OF B-LACTGLOBULIN
280, 5k21A, 0.5571, 3.22, 0.113, 121, 62, PYOCYANIN DEMETHYLASE
281, 5n47A, 0.5570, 3.25, 0.048, 180, 62, STRUCTURE OF ANTICALIN N7E IN COMPLEX WITH THE THREE-DOMAIN FRAGMENT FN7B8 OF HUMAN ONCOFETAL FIBRONECTIN
282, 2lfuA, 0.5570, 3.42, 0.078, 160, 64, THE STRUCTURE OF A N. MENINGITIDES PROTEIN TARGETED FOR VACCINE DEVELOPMENT
283, 3qkgA, 0.5566, 3.25, 0.065, 164, 62, CRYSTAL STRUCTURE OF ALPHA-1-MICROGLOBULIN AT 2.3 A RESOLUTION
284, 2hzqA, 0.5558, 3.32, 0.048, 163, 63, CRYSTAL STRUCTURE OF HUMAN APOLIPOPROTEIN D (APOD) IN COMPLEX WITH PROGESTERONE
285, 4tljA, 0.5557, 3.13, 0.063, 162, 63, ULTRA-HIGH RESOLUTION CRYSTAL STRUCTURE OF CAPRINE BETA-LACTOGLOBULIN
286, 4omwD, 0.5557, 3.15, 0.063, 162, 63, CRYSTAL STRUCTURE OF GOAT BETA-LACTOGLOBULIN (ORTHORHOMBIC FORM)
287, 1yupF, 0.5556, 3.11, 0.063, 159, 63, REINDEER BETA-LACTOGLOBULIN
288, 1b8eA, 0.5556, 3.24, 0.094, 152, 64, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE BOVINE BETA- LACTOGLOBULIN (ISOFORMS A AND B) IN ORTHOROMBIC SPACE GROUP
289, 4omwC, 0.5555, 3.16, 0.063, 162, 63, CRYSTAL STRUCTURE OF GOAT BETA-LACTOGLOBULIN (ORTHORHOMBIC FORM)
290, 4o3yA, 0.5555, 3.20, 0.081, 501, 62, CRYSTAL STRUCTURE OF THE VACCINE ANTIGEN TRANSFERRIN BINDING PROTEIN B (TBPB) MUTANT ARG-179-GLU FROM ACTINOBACILLUS PLEUROPNEUMONIAE H87
291, 4nljA, 0.5554, 3.16, 0.063, 162, 63, CRYSTAL STRUCTURE OF SHEEP BETA-LACTOGLOBULIN (SPACE GROUP P1)
292, 5ez2A, 0.5553, 2.88, 0.113, 169, 62, SANDERCYANIN FLUORESCENT PROTEIN (SFP)
293, 3bx8E, 0.5552, 3.11, 0.050, 162, 60, ENGINEERED HUMAN LIPOCALIN 2 (LCN2) APO-FORM
294, 5k21B, 0.5551, 3.23, 0.113, 123, 62, PYOCYANIN DEMETHYLASE
295, 5ez2B, 0.5551, 2.89, 0.113, 169, 62, SANDERCYANIN FLUORESCENT PROTEIN (SFP)
296, 5eedA, 0.5551, 3.21, 0.092, 162, 65, OVINE LACTOGLOBULIN COMPLEX WITH DECANOL
297, 1yupB, 0.5551, 3.19, 0.063, 158, 63, REINDEER BETA-LACTOGLOBULIN
298, 2q39B, 0.5550, 3.25, 0.092, 151, 65, BETA-LACTOGLOBULIN (LOW HUMIDITY)
299, 2q2pA, 0.5550, 3.28, 0.094, 152, 64, BETA-LACTOGLOBULIN (REVERSE NATIVE)
300, 5io7A, 0.5548, 3.25, 0.094, 162, 64, BOVINE BETA-LACTOGLOBULIN COMPLEX WITH DODECANE AT HIGH PRESSURE (0.43 GPA)
301, 2q2mA, 0.5546, 3.25, 0.094, 152, 64, BETA-LACTOGLOBULIN (NATIVE)
302, 3ph6B, 0.5545, 3.24, 0.063, 156, 63, BOVINE BETA LACTOGLOBULIN CRYTSALLIZED THROUGH LIGANDATION OF YTTRIUM
303, 3ph6A, 0.5541, 3.17, 0.063, 161, 63, BOVINE BETA LACTOGLOBULIN CRYTSALLIZED THROUGH LIGANDATION OF YTTRIUM
304, 3ph5B, 0.5540, 3.24, 0.063, 156, 63, BOVINE BETA LACTOGLOBULIN CRYSTALLIZED THROUGH LIGANDATION OF YTTRIUM CATIONS
305, 6rwqA, 0.5539, 2.95, 0.098, 154, 61, ENGINEERED BETA-LACTOGLOBULIN: VARIANT F105L IN COMPLEX WITH MYRISTIC ACID 
306, 4o3zA, 0.5539, 3.20, 0.081, 500, 62, CRYSTAL STRUCTURE OF THE VACCINE ANTIGEN TRANSFERRIN BINDING PROTEIN B (TBPB) MUTANT TYR-95-ALA FROM ACTINOBACILLUS PLEUROPNEUMONIAE H87
307, 3bx8F, 0.5539, 3.05, 0.049, 158, 61, ENGINEERED HUMAN LIPOCALIN 2 (LCN2) APO-FORM
308, 2akqB, 0.5539, 3.05, 0.065, 156, 62, THE STRUCTURE OF BOVINE B-LACTOGLOBULIN A IN CRYSTALS GROWN AT VERY LOW IONIC STRENGTH
309, 4o49A, 0.5538, 3.21, 0.081, 500, 62, CRYSTAL STRUCTURE OF THE VACCINE ANTIGEN TRANSFERRIN BINDING PROTEIN B (TBPB) MUTANT TYR-174-ALA FROM ACTINOBACILLUS PLEUROPNEUMONIAE H87
310, 4bobA, 0.5538, 2.90, 0.089, 132, 56, STRUCTURE OF COMPLEMENT REGULATOR-ACQUIRING SURFACE PROTEIN 3 (CRASP-3 ERPP OR BBN38) FROM BORRELIA BURGDORFERI
311, 1bebB, 0.5537, 3.14, 0.065, 156, 62, BOVINE BETA-LACTOGLOBULIN LATTICE X
312, 5y5cB, 0.5536, 3.02, 0.048, 158, 62, CRYSTAL STRUCTURE OF DHA BIND TO BOVINE BETA-LACTOGLOBULIN 
313, 4tljB, 0.5536, 3.17, 0.079, 162, 63, ULTRA-HIGH RESOLUTION CRYSTAL STRUCTURE OF CAPRINE BETA-LACTOGLOBULIN
314, 4omxA, 0.5536, 3.17, 0.063, 162, 63, CRYSTAL STRUCTURE OF GOAT BETA-LACTOGLOBULIN (TRIGONAL FORM)
315, 4o3wA, 0.5533, 3.24, 0.079, 546, 63, CRYSTAL STRUCTURE OF THE VACCINE ANTIGEN TRANSFERRIN BINDING PROTEIN B (TBPB) MUTANT TYR-63-ALA FROM ACTINOBACILLUS SUIS H57
316, 6fxbB, 0.5532, 3.14, 0.063, 162, 63, BOVINE BETA-LACTOGLOBULIN VARIANT A AT PH 4.0 
317, 6fxbD, 0.5531, 3.14, 0.063, 162, 63, BOVINE BETA-LACTOGLOBULIN VARIANT A AT PH 4.0 
318, 2blgA, 0.5531, 3.26, 0.092, 162, 65, STRUCTURAL BASIS OF THE TANFORD TRANSITION OF BOVINE BETA- LACTOGLOBULIN FROM CRYSTAL STRUCTURES AT THREE PH VALUES; PH 8.2
319, 1yupA, 0.5529, 3.14, 0.063, 162, 63, REINDEER BETA-LACTOGLOBULIN
320, 5io6A, 0.5528, 3.08, 0.063, 162, 63, BOVINE BETA-LACTOGLOBULIN COMPLEX WITH DODECANE AMBIENT PRESSURE
321, 4ck4B, 0.5528, 3.16, 0.079, 161, 63, OVINE BETA-LACTOGLOBULIN AT ATOMIC RESOLUTION
322, 6e17C, 0.5527, 3.26, 0.051, 158, 59, A131E MUTANT OF CYT P460 OF NITROSOMONAS SP. AL212 WITH NO BOUND 
323, 5io5A, 0.5527, 3.18, 0.078, 162, 64, UNLIGANDED FORM OF BOVINE BETA-LACTOGLOBULIN AMBIENT PRESSURE
324, 5k21C, 0.5526, 3.10, 0.115, 122, 61, PYOCYANIN DEMETHYLASE
325, 4nliA, 0.5525, 3.18, 0.063, 162, 63, CRYSTAL STRUCTURE OF SHEEP BETA-LACTOGLOBULIN (SPACE GROUP P3121)
326, 3fw5B, 0.5524, 3.50, 0.078, 161, 64, CRYSTAL STRUCTURE OF SIDEROCALIN (NGAL LIPOCALIN 2) COMPLEXED WITH FERRIC 4-METHYL-CATECHOL
327, 1yupH, 0.5524, 3.12, 0.063, 152, 63, REINDEER BETA-LACTOGLOBULIN
328, 1uz2X, 0.5524, 3.25, 0.094, 158, 64, THE CYS121SER MUTANT OF BETA-LACTOGLOBULIN
329, 6fxbC, 0.5523, 3.16, 0.079, 162, 63, BOVINE BETA-LACTOGLOBULIN VARIANT A AT PH 4.0 
330, 1gx8A, 0.5523, 3.22, 0.094, 161, 64, BOVINE BETA-LACTOGLOBULIN COMPLEXED WITH RETINOL TRIGONAL LATTICE Z
331, 3pqsA, 0.5520, 3.22, 0.081, 504, 62, THE CRYSTAL STRUCTURES OF PORCINE PATHOGEN APH87_TBPB
332, 6nkqD, 0.5511, 3.09, 0.065, 159, 62, THE STRUCTURE OF BOVINE BETA-LACTOGLOBULIN IN NOVEL CRYSTALS GROWN AT PH 3.8 
333, 5f6zB, 0.5510, 2.97, 0.095, 166, 63, SANDERCYANIN FLUORESCENT PROTEIN PURIFIED FROM SANDER VITREUS
334, 4bf3B, 0.5508, 2.93, 0.107, 127, 56, ERPC A MEMBER OF THE COMPLEMENT REGULATOR ACQUIRING FAMILY OF SURFACE PROTEINS FROM BORRELIA BURGDORFEI POSSESSES AN ARCHITECTURE PREVIOUSLY UNSEEN IN THIS PROTEIN FAMILY.
335, 1gm6A, 0.5508, 3.13, 0.063, 158, 63, 3-D STRUCTURE OF A SALIVARY LIPOCALIN FROM BOAR
336, 5htdA, 0.5507, 3.20, 0.063, 157, 63, RECOMBINANT BOVINE BETA-LACTOGLOBULIN VARIANT L1A/I2S WITH ENDOGENOUS LIGAND (SBLGB 1)
337, 4gnyA, 0.5503, 3.23, 0.092, 157, 65, BOVINE BETA-LACTOGLOBULIN COMPLEX WITH DODECYL SULFATE
338, 5fq8E, 0.5502, 3.20, 0.031, 145, 64, CRYSTAL STRUCTURE OF THE SUSCD COMPLEX BT2261-2264 FROM BACTEROIDES THETAIOTAOMICRON
339, 6nkqB, 0.5501, 3.17, 0.063, 160, 63, THE STRUCTURE OF BOVINE BETA-LACTOGLOBULIN IN NOVEL CRYSTALS GROWN AT PH 3.8 
340, 3i0aB, 0.5500, 3.52, 0.078, 164, 64, CRYSTAL STRUCTURE OF SIDEROCALIN (NGAL LIPOCALIN 2) K134A MUTANT COMPLEXED WITH FERRIC ENTEROBACTIN
341, 5f6zA, 0.5499, 2.90, 0.113, 166, 62, SANDERCYANIN FLUORESCENT PROTEIN PURIFIED FROM SANDER VITREUS
342, 6qi6A, 0.5498, 3.13, 0.063, 155, 63, TRIGONAL FORM OF WT RECOMBINANT BOVINE BETA-LACTOGLOBULIN 
343, 2akqD, 0.5498, 3.22, 0.063, 156, 63, THE STRUCTURE OF BOVINE B-LACTOGLOBULIN A IN CRYSTALS GROWN AT VERY LOW IONIC STRENGTH
344, 6nkqC, 0.5495, 3.18, 0.063, 159, 63, THE STRUCTURE OF BOVINE BETA-LACTOGLOBULIN IN NOVEL CRYSTALS GROWN AT PH 3.8 
345, 2gj5A, 0.5494, 3.28, 0.092, 161, 65, CRYSTAL STRUCTURE OF A SECONDARY VITAMIN D3 BINDING SITE OF MILK BETA-LACTOGLOBULIN
346, 5nukA, 0.5493, 3.18, 0.048, 155, 63, ENGINEERED BETA-LACTOGLOBULIN: VARIANT I56F-L39A-M107F IN COMPLEX WITH CHLORPROMAZINE (LG-FAF-CLP)
347, 5jk2D, 0.5492, 2.93, 0.065, 128, 62, CRYSTAL STRUCTURE OF TREPONEMA PALLIDUM TP0751 (PALLILYSIN)
348, 2qmiF, 0.5492, 2.83, 0.034, 447, 58, STRUCTURE OF THE OCTAMERIC PENICILLIN-BINDING PROTEIN HOMOLOGUE FROM PYROCOCCUS ABYSSI
349, 6nkqE, 0.5489, 3.20, 0.063, 159, 63, THE STRUCTURE OF BOVINE BETA-LACTOGLOBULIN IN NOVEL CRYSTALS GROWN AT PH 3.8 
350, 5fq3A, 0.5489, 3.19, 0.031, 199, 65, CRYSTAL STRUCTURE OF THE LIPOPROTEIN BT2262 FROM BACTEROIDES THETAIOTAOMICRON
351, 5halA, 0.5488, 2.99, 0.066, 103, 61, CRYSTAL STRUCTURE OF A PUTATIVE BETA-LACTAMASE FROM BURKHOLDERIA VIETNAMIENSIS
352, 6nkqF, 0.5484, 3.09, 0.065, 159, 62, THE STRUCTURE OF BOVINE BETA-LACTOGLOBULIN IN NOVEL CRYSTALS GROWN AT PH 3.8 
353, 4lzuA, 0.5482, 3.19, 0.065, 160, 62, BOVINE BETA-LACTOGLOBULIN CRYSTALLIZED IN THE PRESENCE OF 2 MM ZINC CHLORIDE
354, 5jk2E, 0.5480, 3.16, 0.079, 128, 63, CRYSTAL STRUCTURE OF TREPONEMA PALLIDUM TP0751 (PALLILYSIN)
355, 4yzjA, 0.5479, 3.02, 0.048, 334, 62, CRYSTAL STRUCTURE OF SELNOMETHIONIN-LABELED INDOLE PRENYLTRANSFERASE TLEC
356, 3saoB, 0.5479, 3.02, 0.065, 149, 62, THE SIDEROCALIN EX-FABP FUNCTIONS THROUGH DUAL LIGAND SPECIFICITIES
357, 5dyqB, 0.5477, 2.89, 0.145, 128, 55, ABYU L73M L139M
358, 1gx9A, 0.5475, 3.25, 0.094, 161, 64, BOVINE BETA-LACTOGLOBULIN COMPLEXED WITH RETINOIC ACID TRIGONAL LATTICE Z
359, 1b0oA, 0.5475, 3.24, 0.092, 161, 65, BOVINE BETA-LACTOGLOBULIN COMPLEXED WITH PALMITATE LATTICE 2 Z
360, 6qi7A, 0.5474, 2.92, 0.069, 149, 58, ENGINEERED BETA-LACTOGLOBULIN: VARIANT L39Y IN COMPLEX WITH ENDOGENOUS LIGAND 
361, 5jk2C, 0.5474, 3.23, 0.078, 122, 64, CRYSTAL STRUCTURE OF TREPONEMA PALLIDUM TP0751 (PALLILYSIN)
362, 4rlbB, 0.5474, 3.17, 0.095, 213, 63, CRYSTAL STRUCTURE OF ACINETOBACTER BAUMANNII CARO2
363, 1yupG, 0.5474, 3.09, 0.063, 160, 63, REINDEER BETA-LACTOGLOBULIN
364, 1yupC, 0.5473, 3.23, 0.063, 160, 63, REINDEER BETA-LACTOGLOBULIN
365, 6ge7A, 0.5471, 3.27, 0.092, 162, 65, THERMODYNAMIC; CRYSTALLOGRAPHIC AND COMPUTATIONAL STUDIES OF NON MAMMALIAN FATTY ACID BINDING TO BOVINE B-LACTOGLOBULIN 
366, 6rwpA, 0.5469, 2.89, 0.069, 148, 58, ENGINEERED BETA-LACTOGLOBULIN: VARIANT L58F IN COMPLEX WITH MYRISTIC ACID 
367, 5jk2H, 0.5466, 2.93, 0.065, 119, 62, CRYSTAL STRUCTURE OF TREPONEMA PALLIDUM TP0751 (PALLILYSIN)
368, 5dyqC, 0.5464, 2.91, 0.145, 129, 55, ABYU L73M L139M
369, 5dyqA, 0.5464, 2.90, 0.145, 128, 55, ABYU L73M L139M
370, 5jk2B, 0.5460, 2.96, 0.065, 125, 62, CRYSTAL STRUCTURE OF TREPONEMA PALLIDUM TP0751 (PALLILYSIN)
371, 5nbqG, 0.5457, 3.04, 0.071, 129, 56, THE STRUCTURE OF THE TRIPARTITE COMPLEX BETWEEN OSPE THE C-TERMINAL DOMAINS OF FACTOR H AND C3DG
372, 5jk2I, 0.5457, 3.17, 0.079, 116, 63, CRYSTAL STRUCTURE OF TREPONEMA PALLIDUM TP0751 (PALLILYSIN)
373, 4rlbA, 0.5451, 3.28, 0.095, 213, 63, CRYSTAL STRUCTURE OF ACINETOBACTER BAUMANNII CARO2
374, 1yupE, 0.5451, 3.18, 0.079, 154, 63, REINDEER BETA-LACTOGLOBULIN
375, 2k23A, 0.5450, 3.24, 0.062, 178, 65, SOLUTION STRUCTURE ANALYSIS OF THE RLCN2
376, 5jk2A, 0.5449, 3.06, 0.063, 128, 63, CRYSTAL STRUCTURE OF TREPONEMA PALLIDUM TP0751 (PALLILYSIN)
377, 3uaqA, 0.5449, 3.30, 0.048, 276, 63, CRYSTAL STRUCTURE OF THE N-LOBE DOMAIN OF LACTOFERRIN BINDING PROTEIN B (LBPB) OF MORAXELLA BOVIS
378, 3uaqB, 0.5448, 3.31, 0.048, 273, 63, CRYSTAL STRUCTURE OF THE N-LOBE DOMAIN OF LACTOFERRIN BINDING PROTEIN B (LBPB) OF MORAXELLA BOVIS
379, 2f1tB, 0.5447, 3.03, 0.048, 183, 63, OUTER MEMBRANE PROTEIN OMPW
380, 2f1tA, 0.5447, 3.03, 0.048, 183, 63, OUTER MEMBRANE PROTEIN OMPW
381, 6rysA, 0.5446, 3.35, 0.094, 134, 64, ENGINEERED BETA-LACTOGLOBULIN: VARIANT F105L 
382, 3cqrA, 0.5444, 3.00, 0.049, 171, 61, CRYSTAL STRUCTURE OF THE LIPOCALIN DOMAIN OF VIOLAXANTHIN DE-EPOXIDASE (VDE) AT PH5
383, 5jk2F, 0.5440, 2.94, 0.065, 123, 62, CRYSTAL STRUCTURE OF TREPONEMA PALLIDUM TP0751 (PALLILYSIN)
384, 5fq7E, 0.5440, 3.36, 0.031, 145, 65, CRYSTAL STRUCTURE OF THE SUSCD COMPLEX BT2261-2264 FROM BACTEROIDES THETAIOTAOMICRON
385, 4ib9A, 0.5440, 3.31, 0.094, 160, 64, BOVINE BETA-LACTOGLOBULIN (ISOFORM B) IN COMPLEX WITH DODECYLTRIMETHYLAMMONIUM (DTAC)
386, 5dyqD, 0.5437, 2.92, 0.145, 128, 55, ABYU L73M L139M
387, 2fr2A, 0.5437, 3.31, 0.045, 161, 66, CRYSTAL STRUCTURE OF RV2717C FROM M. TUBERCULOSIS
388, 1bsyA, 0.5434, 3.35, 0.092, 162, 65, STRUCTURAL BASIS OF THE TANFORD TRANSITION OF BOVINE BETA- LACTOGLOBULIN FROM CRYSTAL STRUCTURES AT THREE PH VALUES; PH 7.1
389, 4ladA, 0.5430, 3.44, 0.000, 154, 60, CRYSTAL STRUCTURE OF THE UBE2G2:RING-G2BR COMPLEX
390, 3uewA, 0.5428, 3.32, 0.092, 156, 65, BOVINE BETA-LACTOGLOBULIN COMPLEX WITH PALMITIC ACID
391, 3cqrB, 0.5428, 2.88, 0.067, 170, 60, CRYSTAL STRUCTURE OF THE LIPOCALIN DOMAIN OF VIOLAXANTHIN DE-EPOXIDASE (VDE) AT PH5
392, 3a58A, 0.5423, 2.72, 0.058, 184, 52, CRYSTAL STRUCTURE OF SEC3P - RHO1P COMPLEX FROM SACCHAROMYCES CEREVISIAE
393, 6gf9A, 0.5421, 3.33, 0.092, 161, 65, THERMODYNAMIC; CRYSTALLOGRAPHIC AND COMPUTATIONAL STUDIES OF NON MAMMALIAN FATTY ACID BINDING TO BOVINE B-LACTOGLOBULIN 
394, 5lkeA, 0.5421, 3.27, 0.092, 162, 65, BOVINE BETA-LACTOGLOBULIN COMPLEX WITH MYRISTIC ACID AMBIENT PRESSURE
395, 5fq6E, 0.5420, 3.18, 0.000, 146, 63, CRYSTAL STRUCTURE OF THE SUSCD COMPLEX BT2261-2264 FROM BACTEROIDES THETAIOTAOMICRON
396, 5nujA, 0.5419, 3.24, 0.048, 156, 63, ENGINEERED BETA-LACTOGLOBULIN: VARIANT I56F-L39A IN COMPLEX WITH CHLORPROMAZINE (LG-FA-CLP)
397, 4ib7A, 0.5419, 3.24, 0.078, 157, 64, BOVINE BETA-LACTOGLOBULIN (ISOFORM A) IN COMPLEX WITH DODECYLTRIMETHYLAMMONIUM (DTAC)
398, 3nq3A, 0.5415, 3.29, 0.094, 162, 64, BOVINE BETA-LACTOGLOBULIN COMPLEX WITH CAPRIC ACID
399, 1gxaA, 0.5414, 3.28, 0.092, 161, 65, BOVINE BETA-LACTOGLOBULIN COMPLEXED WITH RETINOL AND PALMITIC ACID TRIGONAL LATTICE Z
400, 6gfsA, 0.5411, 3.31, 0.092, 162, 65, THERMODYNAMIC; CRYSTALLOGRAPHIC AND COMPUTATIONAL STUDIES OF NON MAMMALIAN FATTY ACID BINDING TO BOVINE B-LACTOGLOBULIN 
401, 5k06A, 0.5410, 3.25, 0.079, 157, 63, RECOMBINANT BOVINE BETA-LACTOGLOBULIN WITH UNCLEAVED N-TERMINAL METHIONINE (RBLGB)
402, 1bsoA, 0.5410, 3.34, 0.092, 162, 65, 12-BROMODODECANOIC ACID BINDS INSIDE THE CALYX OF BOVINE BETA-LACTOGLOBULIN
403, 2ju8A, 0.5408, 3.39, 0.082, 127, 61, SOLUTION-STATE STRUCTURES OF OLEATE-LIGANDED LFABP MAJOR FORM OF 1:2 PROTEIN-LIGAND COMPLEX
404, 6ghhA, 0.5407, 3.32, 0.092, 162, 65, THERMODYNAMIC; CRYSTALLOGRAPHIC AND COMPUTATIONAL STUDIES OF NON MAMMALIAN FATTY ACID BINDING TO BOVINE B-LACTOGLOBULIN 
405, 4qlpA, 0.5404, 3.21, 0.070, 175, 57, ATOMIC STRUCTURE OF TUBERCULOSIS NECROTIZING TOXIN (TNT) COMPLEXED WITH ITS IMMUNITY FACTOR IFT
406, 3npoA, 0.5403, 3.34, 0.094, 162, 64, BOVINE BETA LACTOGLOBULIN UNLIGANDED FORM
407, 2q03A, 0.5403, 3.38, 0.047, 131, 64, CRYSTAL STRUCTURE OF UNCHARACTERIZED PROTEIN (YP_563039.1) FROM SHEWANELLA DENITRIFICANS OS217 AT 1.80 A RESOLUTION
408, 5nunA, 0.5401, 3.35, 0.092, 159, 65, ENGINEERED BETA-LACTOGLOBULIN: VARIANT F105L-L39A-M107F IN COMPLEX WITH CHLORPROMAZINE (LG-LAF-CLP)
409, 5numA, 0.5400, 3.37, 0.092, 158, 65, ENGINEERED BETA-LACTOGLOBULIN: VARIANT F105L-L39A IN COMPLEX WITH CHLORPROMAZINE (LG-LA-CLP)
410, 4o6gA, 0.5399, 3.37, 0.069, 174, 58, RV3902C FROM M. TUBERCULOSIS
411, 5btuA, 0.5398, 3.13, 0.051, 157, 59, THE STRUCTURE OF DIELS-ALDERASE PYRI4 IN THE BIOSYNTHETIC PATHWAY OF PYRROINDOMYCINS
412, 5fq6N, 0.5396, 3.37, 0.031, 146, 65, CRYSTAL STRUCTURE OF THE SUSCD COMPLEX BT2261-2264 FROM BACTEROIDES THETAIOTAOMICRON
413, 3rz3C, 0.5392, 3.13, 0.035, 156, 57, HUMAN CDC34 E2 IN COMPLEX WITH CC0651 INHIBITOR
414, 2ervB, 0.5392, 3.36, 0.062, 146, 64, CRYSTAL STRUCTURE OF THE OUTER MEMBRANE ENZYME PAGL
415, 4y0rA, 0.5390, 3.27, 0.079, 155, 63, BOVINE BETA-LACTOGLOBULIN COMPLEX WITH PRAMOCAINE CRYSTALLIZED FROM AMMONIUM SULPHATE (BLG-PRM2)
416, 6qpdA, 0.5388, 3.29, 0.048, 157, 63, ENGINEERED BETA-LACTOGLOBULIN: VARIANT I56F 
417, 2ervA, 0.5386, 3.35, 0.062, 150, 64, CRYSTAL STRUCTURE OF THE OUTER MEMBRANE ENZYME PAGL
418, 1p4pA, 0.5385, 2.80, 0.077, 140, 52, OUTER SURFACE PROTEIN B OF B. BURGDORFERI: CRYSTAL STRUCTURE OF THE C-TERMINAL FRAGMENT
419, 4y0qA, 0.5384, 3.27, 0.078, 157, 64, BOVINE BETA-LACTOGLOBULIN COMPLEX WITH PRAMOCAINE CRYSTALLIZED FROM SODIUM CITRATE (BLG-PRM1)
420, 4ibaA, 0.5384, 3.26, 0.078, 157, 64, BOVINE BETA-LACTOGLOBULIN (ISOFORM B) IN COMPLEX WITH DODECYL SULPHATE (SDS)
421, 3uexA, 0.5384, 3.22, 0.078, 159, 64, BOVINE BETA-LACTOGLOBULIN COMPLEX WITH STEARIC ACID
422, 4o3xB, 0.5383, 3.40, 0.031, 241, 64, CRYSTAL STRUCTURE OF THE VACCINE ANTIGEN TRANSFERRIN BINDING PROTEIN B (TBPB) MUTANT PHE-171-ALA FROM ACTINOBACILLUS PLEUROPNEUMONIAE H49
423, 4dq3A, 0.5382, 3.34, 0.092, 158, 65, BOVINE BETA-LACTOGLOBULIN COMPLEX WITH OLEIC ACID
424, 5z1oB, 0.5380, 3.00, 0.075, 316, 53, CRYSTAL STRUCTURE OF AN OSPA MUTANT 
425, 4bodB, 0.5380, 3.32, 0.153, 132, 59, COMPLEMENT REGULATOR ACQUIRING OUTER SURFACE PROTEIN BBCRASP-4 OR ERPC FROM BORRELIA BURGDORFERI
426, 5bu3B, 0.5379, 3.15, 0.051, 181, 59, CRYSTAL STRUCTURE OF DIELS-ALDERASE PYRI4 IN COMPLEX WITH ITS PRODUCT
427, 2i5zO, 0.5379, 2.97, 0.075, 246, 53, THE CRYSTAL STRUCTURE OF OSPA MUTANT
428, 5fq8F, 0.5377, 3.18, 0.016, 146, 63, CRYSTAL STRUCTURE OF THE SUSCD COMPLEX BT2261-2264 FROM BACTEROIDES THETAIOTAOMICRON
429, 3ckfA, 0.5377, 2.98, 0.075, 223, 53, THE CRYSTAL STRUCTURE OF OSPA DELETION MUTANT
430, 2ol7B, 0.5374, 3.00, 0.075, 246, 53, THE CRYSTAL STRUCTURE OF OSPA MUTANT
431, 2hlwA, 0.5374, 3.82, 0.032, 170, 62, SOLUTION STRUCTURE OF THE HUMAN UBIQUITIN-CONJUGATING ENZYME VARIANT UEV1A
432, 5jk2G, 0.5373, 3.17, 0.063, 117, 63, CRYSTAL STRUCTURE OF TREPONEMA PALLIDUM TP0751 (PALLILYSIN)
433, 5bu3A, 0.5373, 3.16, 0.051, 181, 59, CRYSTAL STRUCTURE OF DIELS-ALDERASE PYRI4 IN COMPLEX WITH ITS PRODUCT
434, 4ib8A, 0.5372, 3.35, 0.092, 158, 65, BOVINE BETA-LACTOGLOBULIN (ISOFORM A) IN COMPLEX WITH DODECYL SULPHATE (SDS)
435, 3nq9A, 0.5372, 3.35, 0.092, 162, 65, BOVINE BETA-LACTOGLOBULIN COMPLEX WITH CAPRYLIC ACID
436, 5cllD, 0.5371, 2.98, 0.052, 139, 58, TRUNCATED RAN WILD TYPE IN COMPLEX WITH GDP-BEF AND RANBD1
437, 5cllB, 0.5371, 2.98, 0.052, 139, 58, TRUNCATED RAN WILD TYPE IN COMPLEX WITH GDP-BEF AND RANBD1
438, 4dq4A, 0.5370, 3.23, 0.095, 158, 63, BOVINE BETA-LACTOGLOBULIN COMPLEX WITH LINOLEIC ACID
439, 4ib6A, 0.5369, 3.36, 0.092, 158, 65, BOVINE BETA-LACTOGLOBULIN (ISOFORM A) IN COMPLEX WITH LAURIC ACID (C12)
440, 5eeeA, 0.5368, 3.36, 0.092, 158, 65, BOVINE LACTOGLOBULIN COMPLEX WITH DECANOL
441, 2ol7A, 0.5367, 3.17, 0.093, 250, 54, THE CRYSTAL STRUCTURE OF OSPA MUTANT
442, 5bu3D, 0.5366, 3.17, 0.051, 181, 59, CRYSTAL STRUCTURE OF DIELS-ALDERASE PYRI4 IN COMPLEX WITH ITS PRODUCT
443, 3ebwA, 0.5366, 3.14, 0.083, 154, 60, CRYSTAL STRUCTURE OF MAJOR ALLERGENS PER A 4 FROM COCKROACHES
444, 6aisO, 0.5365, 3.05, 0.057, 244, 53, LOOP DELETION MUTANT (DELETING TWO RESIDUES) 
445, 4y0pA, 0.5365, 3.32, 0.092, 159, 65, BOVINE BETA-LACTOGLOBULIN COMPLEX WITH TETRACAINE (BLG-TET)
446, 3uevA, 0.5365, 3.30, 0.078, 158, 64, BOVINE BETA-LACTOGLOBULIN COMPLEX WITH MYRISTIC ACID
447, 3fiqB, 0.5365, 3.00, 0.100, 157, 60, ODORANT BINDING PROTEIN OBP1
448, 6e17B, 0.5364, 3.20, 0.085, 158, 59, A131E MUTANT OF CYT P460 OF NITROSOMONAS SP. AL212 WITH NO BOUND 
449, 2oy8A, 0.5364, 2.99, 0.075, 315, 53, THE CRYSTAL STRUCTURE OF OSPA MUTANT
450, 4mdkC, 0.5363, 3.25, 0.033, 168, 60, CDC34-UBIQUITIN-CC0651 COMPLEX
451, 1ospO, 0.5363, 3.19, 0.057, 251, 53, CRYSTAL STRUCTURE OF OUTER SURFACE PROTEIN A OF BORRELIA BURGDORFERI COMPLEXED WITH A MURINE MONOCLONAL ANTIBODY FAB
452, 1fj1F, 0.5362, 3.03, 0.075, 251, 53, LYME DISEASE ANTIGEN OSPA IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB LA-2
453, 1gt1A, 0.5361, 2.92, 0.117, 158, 60, COMPLEX OF BOVINE ODORANT BINDING PROTEIN WITH AMINOANTHRACENE AND PYRAZINE
454, 1fj1E, 0.5360, 3.03, 0.075, 251, 53, LYME DISEASE ANTIGEN OSPA IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB LA-2
455, 5b2aO, 0.5359, 3.00, 0.075, 246, 53, CRYSTAL STRUCTURE OF A MUTANT OF OSPA
456, 4gzvB, 0.5359, 3.12, 0.063, 131, 63, CRYSTAL STRUCTURE OF A LIPOCALIN FAMILY PROTEIN (BACOVA_00364) FROM BACTEROIDES OVATUS ATCC 8483 AT 1.95 A RESOLUTION
457, 5ys7A, 0.5358, 3.00, 0.075, 315, 53, CRYSTAL STRUCTURE OF AN OSPA MUTANT 
458, 2i5vO, 0.5358, 3.22, 0.056, 246, 54, CRYSTAL STRUCTURE OF OSPA MUTANT
459, 5b3mO, 0.5354, 3.28, 0.056, 246, 54, A MUTANT OF OSPA
460, 4r0bA, 0.5354, 3.52, 0.145, 153, 62, STRUCTURE OF DIMERIC HUMAN GLYCODELIN
461, 4mdkA, 0.5353, 3.25, 0.033, 168, 60, CDC34-UBIQUITIN-CC0651 COMPLEX
462, 3ckaA, 0.5352, 3.03, 0.075, 315, 53, THE CRYSTAL STRUCTURE OF OSPA MUTANT
463, 4kiiA, 0.5350, 3.30, 0.078, 156, 64, BETA-LACTOGLOBULIN IN COMPLEX WITH CP*RH(III)CL NN-DI(PYRIDIN-2-YL) DODECANAMIDE
464, 2pi3O, 0.5350, 3.21, 0.074, 246, 54, THE CRYSTAL STRUCTURE OF OSPA MUTANT
465, 5lkfA, 0.5349, 3.34, 0.078, 162, 64, BOVINE BETA-LACTOGLOBULIN COMPLEX WITH MYRISTIC ACID AT HIGH PRESSURE (0.55 GPA)
466, 2fkgA, 0.5349, 3.24, 0.074, 315, 54, THE CRYSTAL STRUCTURE OF ENGINEERED OSPA
467, 2k62A, 0.5348, 3.49, 0.063, 125, 63, NMR SOLUTION STRUCTURE OF THE SUPRAMOLECULAR ADDUCT BETWEEN A LIVER CYTOSOLIC BILE ACID BINDING PROTEIN AND A BILE ACID-BASED GD(III)-CHELATE
468, 6j48O, 0.5344, 3.01, 0.075, 246, 53, GLYCINE MUTATION ON SINGLE LAYER BETA-SHEET OF OSPASM1 
469, 5fq6J, 0.5342, 3.23, 0.000, 146, 63, CRYSTAL STRUCTURE OF THE SUSCD COMPLEX BT2261-2264 FROM BACTEROIDES THETAIOTAOMICRON
470, 2oybO, 0.5339, 2.99, 0.075, 246, 53, THE CRYSTAL STRUCTURE OF OSPA MUTANT
471, 2mt6A, 0.5339, 3.15, 0.034, 151, 58, SOLUTION STRUCTURE OF THE HUMAN UBIQUITIN CONJUGATING ENZYME UBE2W
472, 1mvgA, 0.5338, 3.71, 0.063, 125, 63, NMR SOLUTION STRUCTURE OF CHICKEN LIVER BASIC FATTY ACID BINDING PROTEIN (LB-FABP)
473, 4u3qA, 0.5337, 2.99, 0.119, 93, 59, CRYSTAL STRUCTURE OF RECOMBINANT TP0435 FROM TREPONEMA PALLIDUM
474, 1e02A, 0.5337, 3.40, 0.079, 149, 63, PORCINE ODORANT BINDING PROTEIN COMPLEXED WITH UNDECANAL
475, 1dzpA, 0.5337, 3.22, 0.095, 149, 63, PORCINE ODORANT BINDING PROTEIN COMPLEXED WITH DIPHENYLMETHANONE
476, 1dv9A, 0.5337, 3.27, 0.063, 162, 63, STRUCTURAL CHANGES ACCOMPANYING PH-INDUCED DISSOCIATION OF THE B-LACTOGLOBULIN DIMER
477, 2hkdA, 0.5335, 3.05, 0.075, 315, 53, THE CRYSTAL STRUCTURE OF ENGINEERED OSPA
478, 4fuvA, 0.5334, 3.15, 0.079, 213, 63, CRYSTAL STRUCTURE OF ACINETOBACTER BAUMANNII CARO
479, 6qpeA, 0.5333, 3.38, 0.078, 157, 64, ENGINEERED BETA-LACTOGLOBULIN: VARIANT L58F 
480, 3ueuA, 0.5333, 3.42, 0.092, 155, 65, BOVINE BETA-LACTOGLOBULIN COMPLEX WITH LAURIC ACID
481, 2af5A, 0.5333, 3.18, 0.074, 292, 54, 2.5A X-RAY STRUCTURE OF ENGINEERED OSPA PROTEIN
482, 2g8cO, 0.5332, 3.21, 0.056, 246, 54, ATOMIC-RESOLUTION CRYSTAL STRUCTURE OF BORRELIA BURGDORFERI OSPA VIA SURFACE ENTROPY REDUCTION
483, 3nb3C, 0.5331, 2.93, 0.016, 137, 62, THE HOST OUTER MEMBRANE PROTEINS OMPA AND OMPC ARE PACKED AT SPECIFIC SITES IN THE SHIGELLA PHAGE SF6 VIRION AS STRUCTURAL COMPONENTS
484, 3nb3B, 0.5331, 2.93, 0.016, 137, 62, THE HOST OUTER MEMBRANE PROTEINS OMPA AND OMPC ARE PACKED AT SPECIFIC SITES IN THE SHIGELLA PHAGE SF6 VIRION AS STRUCTURAL COMPONENTS
485, 3nb3A, 0.5331, 2.93, 0.016, 137, 62, THE HOST OUTER MEMBRANE PROTEINS OMPA AND OMPC ARE PACKED AT SPECIFIC SITES IN THE SHIGELLA PHAGE SF6 VIRION AS STRUCTURAL COMPONENTS
486, 2oy1O, 0.5331, 3.10, 0.075, 247, 53, THE CRYSTAL STRUCTURE OF OSPA MUTANT
487, 1qjpA, 0.5331, 2.93, 0.016, 137, 62, HIGH RESOLUTION STRUCTURE OF THE OUTER MEMBRANE PROTEIN A (OMPA) TRANSMEMBRANE DOMAIN
488, 6e17A, 0.5330, 3.20, 0.085, 157, 59, A131E MUTANT OF CYT P460 OF NITROSOMONAS SP. AL212 WITH NO BOUND 
489, 3sziA, 0.5330, 3.11, 0.063, 117, 63, STRUCTURE OF APO SHWANAVIDIN (P21 FORM)
490, 2ol8O, 0.5330, 2.93, 0.075, 244, 53, THE CRYSTAL STRUCTURE OF OSPA MUTANT
491, 1e00A, 0.5330, 3.35, 0.079, 149, 63, PORCINE ODORANT BINDING PROTEIN COMPLEXED WITH 26-DIMETHYL-7-OCTEN-2-OL
492, 6j49O, 0.5329, 3.22, 0.056, 246, 54, GRAFTING VLADV SEQUENCE INTO OSPASM1 
493, 5mdxo, 0.5329, 3.41, 0.077, 193, 65, CRYO-EM STRUCTURE OF THE PSII SUPERCOMPLEX FROM ARABIDOPSIS THALIANA
494, 5mdxO, 0.5329, 3.41, 0.077, 193, 65, CRYO-EM STRUCTURE OF THE PSII SUPERCOMPLEX FROM ARABIDOPSIS THALIANA
495, 1rrpB, 0.5328, 2.99, 0.052, 134, 58, STRUCTURE OF THE RAN-GPPNHP-RANBD1 COMPLEX
496, 1bxwA, 0.5327, 3.07, 0.016, 172, 63, OUTER MEMBRANE PROTEIN A (OMPA) TRANSMEMBRANE DOMAIN
497, 4iabD, 0.5326, 3.08, 0.129, 129, 62, CRYSTAL STRUCTURE OF A PUTATIVE MONOSACCHARIDE BINDING PROTEIN (BACUNI_03039) FROM BACTEROIDES UNIFORMIS ATCC 8492 AT 1.70 A RESOLUTION
498, 1rrpD, 0.5326, 2.99, 0.052, 134, 58, STRUCTURE OF THE RAN-GPPNHP-RANBD1 COMPLEX
499, 5b10O, 0.5325, 3.23, 0.056, 246, 54, A MUTANT OF OSPA
500, 3hieB, 0.5325, 2.20, 0.040, 162, 50, STRUCTURE OF THE MEMBRANE-BINDING DOMAIN OF THE SEC3 SUBUNIT OF THE EXOCYST COMPLEX
501, 3sziH, 0.5324, 3.13, 0.063, 117, 63, STRUCTURE OF APO SHWANAVIDIN (P21 FORM)
502, 3ebwB, 0.5324, 2.95, 0.050, 154, 60, CRYSTAL STRUCTURE OF MAJOR ALLERGENS PER A 4 FROM COCKROACHES
503, 6b7lA, 0.5323, 3.36, 0.062, 290, 65, AEROMONAS VERONII IMMUNE MODULATOR A 
504, 3t2xC, 0.5323, 3.10, 0.063, 117, 63, STRUCTURE OF SHWANAVIDIN LOW AFFINITY MUTANT (F43A)
505, 5bu3C, 0.5320, 3.27, 0.068, 181, 59, CRYSTAL STRUCTURE OF DIELS-ALDERASE PYRI4 IN COMPLEX WITH ITS PRODUCT
506, 3sziL, 0.5320, 3.11, 0.063, 120, 63, STRUCTURE OF APO SHWANAVIDIN (P21 FORM)
507, 3ckaB, 0.5320, 2.78, 0.075, 316, 53, THE CRYSTAL STRUCTURE OF OSPA MUTANT
508, 1a3yA, 0.5320, 3.40, 0.079, 149, 63, ODORANT BINDING PROTEIN FROM NASAL MUCOSA OF PIG
509, 4ld7K, 0.5319, 3.09, 0.054, 392, 56, CRYSTAL STRUCTURE OF ANAPT FROM NEOSARTORYA FISCHERI
510, 1pzvA, 0.5319, 3.34, 0.017, 152, 60, CRYSTAL STRUCTURES OF TWO UBC (E2) ENZYMES OF THE UBIQUITIN- CONJUGATING SYSTEM IN CAENORHABDITIS ELEGANS
511, 1obpA, 0.5319, 2.92, 0.117, 158, 60, ODORANT-BINDING PROTEIN FROM BOVINE NASAL MUCOSA
512, 2fkjC, 0.5317, 2.93, 0.075, 361, 53, THE CRYSTAL STRUCTURE OF ENGINEERED OSPA
513, 1ew3A, 0.5315, 2.96, 0.066, 159, 61, CRYSTAL STRUCTURE OF THE MAJOR HORSE ALLERGEN EQU C 1
514, 4n7cA, 0.5314, 3.26, 0.108, 174, 65, STRUCTURAL RE-EXAMINATION OF NATIVE BLA G 4
515, 5z1oA, 0.5313, 2.98, 0.074, 316, 54, CRYSTAL STRUCTURE OF AN OSPA MUTANT 
516, 5fq7F, 0.5313, 3.41, 0.031, 145, 65, CRYSTAL STRUCTURE OF THE SUSCD COMPLEX BT2261-2264 FROM BACTEROIDES THETAIOTAOMICRON
517, 2fkjA, 0.5313, 3.23, 0.093, 361, 54, THE CRYSTAL STRUCTURE OF ENGINEERED OSPA
518, 1o8vA, 0.5313, 3.63, 0.082, 132, 61, THE CRYSTAL STRUCTURE OF ECHINOCOCCUS GRANULOSUS FATTY-ACID-BINDING PROTEIN 1
519, 3h8kA, 0.5311, 3.45, 0.000, 164, 60, CRYSTAL STRUCTURE OF UBE2G2 COMPLXED WITH THE G2BR DOMAIN OF GP78 AT 1.8-A RESOLUTION
520, 5b11O, 0.5309, 3.20, 0.074, 246, 54, A MUTATION OF OSPA
521, 4y0sA, 0.5309, 3.27, 0.078, 157, 64, GOAT BETA-LACTOGLOBULIN COMPLEX WITH PRAMOCAINE (GLG-PRM)
522, 6j47O, 0.5308, 3.21, 0.056, 246, 54, OSPA VARIANT WITH A SHORT CHAMELEON SEQUENCE FROM ALPHA B CRYSTALLIN 
523, 5nbqI, 0.5307, 3.23, 0.103, 125, 58, THE STRUCTURE OF THE TRIPARTITE COMPLEX BETWEEN OSPE THE C-TERMINAL DOMAINS OF FACTOR H AND C3DG
524, 5f75C, 0.5307, 2.98, 0.000, 475, 56, THIOCYANATE DEHYDROGENASE FROM THIOALKALIVIBRIO PARADOXUS
525, 2y32A, 0.5307, 3.16, 0.079, 137, 63, CRYSTAL STRUCTURE OF BRADAVIDIN
526, 6amgB, 0.5306, 3.23, 0.085, 160, 59, CYT P460 OF NITROSOMONAS SP. AL212
527, 1dzmA, 0.5306, 3.41, 0.063, 149, 63, PORCINE ODORANT BINDING PROTEIN COMPLEXED WITH BENZOIC ACID PHENYLMETHYLESTER
528, 3aumO, 0.5305, 3.02, 0.075, 247, 53, CRYSTAL STRUCTURE OF OSPA MUTANT
529, 1xkeA, 0.5305, 3.01, 0.034, 130, 58, SOLUTION STRUCTURE OF THE SECOND RAN-BINDING DOMAIN FROM HUMAN RANBP2
530, 2ra6A, 0.5304, 3.00, 0.034, 141, 59, CRYSTAL STRUCTURE OF THE POSSUM MILK WHEY LIPOCALIN TRICHOSURIN AT PH 4.6 WITH BOUND 4-ETHYLPHENOL
531, 2w0qA, 0.5303, 3.38, 0.051, 717, 59, E. COLI COPPER AMINE OXIDASE IN COMPLEX WITH XENON
532, 1gt5A, 0.5303, 2.91, 0.051, 159, 59, COMPLEXE OF BOVINE ODORANT BINDING PROTEIN WITH BENZOPHENONE
533, 3szjA, 0.5302, 3.11, 0.063, 120, 63, STRUCTURE OF THE SHWANAVIDIN-BIOTIN COMPLEX
534, 3e3cA, 0.5302, 3.16, 0.111, 118, 63, STRUCTURE OF GRLR-LIPID COMPLEX
535, 1jrqA, 0.5302, 3.37, 0.051, 717, 59, X-RAY STRUCTURE ANALYSIS OF THE ROLE OF THE CONSERVED TYROSINE-369 IN ACTIVE SITE OF E. COLI AMINE OXIDASE
536, 3e3cB, 0.5301, 3.16, 0.111, 118, 63, STRUCTURE OF GRLR-LIPID COMPLEX
537, 2ol6O, 0.5301, 3.29, 0.056, 245, 54, THE CRYSTAL STRUCTURE OF OSPA MUTANT
538, 1d6uA, 0.5301, 3.36, 0.051, 717, 59, CRYSTAL STRUCTURE OF E. COLI AMINE OXIDASE ANAEROBICALLY REDUCED WITH BETA-PHENYLETHYLAMINE
539, 5lg4B, 0.5300, 2.71, 0.058, 174, 52, CRYSTAL STRUCTURE OF THE SEC3/SSO2 COMPLEX AT 2.9 ANGSTROM RESOLUTION
540, 1d6zA, 0.5300, 3.35, 0.051, 717, 59, CRYSTAL STRUCTURE OF THE AEROBICALLY FREEZE TRAPPED RATE-DETERMINING CATALYTIC INTERMEDIATE OF E. COLI COPPER-CONTAINING AMINE OXIDASE.
541, 3a58C, 0.5298, 2.77, 0.058, 179, 52, CRYSTAL STRUCTURE OF SEC3P - RHO1P COMPLEX FROM SACCHAROMYCES CEREVISIAE
542, 6e0yC, 0.5297, 3.23, 0.085, 159, 59, A131Q MUTANT OF CYT P460 OF NITROSOMONAS SP. AL212 WITH BOUND NH2OH 
543, 3ebkB, 0.5297, 3.25, 0.108, 164, 65, CRYSTAL STRUCTURE OF MAJOR ALLERGENS BLA G 4 FROM COCKROACHES
544, 1gt4A, 0.5297, 2.95, 0.017, 159, 59, COMPLEX OF BOVINE ODORANT BINDING PROTEIN WITH UNDECANAL
545, 3sziD, 0.5296, 3.12, 0.063, 120, 63, STRUCTURE OF APO SHWANAVIDIN (P21 FORM)
546, 6e0xD, 0.5295, 3.24, 0.085, 159, 59, A131E MUTANT OF CYT P460 OF NITROSOMONAS SP. AL212 
547, 2q03B, 0.5294, 3.41, 0.047, 129, 64, CRYSTAL STRUCTURE OF UNCHARACTERIZED PROTEIN (YP_563039.1) FROM SHEWANELLA DENITRIFICANS OS217 AT 1.80 A RESOLUTION
548, 1rjlC, 0.5294, 3.07, 0.075, 95, 53, STRUCTURE OF THE COMPLEX BETWEEN OSPB-CT AND BACTERICIDAL FAB-H6831
549, 6d68B, 0.5292, 3.42, 0.017, 156, 60, UBE2G1 IN COMPLEX WITH UBIQUITIN VARIANT UBV.G1.1 
550, 3szhE, 0.5292, 3.14, 0.063, 116, 63, CRYSTAL STRUCTURE OF APO SHWANAVIDIN (P1 FORM)
551, 6g5mA, 0.5291, 3.12, 0.000, 463, 57, THE STRUCTURE OF THIOCYANATE DEHYDROGENASE FROM THIOALKALIVIBRIO PARADOXUS COMPLEX WITH CU(I) IONS. 
552, 3sziB, 0.5291, 3.14, 0.063, 113, 63, STRUCTURE OF APO SHWANAVIDIN (P21 FORM)
553, 6grrA, 0.5290, 3.37, 0.051, 718, 59, CRYSTAL STRUCTURE OF ESCHERICHIA COLI AMINE OXIDASE MUTANT I342F/E573Q 
554, 6e0zA, 0.5290, 3.23, 0.085, 159, 59, A131Q MUTANT OF CYT P460 OF NITROSOMONAS SP. AL212 
555, 3sziF, 0.5290, 3.22, 0.063, 117, 63, STRUCTURE OF APO SHWANAVIDIN (P21 FORM)
556, 1hn2A, 0.5289, 2.94, 0.017, 159, 59, CRYSTAL STRUCTURE OF BOVINE OBP COMPLEXED WITH AMINOANTHRACENE
557, 6e0xC, 0.5288, 3.24, 0.085, 159, 59, A131E MUTANT OF CYT P460 OF NITROSOMONAS SP. AL212 
558, 3sziE, 0.5287, 3.11, 0.063, 118, 63, STRUCTURE OF APO SHWANAVIDIN (P21 FORM)
559, 2y32B, 0.5287, 3.17, 0.079, 137, 63, CRYSTAL STRUCTURE OF BRADAVIDIN
560, 2wo0A, 0.5287, 3.36, 0.051, 717, 59, EDTA TREATED E. COLI COPPER AMINE OXIDASE
561, 3g7gF, 0.5286, 3.17, 0.081, 148, 62, CRYSTAL STRUCTURE OF THE PROTEIN WITH UNKNOWN FUNCTION FROM CLOSTRIDIUM ACETOBUTYLICUM ATCC 824
562, 1k5gH, 0.5286, 3.09, 0.052, 146, 58, CRYSTAL STRUCTURE OF RAN-GDP-ALFX-RANBP1-RANGAP COMPLEX
563, 6e0zC, 0.5285, 3.23, 0.085, 158, 59, A131Q MUTANT OF CYT P460 OF NITROSOMONAS SP. AL212 
564, 5xnmo, 0.5284, 3.31, 0.156, 214, 64, STRUCTURE OF UNSTACKED C2S2M2-TYPE PSII-LHCII SUPERCOMPLEX FROM PISUM SATIVUM
565, 5xnmO, 0.5284, 3.31, 0.156, 214, 64, STRUCTURE OF UNSTACKED C2S2M2-TYPE PSII-LHCII SUPERCOMPLEX FROM PISUM SATIVUM
566, 3eexB, 0.5284, 3.02, 0.074, 316, 54, THE CRYSTAL STRUCTURE OF OSPA MUTANT
567, 2wohA, 0.5284, 3.37, 0.051, 717, 59, STRONTIUM SOAKED E. COLI COPPER AMINE OXIDASE
568, 1dzjA, 0.5284, 3.25, 0.095, 148, 63, PORCINE ODORANT BINDING PROTEIN COMPLEXED WITH 2-AMINO-4-BUTYL-5-PROPYLSELENAZOLE
569, 6e0yB, 0.5283, 3.23, 0.085, 159, 59, A131Q MUTANT OF CYT P460 OF NITROSOMONAS SP. AL212 WITH BOUND NH2OH 
570, 6e0xB, 0.5283, 3.24, 0.085, 161, 59, A131E MUTANT OF CYT P460 OF NITROSOMONAS SP. AL212 
571, 3ec5A, 0.5283, 2.80, 0.075, 316, 53, THE CRYSTAL STRUCTURE OF THIOFLAVIN-T (THT) BINDING OSPA MUTANT
572, 3ebkA, 0.5283, 3.28, 0.106, 165, 66, CRYSTAL STRUCTURE OF MAJOR ALLERGENS BLA G 4 FROM COCKROACHES
573, 1u2bA, 0.5283, 3.06, 0.035, 128, 57, TRIGLYCINE VARIANT OF THE GRP1 PLECKSTRIN HOMOLOGY DOMAIN UNLIGANDED
574, 1e06A, 0.5283, 3.35, 0.078, 149, 64, PORCINE ODORANT BINDING PROTEIN COMPLEXED WITH 5-METHYL-2-(1-METHYLETHYL)PHENOL
575, 1k5gK, 0.5281, 3.09, 0.052, 146, 58, CRYSTAL STRUCTURE OF RAN-GDP-ALFX-RANBP1-RANGAP COMPLEX
576, 6e0zB, 0.5280, 3.23, 0.085, 161, 59, A131Q MUTANT OF CYT P460 OF NITROSOMONAS SP. AL212 
577, 1k5gE, 0.5280, 3.09, 0.052, 146, 58, CRYSTAL STRUCTURE OF RAN-GDP-ALFX-RANBP1-RANGAP COMPLEX
578, 1k5gB, 0.5280, 3.09, 0.052, 146, 58, CRYSTAL STRUCTURE OF RAN-GDP-ALFX-RANBP1-RANGAP COMPLEX
579, 4n7dA, 0.5278, 3.27, 0.108, 170, 65, SELENOMETHIONINE INCORPORATED BLA G 4
580, 1qafA, 0.5278, 3.37, 0.051, 717, 59, THE ACTIVE SITE BASE CONTROLS COFACTOR REACTIVITY IN ESCHERICHIA COLI AMINE OXIDASE : X-RAY CRYSTALLOGRAPHIC STUDIES WITH MUTATIONAL VARIANTS
581, 4u9cA, 0.5277, 3.58, 0.062, 286, 64, STRUCTURE OF THE LBPB N-LOBE FROM NEISSERIA MENINGITIDIS
582, 1g85A, 0.5277, 2.95, 0.017, 159, 59, CRYSTAL STRUCTURE OF BOVINE ODORANT BINDING PROTEIN COMPLEXED WITH IS NATURAL LIGAND
583, 6e0xA, 0.5276, 3.24, 0.085, 160, 59, A131E MUTANT OF CYT P460 OF NITROSOMONAS SP. AL212 
584, 3szjB, 0.5276, 3.09, 0.063, 119, 63, STRUCTURE OF THE SHWANAVIDIN-BIOTIN COMPLEX
585, 3eexA, 0.5276, 3.01, 0.074, 316, 54, THE CRYSTAL STRUCTURE OF OSPA MUTANT
586, 1e02B, 0.5276, 3.39, 0.079, 147, 63, PORCINE ODORANT BINDING PROTEIN COMPLEXED WITH UNDECANAL
587, 4bboC, 0.5275, 3.12, 0.079, 112, 63, CRYSTAL STRUCTURE OF CORE-BRADAVIDIN
588, 3sziI, 0.5273, 3.14, 0.063, 117, 63, STRUCTURE OF APO SHWANAVIDIN (P21 FORM)
589, 2r09B, 0.5273, 2.85, 0.036, 333, 56, CRYSTAL STRUCTURE OF AUTOINHIBITED FORM OF GRP1 ARF GTPASE EXCHANGE FACTOR
590, 1gt3A, 0.5273, 2.95, 0.017, 159, 59, COMPLEX OF BOVINE ODORANT BINDING PROTEIN WITH DIHYDROMYRCENOL
591, 3sziC, 0.5272, 3.11, 0.063, 117, 63, STRUCTURE OF APO SHWANAVIDIN (P21 FORM)
592, 5zpuB, 0.5270, 3.00, 0.052, 120, 58, LFS829 IN COMPLEX WITH CRM1-RAN-RANBP1 
593, 5uraC, 0.5270, 3.72, 0.113, 134, 62, ENANTIOMER-SPECIFIC BINDING OF THE POTENT ANTINOCICEPTIVE AGENT SBFI- 26 TO ANANDAMIDE TRANSPORTERS FABP7
594, 4hayB, 0.5269, 3.06, 0.034, 121, 58, CRYSTAL STRUCTURE OF CRM1 INHIBITOR LEPTOMYCIN B IN COMPLEX WITH CRM1(K548EK579Q)-RAN-RANBP1
595, 2y32C, 0.5268, 3.19, 0.079, 138, 63, CRYSTAL STRUCTURE OF BRADAVIDIN
596, 2oy7A, 0.5268, 2.80, 0.075, 315, 53, THE CRYSTAL STRUCTURE OF OSPA MUTANT
597, 1fhxB, 0.5268, 2.91, 0.018, 124, 56, STRUCTURE OF THE PLECKSTRIN HOMOLOGY DOMAIN FROM GRP1 IN COMPLEX WITH INOSITOL 1345-TETRAKISPHOSPHATE
598, 1dzkA, 0.5268, 3.35, 0.078, 148, 64, PORCINE ODORANT BINDING PROTEIN COMPLEXED WITH PYRAZINE (2-ISOBUTYL-3-METOXYPYRAZINE)
599, 5uwpB, 0.5266, 3.05, 0.034, 128, 58, CRYSTAL STRUCTURE OF MDIA2 NES PEPTIDE IN COMPLEX WITH CRM1-RAN-RANBP1
600, 5fq6F, 0.5266, 3.29, 0.047, 146, 64, CRYSTAL STRUCTURE OF THE SUSCD COMPLEX BT2261-2264 FROM BACTEROIDES THETAIOTAOMICRON
601, 2poaA, 0.5266, 3.34, 0.048, 133, 63, SCHISTOSOMA MANSONI SM14 FATTY ACID-BINDING PROTEIN: IMPROVEMENT OF PROTEIN STABILITY BY SUBSTITUTION OF THE SINGLE CYS62 RESIDUE
602, 5uraA, 0.5264, 3.71, 0.095, 134, 63, ENANTIOMER-SPECIFIC BINDING OF THE POTENT ANTINOCICEPTIVE AGENT SBFI- 26 TO ANANDAMIDE TRANSPORTERS FABP7
603, 5oykA, 0.5264, 3.52, 0.066, 319, 61, OUTER-MEMBRANE EXPRESSED OMPT OF VIBRIO CHOLERAE 
604, 1ftpA, 0.5264, 3.67, 0.081, 133, 62, THREE-DIMENSIONAL STRUCTURE OF THE MUSCLE FATTY-ACID- BINDING PROTEIN ISOLATED FROM THE DESERT LOCUST SCHISTOCERCA GREGARIA
605, 1bj7A, 0.5264, 3.29, 0.063, 150, 63, BOVINE LIPOCALIN ALLERGEN BOS D 2
606, 5uwwB, 0.5263, 3.05, 0.034, 128, 58, CRYSTAL STRUCTURE OF DEAF1 PEPTIDE IN COMPLEX WITH CRM1 K579A MUTANT- RAN-RANBP1
607, 5o1rB, 0.5261, 3.44, 0.111, 115, 63, HUMAN FAB 5H2 BOUND TO NHBA-C3 FROM NEISSERIA MENINGITIDIS SEROGROUP B 
608, 2fkjB, 0.5261, 2.87, 0.075, 361, 53, THE CRYSTAL STRUCTURE OF ENGINEERED OSPA
609, 6d68A, 0.5260, 3.53, 0.016, 158, 61, UBE2G1 IN COMPLEX WITH UBIQUITIN VARIANT UBV.G1.1 
610, 3ckgA, 0.5260, 2.79, 0.094, 236, 53, THE CRYSTAL STRUCTURE OF OSPA DELETION MUTANT
611, 1a3yB, 0.5260, 3.41, 0.079, 147, 63, ODORANT BINDING PROTEIN FROM NASAL MUCOSA OF PIG
612, 2r0dB, 0.5259, 2.84, 0.036, 341, 56, CRYSTAL STRUCTURE OF AUTOINHIBITED FORM OF GRP1 ARF GTPASE EXCHANGE FACTOR
613, 5uwhB, 0.5258, 3.01, 0.034, 126, 58, CRYSTAL STRUCTURE OF PAXILLIN NES PEPTIDE IN COMPLEX WITH CRM1-RAN- RANBP1
614, 5d16A, 0.5258, 3.30, 0.085, 161, 59, STRUCTURE OF THE C-TERMINAL DOMAIN OF TNSE DOUBLE MUTANT - A453V/D523N
615, 6ehdA, 0.5257, 3.32, 0.069, 322, 58, OMPT (IN-VITRO FOLDED); AN OUTER MEMBRANE PROTEIN OF VIBRIO CHOLERAE 
616, 4gmxB, 0.5257, 3.07, 0.034, 123, 58, CRYSTAL STRUCTURE OF KPT185 IN COMPLEX WITH CRM1-RAN-RANBP1
617, 3c5oA, 0.5257, 3.03, 0.068, 148, 59, CRYSTAL STRUCTURE OF THE CONSERVED PROTEIN OF UNKNOWN FUNCTION RPA1785 FROM RHODOPSEUDOMONAS PALUSTRIS
618, 3fiqA, 0.5256, 3.45, 0.125, 154, 64, ODORANT BINDING PROTEIN OBP1
619, 3fw4B, 0.5255, 3.55, 0.081, 142, 62, CRYSTAL STRUCTURE OF SIDEROCALIN (NGAL LIPOCALIN 2) COMPLEXED WITH FERRIC CATECHOL
620, 1fgyA, 0.5255, 2.82, 0.036, 125, 56, GRP1 PH DOMAIN WITH INS(1345)P4
621, 6a3cB, 0.5253, 3.06, 0.034, 128, 58, MVM NES MUTANT NM12 IN COMPLEX WITH CRM1-RAN-RANBP1 
622, 5uwrB, 0.5253, 3.06, 0.034, 127, 58, CRYSTAL STRUCTURE OF CDC7 NES PEPTIDE (EXTENDED) IN COMPLEX WITH CRM1- RAN-RANBP1
623, 4havB, 0.5253, 3.06, 0.034, 131, 58, CRYSTAL STRUCTURE OF CRM1 INHIBITOR ANGUINOMYCIN A IN COMPLEX WITH CRM1-RAN-RANBP1
624, 1g90A, 0.5253, 3.12, 0.016, 176, 63, NMR SOLUTION STRUCTURE OF OUTER MEMBRANE PROTEIN A TRANSMEMBRANE DOMAIN: 10 CONFORMERS
625, 5dhfB, 0.5251, 3.07, 0.034, 127, 58, CRYSTAL STRUCTURE OF HRIO2 NES PEPTIDE IN COMPLEX WITH CRM1-RAN-RANBP1
626, 1e06B, 0.5250, 3.36, 0.081, 147, 62, PORCINE ODORANT BINDING PROTEIN COMPLEXED WITH 5-METHYL-2-(1-METHYLETHYL)PHENOL
627, 5uwqB, 0.5249, 3.07, 0.034, 128, 58, CRYSTAL STRUCTURE OF CDC7 NES PEPTIDE IN COMPLEX WITH CRM1-RAN-RANBP1
628, 4o4uD, 0.5248, 3.55, 0.062, 507, 64, CRYSTAL STRUCTURE OF THE VACCINE ANTIGEN TRANSFERRIN BINDING PROTEIN B (TBPB) MUTANT TRP-176-ALA FROM HAEMOPHILUS PARASUIS HP5
629, 2r73D, 0.5247, 3.28, 0.016, 146, 62, CRYSTAL STRUCTURE OF THE POSSUM MILK WHEY LIPOCALIN TRICHOSURIN AT PH 8.2
630, 6a3aB, 0.5246, 3.04, 0.034, 129, 58, MVM NES MUTANT NM2 IN COMPLEX WITH CRM1-RAN-RANBP1 
631, 1dzmB, 0.5246, 3.40, 0.079, 147, 63, PORCINE ODORANT BINDING PROTEIN COMPLEXED WITH BENZOIC ACID PHENYLMETHYLESTER
632, 4haxB, 0.5245, 3.07, 0.034, 131, 58, CRYSTAL STRUCTURE OF CRM1 INHIBITOR RATJADONE A IN COMPLEX WITH CRM1(K579A)-RAN-RANBP1
633, 4bboD, 0.5245, 3.13, 0.079, 110, 63, CRYSTAL STRUCTURE OF CORE-BRADAVIDIN
634, 4bboB, 0.5245, 3.16, 0.079, 113, 63, CRYSTAL STRUCTURE OF CORE-BRADAVIDIN
635, 2je2A, 0.5244, 3.25, 0.069, 157, 58, CYTOCHROME P460 FROM NITROSOMONAS EUROPAEA - PROBABLE NONPHYSIOLOGICAL OXIDIZED FORM
636, 5jakA, 0.5243, 3.38, 0.119, 140, 59, CRYSTAL STRUCTURE OF THE FLAGELLAR ASSEMBLY FACTOR FLIW
637, 5di9B, 0.5243, 3.02, 0.034, 128, 58, CRYSTAL STRUCTURE OF HRIO2 NES REVERSE MUTANT PEPTIDE IN COMPLEX WITH CRM1-RAN-RANBP1
638, 4hawB, 0.5243, 3.06, 0.034, 131, 58, CRYSTAL STRUCTURE OF CRM1 INHIBITOR LEPTOMYCIN B IN COMPLEX WITH CRM1(K548A)-RAN-RANBP1
639, 2yg2A, 0.5243, 3.15, 0.115, 162, 61, STRUCTURE OF APOLIOPROTEIN M IN COMPLEX WITH SPHINGOSINE 1-PHOSPHATE
640, 6ezzA, 0.5242, 3.56, 0.049, 718, 61, CRYSTAL STRUCTURE OF ESCHERICHIA COLI AMINE OXIDASE MUTANT E573Q 
641, 3pcsC, 0.5242, 2.98, 0.073, 345, 55, STRUCTURE OF ESPG-PAK2 AUTOINHIBITORY IALPHA3 HELIX COMPLEX
642, 6hwhA, 0.5241, 3.23, 0.082, 380, 61, STRUCTURE OF A FUNCTIONAL OBLIGATE RESPIRATORY SUPERCOMPLEX FROM MYCOBACTERIUM SMEGMATIS 
643, 1spuA, 0.5241, 3.56, 0.049, 717, 61, STRUCTURE OF OXIDOREDUCTASE
644, 6a3bB, 0.5240, 3.06, 0.034, 129, 58, MVM NES MUTANT NM13 IN COMPLEX WITH CRM1-RAN-RANBP1 
645, 5dmdA, 0.5240, 3.45, 0.082, 144, 61, CRYSTAL STRUCTURE OF THE FLAGELLAR ASSEMBLY FACTOR FLIW
646, 4wfuA, 0.5240, 3.29, 0.063, 151, 63, BOVINE ALLERGEN BOS D 2 IN THE TRIGONAL SPACE GROUP P3221.
647, 6os5A, 0.5239, 2.79, 0.055, 353, 55, CRYSTAL STRUCTURE OF CYMD PRENYLTRANSFERASE COMPLEXED WITH L- TRYPTOPHAN 
648, 1dzkB, 0.5239, 3.40, 0.079, 148, 63, PORCINE ODORANT BINDING PROTEIN COMPLEXED WITH PYRAZINE (2-ISOBUTYL-3-METOXYPYRAZINE)
649, 5dhaB, 0.5238, 3.06, 0.034, 127, 58, CRYSTAL STRUCTURE OF CPEB4 NES REVERSE MUTANT PEPTIDE IN COMPLEX WITH CRM1-RAN-RANBP1
650, 2je3A, 0.5238, 3.25, 0.069, 157, 58, CYTOCHROME P460 FROM NITROSOMONAS EUROPAEA - PROBABLE PHYSIOLOGICAL FORM
651, 5jxmA, 0.5237, 2.76, 0.036, 356, 55, CRYSTAL STRUCTURE OF PRENYLTRANSFERASE PRIB APO FORM
652, 4gptB, 0.5237, 3.00, 0.052, 123, 58, CRYSTAL STRUCTURE OF KPT251 IN COMPLEX WITH CRM1-RAN-RANBP1
653, 6e0zD, 0.5236, 3.24, 0.085, 161, 59, A131Q MUTANT OF CYT P460 OF NITROSOMONAS SP. AL212 
654, 4o4uA, 0.5236, 3.68, 0.062, 505, 65, CRYSTAL STRUCTURE OF THE VACCINE ANTIGEN TRANSFERRIN BINDING PROTEIN B (TBPB) MUTANT TRP-176-ALA FROM HAEMOPHILUS PARASUIS HP5
655, 5lalA, 0.5234, 3.44, 0.067, 153, 60, STRUCTURE OF ARABIDOPSIS DIRIGENT PROTEIN ATDIR6
656, 3szhA, 0.5234, 3.25, 0.063, 115, 63, CRYSTAL STRUCTURE OF APO SHWANAVIDIN (P1 FORM)
657, 3rwrV, 0.5234, 2.51, 0.040, 157, 50, CRYSTAL STRUCTURE OF THE HUMAN XRCC4-XLF COMPLEX
658, 2oy5O, 0.5232, 3.16, 0.057, 250, 53, THE CRYSTAL STRUCTURE OF OSPA MUTANT
659, 4u3qB, 0.5231, 2.92, 0.119, 99, 59, CRYSTAL STRUCTURE OF RECOMBINANT TP0435 FROM TREPONEMA PALLIDUM
660, 1dyuA, 0.5231, 3.57, 0.049, 717, 61, THE ACTIVE SITE BASE CONTROLS COFACTOR REACTIVITY IN ESCHERICHIA COLI AMINE OXIDASE: X-RAY CRYSTALLOGRAPHIC STUDIES WITH MUTATIONAL VARIANTS.
661, 5o1rA, 0.5230, 3.46, 0.095, 115, 63, HUMAN FAB 5H2 BOUND TO NHBA-C3 FROM NEISSERIA MENINGITIDIS SEROGROUP B 
662, 1fgzA, 0.5230, 2.86, 0.036, 125, 56, GRP1 PH DOMAIN (UNLIGANDED)
663, 1vyfA, 0.5228, 3.64, 0.081, 135, 62, SCHISTOSOMA MANSONI FATTY ACID BINDING PROTEIN IN COMPLEX WITH OLEIC ACID
664, 1u27A, 0.5228, 3.10, 0.035, 119, 57, TRIGLYCINE VARIANT OF THE ARNO PLECKSTRIN HOMOLOGY DOMAIN IN COMPLEX WITH INS(1345)P4
665, 1j7dA, 0.5227, 3.53, 0.051, 140, 59, CRYSTAL STRUCTURE OF HMMS2-HUBC13
666, 4wfvA, 0.5226, 3.32, 0.063, 153, 63, BOVINE ALLERGEN BOS D 2 IN THE MONOCLINIC SPACE GROUP C2.
667, 5uwtB, 0.5225, 3.04, 0.034, 127, 58, CRYSTAL STRUCTURE OF HXK2 PEPTIDE IN COMPLEX WITH CRM1 K579A MUTANT- RAN-RANBP1
668, 4o4uC, 0.5224, 3.60, 0.050, 499, 60, CRYSTAL STRUCTURE OF THE VACCINE ANTIGEN TRANSFERRIN BINDING PROTEIN B (TBPB) MUTANT TRP-176-ALA FROM HAEMOPHILUS PARASUIS HP5
669, 5ystB, 0.5223, 3.01, 0.052, 123, 58, RANM189D IN COMPLEX WITH RANBP1-CRM1 
670, 3jcuo, 0.5223, 3.44, 0.123, 243, 65, CRYO-EM STRUCTURE OF SPINACH PSII-LHCII SUPERCOMPLEX AT 3.2 ANGSTROM RESOLUTION
671, 3jcuO, 0.5223, 3.44, 0.123, 243, 65, CRYO-EM STRUCTURE OF SPINACH PSII-LHCII SUPERCOMPLEX AT 3.2 ANGSTROM RESOLUTION
672, 1e00B, 0.5223, 3.40, 0.079, 148, 63, PORCINE ODORANT BINDING PROTEIN COMPLEXED WITH 26-DIMETHYL-7-OCTEN-2-OL
673, 1dzjB, 0.5223, 3.38, 0.063, 148, 63, PORCINE ODORANT BINDING PROTEIN COMPLEXED WITH 2-AMINO-4-BUTYL-5-PROPYLSELENAZOLE
674, 5yroB, 0.5222, 3.01, 0.052, 123, 58, RANL182A IN COMPLEX WITH RANBP1-CRM1 
675, 3ii6C, 0.5222, 2.31, 0.061, 201, 49, STRUCTURE OF HUMAN XRCC4 IN COMPLEX WITH THE TANDEM BRCT DOMAINS OF DNA LIGASEIV.
676, 1lvnA, 0.5222, 3.56, 0.049, 717, 61, CRYSTAL STRUCTURE OF E. COLI AMINE OXIDASE COMPLEXED WITH TRANYLCYPROMINE
677, 4e1tA, 0.5221, 4.03, 0.092, 245, 65, X-RAY CRYSTAL STRUCTURE OF THE TRANSMEMBRANE BETA-DOMAIN FROM INVASIN FROM YERSINIA PSEUDOTUBERCULOSIS
678, 1e5pD, 0.5219, 3.11, 0.148, 146, 61, CRYSTAL STRUCTURE OF APHRODISIN A SEX PHEROMONE FROM FEMALE HAMSTER
679, 5bvqA, 0.5218, 3.53, 0.081, 132, 62, LIGAND-UNBOUND PFABP4
680, 3vonY, 0.5218, 3.28, 0.035, 137, 57, CRYSTALSTRUCTURE OF THE UBIQUITIN PROTEASE
681, 5xnlo, 0.5217, 3.41, 0.154, 248, 65, STRUCTURE OF STACKED C2S2M2-TYPE PSII-LHCII SUPERCOMPLEX FROM PISUM SATIVUM
682, 5xnlO, 0.5217, 3.41, 0.154, 248, 65, STRUCTURE OF STACKED C2S2M2-TYPE PSII-LHCII SUPERCOMPLEX FROM PISUM SATIVUM
683, 2wofA, 0.5217, 3.32, 0.051, 717, 59, EDTA TREATED E. COLI COPPER AMINE OXIDASE
684, 3vonm, 0.5216, 3.28, 0.035, 137, 57, CRYSTALSTRUCTURE OF THE UBIQUITIN PROTEASE
685, 2y32D, 0.5216, 3.18, 0.079, 137, 63, CRYSTAL STRUCTURE OF BRADAVIDIN
686, 1vygA, 0.5216, 3.62, 0.079, 135, 63, SCHISTOSOMA MANSONI FATTY ACID BINDING PROTEIN IN COMPLEX WITH ARACHIDONIC ACID
687, 3vonF, 0.5215, 3.32, 0.035, 138, 57, CRYSTALSTRUCTURE OF THE UBIQUITIN PROTEASE
688, 1dzpB, 0.5215, 3.28, 0.079, 147, 63, PORCINE ODORANT BINDING PROTEIN COMPLEXED WITH DIPHENYLMETHANONE
689, 4puxA, 0.5214, 3.02, 0.070, 155, 57, CRYSTAL STRUCTURE OF A BETA-BARREL LIKE PROTEIN (ABAYE2633) FROM ACINETOBACTER BAUMANNII AYE AT 1.43 A RESOLUTION
690, 2kt4B, 0.5214, 3.15, 0.050, 157, 60, LIPOCALIN Q83 IS A SIDEROCALIN
691, 1qalA, 0.5213, 3.44, 0.050, 717, 60, THE ACTIVE SITE BASE CONTROLS COFACTOR REACTIVITY IN ESCHERICHIA COLI AMINE OXIDASE : X-RAY CRYSTALLOGRAPHIC STUDIES WITH MUTATIONAL VARIANTS
692, 5dh9B, 0.5212, 3.02, 0.052, 128, 58, CRYSTAL STRUCTURE OF PKI NES FLIP MUTANT PEPTIDE IN COMPLEX WITH CRM1- RAN-RANBP1
693, 5hz8A, 0.5211, 3.71, 0.063, 135, 63, FABP4_3 IN COMPLEX WITH 68-DICHLORO-4-PHENYL-2-PIPERIDIN-1-YL- QUINOLINE-3-CARBOXYLIC ACID
694, 2ra6B, 0.5209, 3.06, 0.049, 142, 61, CRYSTAL STRUCTURE OF THE POSSUM MILK WHEY LIPOCALIN TRICHOSURIN AT PH 4.6 WITH BOUND 4-ETHYLPHENOL
695, 1towA, 0.5209, 3.66, 0.063, 131, 63, CRYSTAL STRUCTURE OF HUMAN ADIPOCYTE FATTY ACID BINDING PROTEIN IN COMPLEX WITH A CARBOXYLIC ACID LIGAND
696, 1ry9C, 0.5209, 3.31, 0.017, 133, 60, SPA15 A TYPE III SECRETION CHAPERONE FROM SHIGELLA FLEXNERI
697, 1eysH, 0.5209, 2.94, 0.071, 238, 56, CRYSTAL STRUCTURE OF PHOTOSYNTHETIC REACTION CENTER FROM A THERMOPHILIC BACTERIUM THERMOCHROMATIUM TEPIDUM
698, 1bwyA, 0.5209, 3.61, 0.113, 132, 62, NMR STUDY OF BOVINE HEART FATTY ACID BINDING PROTEIN
699, 6a3eB, 0.5208, 3.03, 0.052, 128, 58, MVM NES MUTANT NM15 IN COMPLEX WITH CRM1-RAN-RANBP1 
700, 2r73A, 0.5208, 3.31, 0.016, 146, 62, CRYSTAL STRUCTURE OF THE POSSUM MILK WHEY LIPOCALIN TRICHOSURIN AT PH 8.2
701, 6icsO, 0.5206, 3.29, 0.073, 242, 55, LOOP DELETION MUTANT (DELETING FOUR RESIDUES) 
702, 1xi6A, 0.5206, 3.66, 0.100, 234, 60, EXTRAGENIC SUPPRESSOR FROM PYROCOCCUS FURIOSUS PFU-1862794- 001
703, 1hqpA, 0.5206, 3.40, 0.078, 149, 64, CRYSTAL STRUCTURE OF A TRUNCATED FORM OF PORCINE ODORANT- BINDING PROTEIN
704, 5jljB, 0.5205, 3.05, 0.034, 126, 58, CRYSTAL STRUCTURE OF KPT8602 IN COMPLEX WITH CRM1-RAN-RANBP1
705, 5ixhA, 0.5205, 3.06, 0.067, 159, 60, CRYSTAL STRUCTURE OF BURKHOLDERIA CENOCEPACIA BCNA
706, 5bvqB, 0.5205, 3.54, 0.081, 132, 62, LIGAND-UNBOUND PFABP4
707, 2ge4A, 0.5205, 3.09, 0.048, 177, 63, HIGH-RESOLUTION SOLUTION STRUCTURE OF OUTER MEMBRANE PROTEIN A TRANSMEMBRANE DOMAIN
708, 4o4xB, 0.5204, 2.82, 0.037, 502, 54, CRYSTAL STRUCTURE OF THE VACCINE ANTIGEN TRANSFERRIN BINDING PROTEIN B (TBPB) DOUBLE MUTANT TYR-167-ALA AND TRP-176-ALA FROM HAEMOPHILUS PARASUIS HP5
709, 3vonB, 0.5202, 3.15, 0.036, 138, 56, CRYSTALSTRUCTURE OF THE UBIQUITIN PROTEASE
710, 1exsA, 0.5202, 3.20, 0.100, 160, 60, STRUCTURE OF PORCINE BETA-LACTOGLOBULIN
711, 1vdwA, 0.5201, 3.64, 0.067, 248, 60, A HYPOTHETICAL PROTEIN PH1897 FROM PYROCOCCUS HORIKOSHII WITH SIMILARITIES FOR INOSITOL-1 MONOPHOSPHATASE
712, 1ry9A, 0.5201, 3.33, 0.017, 133, 60, SPA15 A TYPE III SECRETION CHAPERONE FROM SHIGELLA FLEXNERI
713, 4o4xA, 0.5198, 2.75, 0.019, 503, 54, CRYSTAL STRUCTURE OF THE VACCINE ANTIGEN TRANSFERRIN BINDING PROTEIN B (TBPB) DOUBLE MUTANT TYR-167-ALA AND TRP-176-ALA FROM HAEMOPHILUS PARASUIS HP5
714, 2nnqA, 0.5198, 3.74, 0.063, 131, 63, CRYSTAL STRUCTURE OF HUMAN ADIPOCYTE FATTY ACID BINDING PROTEIN IN COMPLEX WITH ((2 -(5-ETHYL-34-DIPHENYL-1H-PYRAZOL-1-YL)-3- BIPHENYLYL)OXY)ACETIC ACID
715, 4zjmB, 0.5196, 3.08, 0.140, 110, 57, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS LPQH (RV3763)
716, 1ry9D, 0.5196, 3.31, 0.017, 133, 60, SPA15 A TYPE III SECRETION CHAPERONE FROM SHIGELLA FLEXNERI
717, 2ra6D, 0.5194, 3.34, 0.032, 143, 62, CRYSTAL STRUCTURE OF THE POSSUM MILK WHEY LIPOCALIN TRICHOSURIN AT PH 4.6 WITH BOUND 4-ETHYLPHENOL
718, 4ghbA, 0.5193, 3.17, 0.130, 252, 54, CRYSTAL STRUCTURE OF A PORIN-LIKE PROTEIN (BACUNI_01323) FROM BACTEROIDES UNIFORMIS ATCC 8492 AT 2.32 A RESOLUTION
719, 3cegB, 0.5193, 3.50, 0.067, 285, 60, CRYSTAL STRUCTURE OF THE UBC DOMAIN OF BACULOVIRAL IAP REPEAT- CONTAINING PROTEIN 6
720, 4ylaA, 0.5191, 3.17, 0.066, 374, 61, CRYSTAL STRUCTURE OF THE INDOLE PRENYLTRANSFERASE MPND COMPLEXED WITH INDOLACTAM V AND DMSPP
721, 2ra6C, 0.5191, 3.36, 0.032, 143, 62, CRYSTAL STRUCTURE OF THE POSSUM MILK WHEY LIPOCALIN TRICHOSURIN AT PH 4.6 WITH BOUND 4-ETHYLPHENOL
722, 2fljA, 0.5191, 3.65, 0.063, 133, 63, FATTY ACID BINDING PROTEIN FROM LOCUST FLIGHT MUSCLE IN COMPLEX WITH OLEATE
723, 1ftpB, 0.5191, 3.65, 0.063, 133, 63, THREE-DIMENSIONAL STRUCTURE OF THE MUSCLE FATTY-ACID- BINDING PROTEIN ISOLATED FROM THE DESERT LOCUST SCHISTOCERCA GREGARIA
724, 5epqA, 0.5188, 3.58, 0.000, 153, 66, STRUCTURE AT 1.75 A RESOLUTION OF A GLYCOSYLATED LIPID-BINDING LIPOCALIN-LIKE PROTEIN
725, 4nyqA, 0.5188, 3.58, 0.000, 153, 66, IN-VIVO CRYSTALLISATION (MIDGUTS OF A VIVIPAROUS COCKROACH) AND STRUCTURE AT 1.2 A RESOLUTION OF A GLYCOSYLATED LIPID-BINDING LIPOCALIN-LIKE PROTEIN
726, 2uz2D, 0.5188, 3.30, 0.016, 119, 63, CRYSTAL STRUCTURE OF XENAVIDIN
727, 6aylA, 0.5185, 3.75, 0.048, 133, 63, HUMAN ADIPOCYTE LIPID-BINDING PROTEIN FABP4 IN COMPLEX WITH FLUORESCEIN 
728, 3ii6A, 0.5185, 2.44, 0.060, 201, 50, STRUCTURE OF HUMAN XRCC4 IN COMPLEX WITH THE TANDEM BRCT DOMAINS OF DNA LIGASEIV.
729, 3dlaB, 0.5183, 3.79, 0.103, 649, 58, X-RAY CRYSTAL STRUCTURE OF GLUTAMINE-DEPENDENT NAD+ SYNTHETASE FROM MYCOBACTERIUM TUBERCULOSIS BOUND TO NAAD+ AND DON
730, 3b2iA, 0.5181, 3.73, 0.079, 130, 63, IODIDE DERIVATIVE OF HUMAN LFABP
731, 5d17G, 0.5180, 3.34, 0.086, 156, 58, STRUCTURE OF THE C-TERMINAL DOMAIN OF TNSE AT 2.85 RESOLUTION
732, 3p6fA, 0.5180, 3.70, 0.048, 139, 63, HUMAN ADIPOCYTE LIPID-BINDING PROTEIN FABP4 IN COMPLEX WITH (S)-3- PHENYL BUTYRIC ACID
733, 3snvA, 0.5179, 3.03, 0.153, 125, 59, CRYSTAL STRUCTURE OF SYMFOIL-4T PERMUTATION  1: DE NOVO DESIGNED BETA- TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE
734, 3p6eA, 0.5179, 3.69, 0.048, 139, 63, HUMAN ADIPOCYTE LIPID-BINDING PROTEIN FABP4 IN COMPLEX WITH 3-(4- METHOXYPHENYL) PROPIONIC ACID
735, 2r0dA, 0.5179, 3.15, 0.018, 343, 57, CRYSTAL STRUCTURE OF AUTOINHIBITED FORM OF GRP1 ARF GTPASE EXCHANGE FACTOR
736, 1g65L, 0.5179, 3.63, 0.107, 222, 56, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
737, 5d48A, 0.5178, 3.71, 0.063, 136, 63, CRYSTAL STRUCTURE OF FABP4 IN COMPLEX WITH 3-{5-CYCLOPROPYL-3-(35- DIMETHYL-1H-PYRAZOL-4-YL)-2-[3-(PROPAN-2-YLOXY) PHENYL]-1H-INDOL-1- YL}PROPANOIC ACID
738, 4l6eA, 0.5177, 2.99, 0.053, 120, 57, CRYSTAL STRUCTURE OF THE RANBD1 FOURTH DOMAIN OF E3 SUMO-PROTEIN LIGASE RANBP2. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET HR9193B
739, 1lf6A, 0.5177, 2.63, 0.115, 674, 52, CRYSTAL STRUCTURE OF BACTERIAL GLUCOAMYLASE
740, 5y5sH, 0.5174, 3.16, 0.070, 255, 57, STRUCTURE OF PHOTOSYNTHETIC LH1-RC SUPER-COMPLEX AT 1.9 ANGSTROM RESOLUTION 
741, 5dyvB, 0.5174, 2.86, 0.071, 133, 56, ABYU - WILDTYPE
742, 3sytB, 0.5174, 3.86, 0.121, 660, 58, CRYSTAL STRUCTURE OF GLUTAMINE-DEPENDENT NAD+ SYNTHETASE FROM M. TUBERCULOSIS BOUND TO AMP/PPI NAD+ AND GLUTAMATE
743, 2hlvA, 0.5174, 3.06, 0.113, 149, 62, BOVINE ODORANT BINDING PROTEIN DESWAPPED TRIPLE MUTANT
744, 3cegA, 0.5172, 3.51, 0.067, 285, 60, CRYSTAL STRUCTURE OF THE UBC DOMAIN OF BACULOVIRAL IAP REPEAT- CONTAINING PROTEIN 6
745, 5y12A, 0.5170, 3.65, 0.048, 136, 63, CRYSTAL STRUCTURE OF HUMAN FABP4 COMPLEXED WITH LIGAND 5-((4- METHOXYNAPHTHALENE)-1-SULFONAMIDO)PENTANOIC ACID 
746, 4qltZ, 0.5170, 3.64, 0.107, 222, 56, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
747, 5cybA, 0.5169, 3.03, 0.052, 89, 58, STRUCTURE OF A LIPOCALIN LIPOPROTEIN AFFECTING VIRULENCE IN STREPTOCOCCUS PNEUMONIAE
748, 4qltL, 0.5169, 3.64, 0.107, 222, 56, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
749, 4gdaA, 0.5169, 3.19, 0.048, 124, 62, CIRCULAR PERMUTED STREPTAVIDIN A50/N49
750, 1fhxA, 0.5169, 2.96, 0.035, 122, 57, STRUCTURE OF THE PLECKSTRIN HOMOLOGY DOMAIN FROM GRP1 IN COMPLEX WITH INOSITOL 1345-TETRAKISPHOSPHATE
751, 1e5pC, 0.5169, 3.27, 0.113, 144, 62, CRYSTAL STRUCTURE OF APHRODISIN A SEX PHEROMONE FROM FEMALE HAMSTER
752, 2hnxA, 0.5168, 3.73, 0.063, 136, 63, CRYSTAL STRUCTURE OF AP2
753, 5uraB, 0.5167, 3.76, 0.111, 135, 63, ENANTIOMER-SPECIFIC BINDING OF THE POTENT ANTINOCICEPTIVE AGENT SBFI- 26 TO ANANDAMIDE TRANSPORTERS FABP7
754, 4zjmE, 0.5167, 3.15, 0.140, 113, 57, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS LPQH (RV3763)
755, 3t2xD, 0.5167, 3.16, 0.119, 119, 59, STRUCTURE OF SHWANAVIDIN LOW AFFINITY MUTANT (F43A)
756, 3sziJ, 0.5167, 3.27, 0.078, 119, 64, STRUCTURE OF APO SHWANAVIDIN (P21 FORM)
757, 1swgA, 0.5167, 3.24, 0.048, 112, 62, CIRCULAR PERMUTED STREPTAVIDIN E51/A46 IN COMPLEX WITH BIOTIN
758, 1fhwA, 0.5166, 3.04, 0.035, 122, 57, STRUCTURE OF THE PLECKSTRIN HOMOLOGY DOMAIN FROM GRP1 IN COMPLEX WITH INOSITOL(13456)PENTAKISPHOSPHATE
759, 3t2xA, 0.5164, 3.16, 0.136, 119, 59, STRUCTURE OF SHWANAVIDIN LOW AFFINITY MUTANT (F43A)
760, 3q6lA, 0.5163, 3.72, 0.063, 131, 63, CRYSTAL STRUCTURE OF HUMAN ADIPOCYTE FATTY ACID BINDING PROTEIN (FABP4) AT 1.4 ANG. RESOLUTION
761, 1ryp1, 0.5163, 3.66, 0.107, 222, 56, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
762, 5y13A, 0.5162, 3.66, 0.048, 136, 63, CRYSTAL STRUCTURE OF HUMAN FABP4 COMPLEXED WITH LIGAND 5-((4- BROMONAPHTHALENE)-1-SULFONAMIDO)PENTANOIC ACID 
763, 1u29A, 0.5162, 3.17, 0.053, 119, 57, TRIGLYCINE VARIANT OF THE ARNO PLECKSTRIN HOMOLOGY DOMAIN IN COMPLEX WITH INS(145)P3
764, 1swgB, 0.5162, 3.24, 0.048, 112, 62, CIRCULAR PERMUTED STREPTAVIDIN E51/A46 IN COMPLEX WITH BIOTIN
765, 6hv4Z, 0.5161, 3.49, 0.109, 222, 55, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH ONX 0914 
766, 6hv4L, 0.5161, 3.49, 0.109, 222, 55, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH ONX 0914 
767, 6hihB, 0.5161, 3.26, 0.018, 136, 56, CYTOCHROME C PRIME BETA FROM METHYLOCOCCUS CAPSULATUS (BATH) 
768, 5l54Z, 0.5161, 3.64, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
769, 3zxuA, 0.5161, 3.29, 0.086, 211, 58, CRYSTAL STRUCTURE OF THE CTF19-MCM21 KINETOCHORE HETERODIMER FROM YEAST
770, 3fr2A, 0.5161, 3.72, 0.063, 131, 63, N-BENZYL-INDOLO CARBOXYLIC ACIDS: DESIGN AND SYNTHESIS OF POTENT AND SELECTIVE ADIPOCYTE FATTY-ACID BINDING PROTEIN (A-FABP) INHIBITORS
771, 4y8hZ, 0.5160, 3.66, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
772, 3szhD, 0.5160, 3.15, 0.102, 116, 59, CRYSTAL STRUCTURE OF APO SHWANAVIDIN (P1 FORM)
773, 1pboA, 0.5160, 3.14, 0.095, 157, 63, COMPLEX OF BOVINE ODORANT BINDING PROTEIN (OBP) WITH A SELENIUM CONTAINING ODORANT
774, 5l54L, 0.5159, 3.64, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
775, 5xmzA, 0.5158, 3.43, 0.077, 122, 65, VERTICILLIUM EFFECTOR PEVD1
776, 1gt3B, 0.5158, 3.16, 0.095, 155, 63, COMPLEX OF BOVINE ODORANT BINDING PROTEIN WITH DIHYDROMYRCENOL
777, 4jsuZ, 0.5157, 3.65, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
778, 4jsuL, 0.5157, 3.65, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
779, 3sdiL, 0.5157, 3.66, 0.107, 222, 56, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
780, 3sdbA, 0.5157, 3.64, 0.105, 647, 57, CRYSTAL STRUCTURE OF C176A MUTANT OF GLUTAMINE-DEPENDENT NAD+ SYNTHETASE FROM M. TUBERCULOSIS IN APO FORM
781, 3fr4A, 0.5157, 3.73, 0.063, 131, 63, N-BENZYL-INDOLO CARBOXYLIC ACIDS: DESIGN AND SYNTHESIS OF POTENT AND SELECTIVE ADIPOCYTE FATTY-ACID BINDING PROTEIN (A-FABP) INHIBITORS
782, 5bvsA, 0.5156, 3.58, 0.081, 132, 62, LINOLEATE-BOUND PFABP4
783, 3nzxL, 0.5156, 3.65, 0.107, 222, 56, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
784, 3aa6B, 0.5156, 2.58, 0.130, 242, 54, CRYSTAL STRUCTURE OF ACTIN CAPPING PROTEIN IN COMPLEX WITH THE CP- BINDING MOTIF DERIVED FROM CD2AP
785, 6hvwL, 0.5155, 3.66, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 43 
786, 5y0xA, 0.5155, 3.67, 0.048, 136, 63, CRYSTAL STRUCTURE OF HUMAN FABP4 COMPLEXED WITH LIGAND 2-FLUORO-3-((4- METHOXYNAPHTHALENE)-1-SULFONAMIDO)BENZOIC ACID 
787, 3szgC, 0.5155, 3.87, 0.121, 660, 58, CRYSTAL STRUCTURE OF C176A GLUTAMINE-DEPENDENT NAD+ SYNTHETASE FROM M. TUBERCULOSIS BOUND TO AMP/PPI AND NAAD+
788, 3mg7Z, 0.5155, 3.66, 0.107, 222, 56, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
789, 3mg6Z, 0.5155, 3.66, 0.107, 222, 56, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
790, 4y8gZ, 0.5154, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
791, 4qjoC, 0.5154, 3.44, 0.117, 261, 60, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF HUMAN CARBONIC ANHYDRASE ISOZYME XII WITH INHIBITOR
792, 3un4L, 0.5154, 3.66, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
793, 3snvB, 0.5154, 3.09, 0.153, 124, 59, CRYSTAL STRUCTURE OF SYMFOIL-4T PERMUTATION  1: DE NOVO DESIGNED BETA- TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE
794, 3nzxZ, 0.5154, 3.65, 0.107, 222, 56, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
795, 3c5oB, 0.5154, 3.35, 0.032, 152, 63, CRYSTAL STRUCTURE OF THE CONSERVED PROTEIN OF UNKNOWN FUNCTION RPA1785 FROM RHODOPSEUDOMONAS PALUSTRIS
796, 1rypM, 0.5154, 3.66, 0.107, 222, 56, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
797, 4y8gL, 0.5153, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
798, 4bj8O, 0.5153, 3.20, 0.048, 122, 63, ZEBAVIDIN
799, 3un4Z, 0.5153, 3.66, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
800, 5y0gA, 0.5152, 3.69, 0.048, 136, 63, CRYSTAL STRUCTURE OF HUMAN FABP4 COMPLEXED WITH LIGAND 4-FLUORO-3-((4- METHOXYNAPHTHALENE)-1-SULFONAMIDO) BENZOIC ACID 
801, 5dmdB, 0.5152, 3.54, 0.082, 141, 61, CRYSTAL STRUCTURE OF THE FLAGELLAR ASSEMBLY FACTOR FLIW
802, 4yl7A, 0.5152, 3.10, 0.032, 370, 63, CRYSTAL STRUCTURE OF THE INDOLE PRENYLTRANSFERASE MPND FROM MARINACTINOSPORA THERMOTOLERANS
803, 4qjwC, 0.5152, 3.45, 0.117, 261, 60, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF HUMAN CARBONIC ANHYDRASE ISOZYME XII WITH INHIBITOR
804, 4y84L, 0.5151, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
805, 5haeA, 0.5150, 3.32, 0.078, 155, 64, CRYSTAL STRUCTURE OF LTBP1 LTC4 COMPLEX COLLECTED ON AN IN-HOUSE SOURCE
806, 4runB, 0.5150, 3.30, 0.050, 152, 60, CRYSTAL STRUCTURE OF HUMAN ODORANT BINDING PROTEIN OBPIIA
807, 3sdiZ, 0.5150, 3.67, 0.107, 222, 56, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
808, 1g85B, 0.5150, 3.17, 0.095, 155, 63, CRYSTAL STRUCTURE OF BOVINE ODORANT BINDING PROTEIN COMPLEXED WITH IS NATURAL LIGAND
809, 1g65Z, 0.5150, 3.48, 0.109, 222, 55, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
810, 1g0uZ, 0.5150, 3.66, 0.107, 222, 56, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
811, 4y84Z, 0.5149, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
812, 3mg8L, 0.5149, 3.66, 0.107, 222, 56, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
813, 3gpjL, 0.5149, 3.67, 0.107, 222, 56, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
814, 4y8hL, 0.5148, 3.49, 0.109, 222, 55, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
815, 1hn2B, 0.5148, 3.16, 0.095, 155, 63, CRYSTAL STRUCTURE OF BOVINE OBP COMPLEXED WITH AMINOANTHRACENE
816, 6g7aB, 0.5147, 3.58, 0.115, 262, 61, CRYSTAL STRUCTURE OF HUMAN CARBONIC ANHYDRASE ISOZYME XII 2- (BENZYLAMINO)-4-CHLORO-N-(2-HYDROXYETHYL)-5-SULFAMOYL-BENZAMIDE 
817, 5l55Z, 0.5147, 3.66, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
818, 4gk7Z, 0.5147, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
819, 3oevL, 0.5147, 3.66, 0.107, 222, 56, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
820, 3gpjZ, 0.5147, 3.67, 0.107, 222, 56, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
821, 1g0uL, 0.5147, 3.66, 0.107, 222, 56, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
822, 3zxuC, 0.5146, 3.29, 0.086, 211, 58, CRYSTAL STRUCTURE OF THE CTF19-MCM21 KINETOCHORE HETERODIMER FROM YEAST
823, 3mg6L, 0.5146, 3.66, 0.107, 222, 56, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
824, 2ifbA, 0.5146, 3.70, 0.097, 131, 62, CRYSTAL STRUCTURE OF RAT INTESTINAL FATTY-ACID-BINDING PROTEIN. REFINEMENT AND ANALYSIS OF THE ESCHERICHIA COLI- DRIVED PROTEIN WITH BOUND PALMITATE
825, 6fvxAA, 0.5145, 3.73, 0.105, 222, 57, struct.pdbx_descriptor              
826, 5l55L, 0.5145, 3.66, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
827, 5f75A, 0.5145, 3.26, 0.000, 474, 57, THIOCYANATE DEHYDROGENASE FROM THIOALKALIVIBRIO PARADOXUS
828, 3t2wA, 0.5145, 3.18, 0.133, 115, 60, CRYSTAL STRUCTURE OF SHWANAVIDIN (F43A) - BIOTIN COMPLEX
829, 2c1sB, 0.5145, 3.32, 0.032, 123, 63, X-RAY STRUCTURE OF BIOTIN BINDING PROTEIN FROM CHICKEN
830, 5ha0A, 0.5144, 3.34, 0.078, 156, 64, CRYSTAL STRUCTURE OF THE LTBP1 LEUKOTRIENE D4 COMPLEX
831, 4gk7L, 0.5144, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
832, 1d6yA, 0.5143, 3.71, 0.062, 717, 64, CRYSTAL STRUCTURE OF E. COLI COPPER-CONTAINING AMINE OXIDASE ANAEROBICALLY REDUCED WITH BETA-PHENYLETHYLAMINE AND COMPLEXED WITH NITRIC OXIDE.
833, 6hvsL, 0.5142, 3.66, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 18 
834, 5y0fA, 0.5142, 3.69, 0.048, 136, 63, CRYSTAL STRUCTURE OF HUMAN FABP4 COMPLEXED WITH LIGAND 2-FLUORO-5-((4- METHOXYNAPHTHALENE)-1-SULFONAMIDO) BENZOIC ACID 
835, 4bj8K, 0.5142, 3.21, 0.048, 120, 63, ZEBAVIDIN
836, 3szgB, 0.5142, 3.80, 0.103, 649, 58, CRYSTAL STRUCTURE OF C176A GLUTAMINE-DEPENDENT NAD+ SYNTHETASE FROM M. TUBERCULOSIS BOUND TO AMP/PPI AND NAAD+
837, 3mg8Z, 0.5142, 3.67, 0.107, 222, 56, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
838, 5ll9C, 0.5141, 3.34, 0.133, 261, 60, CRYSTAL STRUCTURE OF HUMAN CARBONIC ANHYDRASE ISOZYME XII WITH 4-(1H- BENZIMIDAZOL-1-YLACETYL)-2-CHLOROBENZENESULFONAMIDE
839, 3oeuZ, 0.5141, 3.66, 0.107, 222, 56, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
840, 3fr5A, 0.5141, 3.72, 0.048, 131, 63, N-BENZYL-INDOLO CARBOXYLIC ACIDS: DESIGN AND SYNTHESIS OF POTENT AND SELECTIVE ADIPOCYTE FATTY-ACID BINDING PROTEIN (A-FABP) INHIBITORS
841, 6jluO, 0.5140, 3.26, 0.081, 249, 62, Structure of PSII-FCP supercomplex from a centric diatom Chaetoceros gracilis at 3.02 angstrom resolution  
842, 6jluNA, 0.5140, 3.26, 0.081, 249, 62, Structure of PSII-FCP supercomplex from a centric diatom Chaetoceros gracilis at 3.02 angstrom resolution  
843, 6hvwZ, 0.5140, 3.50, 0.109, 222, 55, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 43 
844, 6hvuL, 0.5140, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 29 
845, 6hvsZ, 0.5140, 3.66, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 18 
846, 4qz5Z, 0.5140, 3.66, 0.107, 222, 56, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
847, 4qz5L, 0.5140, 3.66, 0.107, 222, 56, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
848, 4qluZ, 0.5140, 3.66, 0.107, 222, 56, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
849, 4qluL, 0.5140, 3.67, 0.107, 222, 56, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
850, 4ltcZ, 0.5140, 3.65, 0.107, 222, 56, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
851, 4lqiZ, 0.5140, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
852, 3wxr1, 0.5140, 3.65, 0.107, 222, 56, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
853, 1dk4A, 0.5140, 3.73, 0.067, 252, 60, CRYSTAL STRUCTURE OF MJ0109 GENE PRODUCT INOSITOL MONOPHOSPHATASE
854, 6huqL, 0.5139, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 20 
855, 4lqiL, 0.5139, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
856, 3mg4Z, 0.5139, 3.67, 0.107, 222, 56, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
857, 3dy4L, 0.5139, 3.51, 0.109, 222, 55, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
858, 1gkaA, 0.5139, 2.98, 0.103, 180, 58, THE MOLECULAR BASIS OF THE COLORATION MECHANISM IN LOBSTER SHELL. BETA-CRUSTACYANIN AT 3.2 A RESOLUTION
859, 1g0iB, 0.5139, 3.74, 0.067, 252, 60, CRYSTAL STRUCTURE OF MJ0109 GENE PRODUCT INOSITOL MONOPHOSPHATASE-FRUCTOSE 16 BISPHOSPHATASE
860, 6hvrZ, 0.5138, 3.50, 0.109, 222, 55, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 16 
861, 6hvrL, 0.5138, 3.50, 0.109, 222, 55, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 16 
862, 6huvZ, 0.5138, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 39 
863, 6huvL, 0.5138, 3.66, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 39 
864, 6huqZ, 0.5138, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 20 
865, 6hdsC, 0.5138, 3.17, 0.161, 125, 62, CRYSTAL STRUCTURE OF APO SHORT AFIFAVIDIN 
866, 5cz8L, 0.5138, 3.66, 0.107, 222, 56, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
867, 4no6Z, 0.5138, 3.68, 0.107, 222, 56, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
868, 4no6L, 0.5138, 3.68, 0.107, 222, 56, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
869, 4nnnZ, 0.5138, 3.49, 0.109, 222, 55, YCP IN COMPLEX WITH MG132
870, 4nnnL, 0.5138, 3.49, 0.109, 222, 55, YCP IN COMPLEX WITH MG132
871, 3dy4Z, 0.5138, 3.51, 0.109, 222, 55, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
872, 1xszB, 0.5138, 3.40, 0.074, 356, 54, THE STRUCTURE OF RALF
873, 5cz8Z, 0.5137, 3.66, 0.107, 222, 56, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
874, 4g4sM, 0.5137, 3.65, 0.107, 222, 56, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
875, 3oeuL, 0.5137, 3.66, 0.107, 222, 56, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
876, 3hyeL, 0.5136, 3.67, 0.107, 222, 56, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
877, 3cxjD, 0.5136, 3.39, 0.123, 138, 57, CRYSTAL STRUCTURE OF AN UNCHARACTERIZED PROTEIN FROM METHANOTHERMOBACTER THERMAUTOTROPHICUS
878, 1xszA, 0.5136, 3.32, 0.074, 356, 54, THE STRUCTURE OF RALF
879, 4qlqZ, 0.5135, 3.51, 0.109, 222, 55, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
880, 4qlqL, 0.5135, 3.51, 0.109, 222, 55, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
881, 4qbyZ, 0.5135, 3.68, 0.107, 222, 56, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
882, 4no8L, 0.5135, 3.66, 0.107, 222, 56, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
883, 3sdkZ, 0.5135, 3.66, 0.107, 222, 56, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
884, 5d17A, 0.5134, 3.20, 0.070, 157, 57, STRUCTURE OF THE C-TERMINAL DOMAIN OF TNSE AT 2.85 RESOLUTION
885, 4qz4Z, 0.5134, 3.50, 0.109, 222, 55, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
886, 4qz4L, 0.5134, 3.50, 0.109, 222, 55, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
887, 4qbyL, 0.5134, 3.68, 0.107, 222, 56, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
888, 4no8Z, 0.5134, 3.66, 0.107, 222, 56, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
889, 3t2xB, 0.5134, 3.17, 0.119, 119, 59, STRUCTURE OF SHWANAVIDIN LOW AFFINITY MUTANT (F43A)
890, 3luzA, 0.5134, 3.51, 0.034, 238, 59, CRYSTAL STRUCTURE OF EXTRAGENIC SUPPRESSOR PROTEIN SUHB FROM BARTONELLA HENSELAE VIA COMBINED IODIDE SAD MOLECULAR REPLACEMENT
891, 3hyeZ, 0.5134, 3.67, 0.107, 222, 56, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
892, 6hw0Z, 0.5133, 3.66, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH 7 
893, 6hw0L, 0.5133, 3.66, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH 7 
894, 6huuZ, 0.5133, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 29 
895, 5llpC, 0.5133, 3.33, 0.133, 260, 60, CRYSTAL STRUCTURE OF HUMAN CARBONIC ANHYDRASEISOZYME XII WITH 3-[(1S)- 1234-TETRAHYDRONAPTHALEN-1-YLAMINO)-256-TRIFLUORO-4-[(2- HYDROXYETHYL)SULFONYL]BENZENESULFONAMIDE
896, 4y75L, 0.5133, 3.66, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
897, 4qlvZ, 0.5133, 3.66, 0.107, 222, 56, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
898, 3wmmH, 0.5133, 2.98, 0.071, 258, 56, CRYSTAL STRUCTURE OF THE LH1-RC COMPLEX FROM THERMOCHROMATIUM TEPIDUM IN C2 FORM
899, 3gpwZ, 0.5133, 3.68, 0.107, 222, 56, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
900, 4y8lZ, 0.5132, 3.66, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
901, 4y75Z, 0.5132, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
902, 4ltcL, 0.5132, 3.65, 0.107, 222, 56, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
903, 3vonW, 0.5132, 3.48, 0.034, 137, 58, CRYSTALSTRUCTURE OF THE UBIQUITIN PROTEASE
904, 3szhC, 0.5132, 3.15, 0.102, 117, 59, CRYSTAL STRUCTURE OF APO SHWANAVIDIN (P1 FORM)
905, 3p6hA, 0.5132, 3.70, 0.048, 139, 63, HUMAN ADIPOCYTE LIPID-BINDING PROTEIN FABP4 IN COMPLEX WITH (S)- IBUPROFEN
906, 3nx2A, 0.5132, 3.51, 0.066, 162, 61, ENTEROBACTER SP. PX6-4 FERULIC ACID DECARBOXYLASE IN COMPLEX WITH SUBSTRATE ANALOGUES
907, 3gpwL, 0.5132, 3.68, 0.107, 222, 56, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
908, 2r73B, 0.5132, 3.35, 0.016, 145, 64, CRYSTAL STRUCTURE OF THE POSSUM MILK WHEY LIPOCALIN TRICHOSURIN AT PH 8.2
909, 6hv7Z, 0.5131, 3.50, 0.109, 222, 55, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 7 
910, 6hucL, 0.5131, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 18 
911, 6aq1B, 0.5131, 3.61, 0.097, 134, 62, THE CRYSTAL STRUCTURE OF HUMAN FABP3 
912, 5fggZ, 0.5131, 3.50, 0.109, 222, 55, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
913, 5fggL, 0.5131, 3.50, 0.109, 222, 55, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
914, 4y8pZ, 0.5131, 3.50, 0.109, 222, 55, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
915, 4y8lL, 0.5131, 3.66, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
916, 4y70L, 0.5131, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
917, 4qlvL, 0.5131, 3.66, 0.107, 222, 56, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
918, 4qlsZ, 0.5131, 3.67, 0.107, 222, 56, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
919, 4fzcL, 0.5131, 3.67, 0.107, 222, 56, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
920, 3okjL, 0.5131, 3.67, 0.107, 222, 56, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
921, 3dy3L, 0.5131, 3.67, 0.107, 222, 56, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
922, 6hwfZ, 0.5130, 3.50, 0.109, 222, 55, YEAST 20S PROTEASOME BETA2-G45A MUTANT IN COMPLEX WITH ONX 0914 
923, 6hvtL, 0.5130, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 20 
924, 6hv7L, 0.5130, 3.50, 0.109, 222, 55, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 7 
925, 6hucZ, 0.5130, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 18 
926, 4y8pL, 0.5130, 3.50, 0.109, 222, 55, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
927, 4qlsL, 0.5130, 3.67, 0.107, 222, 56, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
928, 2obdA, 0.5130, 3.76, 0.034, 472, 59, CRYSTAL STRUCTURE OF CHOLESTERYL ESTER TRANSFER PROTEIN
929, 1pboB, 0.5130, 3.31, 0.095, 151, 63, COMPLEX OF BOVINE ODORANT BINDING PROTEIN (OBP) WITH A SELENIUM CONTAINING ODORANT
930, 6i8xA, 0.5129, 3.71, 0.062, 149, 64, AS-P18; AN EXTRACELLULAR FATTY ACID BINDING PROTEIN 
931, 6hwfL, 0.5129, 3.50, 0.109, 222, 55, YEAST 20S PROTEASOME BETA2-G45A MUTANT IN COMPLEX WITH ONX 0914 
932, 6hwbZ, 0.5129, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH 44B 
933, 6hvtZ, 0.5129, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 20 
934, 6hvaZ, 0.5129, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 13 
935, 6huuL, 0.5129, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 29 
936, 6htrL, 0.5129, 3.66, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 13 
937, 5jhsZ, 0.5129, 3.66, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
938, 5jhsL, 0.5129, 3.66, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
939, 4y8iZ, 0.5129, 3.66, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
940, 4y8iL, 0.5129, 3.66, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
941, 4hnpL, 0.5129, 3.69, 0.107, 222, 56, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
942, 4fzcZ, 0.5129, 3.68, 0.107, 222, 56, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
943, 3holA, 0.5129, 3.54, 0.078, 505, 64, THE STRUCTURE OF INTACT AP-TBPB (N AND C LOBES)
944, 6hwbL, 0.5128, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH 44B 
945, 6hw4L, 0.5128, 3.66, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH 16 
946, 6hvuZ, 0.5128, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 29 
947, 6hvaL, 0.5128, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 13 
948, 4y9zZ, 0.5128, 3.50, 0.109, 222, 55, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
949, 3szhF, 0.5128, 3.20, 0.100, 117, 60, CRYSTAL STRUCTURE OF APO SHWANAVIDIN (P1 FORM)
950, 3szgD, 0.5128, 4.00, 0.117, 658, 60, CRYSTAL STRUCTURE OF C176A GLUTAMINE-DEPENDENT NAD+ SYNTHETASE FROM M. TUBERCULOSIS BOUND TO AMP/PPI AND NAAD+
951, 3shjL, 0.5128, 3.69, 0.107, 222, 56, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
952, 3mg7L, 0.5128, 3.50, 0.109, 222, 55, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
953, 3lk45, 0.5128, 3.63, 0.085, 237, 59, CRYSTAL STRUCTURE OF CAPZ BOUND TO THE UNCAPPING MOTIF FROM CD2AP
954, 2f16L, 0.5128, 3.68, 0.107, 222, 56, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
955, 1qakA, 0.5128, 3.71, 0.062, 718, 64, THE ACTIVE SITE BASE CONTROLS COFACTOR REACTIVITY IN ESCHERICHIA COLI AMINE OXIDASE : X-RAY CRYSTALLOGRAPHIC STUDIES WITH MUTATIONAL VARIANTS
956, 1g0hB, 0.5128, 3.86, 0.066, 252, 61, CRYSTAL STRUCTURE OF MJ0109 GENE PRODUCT INOSITOL MONOPHOSPHATASE-FRUCTOSE 16 BISPHOSPHATASE
957, 6hwdZ, 0.5127, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME BETA2-G45A MUTANT IN COMPLEX WITH BORTEZOMIB 
958, 6hwdL, 0.5127, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME BETA2-G45A MUTANT IN COMPLEX WITH BORTEZOMIB 
959, 6hw4Z, 0.5127, 3.66, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH 16 
960, 6htdL, 0.5127, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 4 
961, 5l52L, 0.5127, 3.50, 0.109, 222, 55, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
962, 4y9zL, 0.5127, 3.50, 0.109, 222, 55, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
963, 4y7yZ, 0.5127, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
964, 4y7yL, 0.5127, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
965, 4qz7Z, 0.5127, 3.51, 0.109, 222, 55, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
966, 4qz7L, 0.5127, 3.51, 0.109, 222, 55, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
967, 4qz0Z, 0.5127, 3.51, 0.109, 222, 55, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
968, 4qz0L, 0.5127, 3.51, 0.109, 222, 55, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
969, 4hrdZ, 0.5127, 3.68, 0.107, 222, 56, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
970, 3shjZ, 0.5127, 3.69, 0.107, 222, 56, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
971, 3nzwZ, 0.5127, 3.66, 0.107, 222, 56, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
972, 3dy3Z, 0.5127, 3.67, 0.107, 222, 56, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
973, 2f16Z, 0.5127, 3.68, 0.107, 222, 56, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
974, 5l52Z, 0.5126, 3.50, 0.109, 222, 55, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
975, 5jhrZ, 0.5126, 3.50, 0.109, 222, 55, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
976, 5jhrL, 0.5126, 3.50, 0.109, 222, 55, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
977, 4y7wL, 0.5126, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
978, 3tddZ, 0.5126, 3.68, 0.107, 222, 56, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
979, 3tddL, 0.5126, 3.68, 0.107, 222, 56, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
980, 3szgA, 0.5126, 4.00, 0.117, 650, 60, CRYSTAL STRUCTURE OF C176A GLUTAMINE-DEPENDENT NAD+ SYNTHETASE FROM M. TUBERCULOSIS BOUND TO AMP/PPI AND NAAD+
981, 3nzwL, 0.5126, 3.66, 0.107, 222, 56, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
982, 1jd0B, 0.5126, 3.53, 0.131, 259, 61, CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN CARBONIC ANHYDRASE XII COMPLEXED WITH ACETAZOLAMIDE
983, 6hvvZ, 0.5125, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 39 
984, 6htpZ, 0.5125, 3.68, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 7 
985, 6htpL, 0.5125, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 7 
986, 5cgiL, 0.5125, 3.50, 0.109, 222, 55, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
987, 4ya7Z, 0.5125, 3.50, 0.109, 222, 55, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
988, 4ya7L, 0.5125, 3.50, 0.109, 222, 55, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
989, 4ya2Z, 0.5125, 3.50, 0.109, 222, 55, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
990, 4ya2L, 0.5125, 3.50, 0.109, 222, 55, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
991, 4o4uB, 0.5125, 3.57, 0.078, 500, 64, CRYSTAL STRUCTURE OF THE VACCINE ANTIGEN TRANSFERRIN BINDING PROTEIN B (TBPB) MUTANT TRP-176-ALA FROM HAEMOPHILUS PARASUIS HP5
992, 4no1L, 0.5125, 3.50, 0.109, 222, 55, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
993, 3e47L, 0.5125, 3.69, 0.107, 222, 56, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
994, 6hw3L, 0.5124, 3.50, 0.109, 222, 55, YEAST 20S PROTEASOME IN COMPLEX WITH 13 
995, 6htdZ, 0.5124, 3.68, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 4 
996, 6hiuB, 0.5124, 3.20, 0.053, 143, 57, CYTOCHROME P460 FROM METHYLOCOCCUS CAPSULATUS (BATH) 
997, 6hdtA, 0.5124, 3.18, 0.161, 127, 62, CRYSTAL STRUCTURE OF SHORT AFIFAVIDIN - BIOTIN COMPLEX 
998, 5msbA, 0.5124, 3.39, 0.133, 261, 60, CRYSTAL STRUCTURE OF HUMAN CARBONIC ANHYDRASE ISOZYME XII WITH 235 6-TETRAFLUORO-4[(2-HYDROXYETHYL)SULFONYL]BENZENESULFONAMIDE
999, 5d17F, 0.5124, 3.18, 0.070, 156, 57, STRUCTURE OF THE C-TERMINAL DOMAIN OF TNSE AT 2.85 RESOLUTION
1000, 5cgiZ, 0.5124, 3.50, 0.109, 222, 55, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1001, 4qw6Z, 0.5124, 3.67, 0.107, 222, 56, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1002, 4q1sL, 0.5124, 3.68, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1003, 4no1Z, 0.5124, 3.50, 0.109, 222, 55, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1004, 4j70Z, 0.5124, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1005, 6hwaZ, 0.5123, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH 43 
1006, 6hwaL, 0.5123, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH 43 
1007, 6hw3Z, 0.5123, 3.50, 0.109, 222, 55, YEAST 20S PROTEASOME IN COMPLEX WITH 13 
1008, 6hv5Z, 0.5123, 3.68, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 4 
1009, 4qw6L, 0.5123, 3.67, 0.107, 222, 56, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1010, 3szhB, 0.5123, 3.19, 0.117, 116, 60, CRYSTAL STRUCTURE OF APO SHWANAVIDIN (P1 FORM)
1011, 2c1sA, 0.5123, 3.32, 0.032, 123, 63, X-RAY STRUCTURE OF BIOTIN BINDING PROTEIN FROM CHICKEN
1012, 6hv5L, 0.5122, 3.68, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 4 
1013, 5hz9F, 0.5122, 3.80, 0.095, 134, 63, HUMAN FABP3 IN COMPLEX WITH 6-CHLORO-2-METHYL-4-PHENYL-QUINOLINE-3- CARBOXYLIC ACID
1014, 4y8sZ, 0.5122, 3.50, 0.109, 222, 55, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1015, 4y8sL, 0.5122, 3.50, 0.109, 222, 55, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1016, 4y8qZ, 0.5122, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1017, 4y8jZ, 0.5122, 3.50, 0.109, 222, 55, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1018, 4y8jL, 0.5122, 3.50, 0.109, 222, 55, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1019, 4qz6Z, 0.5122, 3.50, 0.109, 222, 55, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1020, 4qz6L, 0.5122, 3.50, 0.109, 222, 55, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1021, 3wzqD, 0.5122, 3.14, 0.113, 125, 62, CRYSTAL STRUCTURE OF THE CORE STREPTAVIDIN MUTANT V212 (Y22S/N23D/S27D/S45N/Y83S/R84K/E101D/R103K/E116N) COMPLEXED WITH IMINOBIOTIN LONG TAIL (IMNTAIL) AT 1.7 A RESOLUTION
1022, 3mg0L, 0.5122, 3.51, 0.109, 222, 55, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1023, 2fakZ, 0.5122, 3.68, 0.107, 222, 56, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1024, 2fakL, 0.5122, 3.67, 0.107, 222, 56, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1025, 2c1qA, 0.5122, 3.31, 0.032, 123, 63, X-RAY STRUCTURE OF BIOTIN BINDING PROTEIN FROM CHICKEN
1026, 6hvvL, 0.5121, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) IN COMPLEX WITH 39 
1027, 4y8qL, 0.5121, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1028, 4qz3Z, 0.5121, 3.50, 0.109, 222, 55, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1029, 4no9Z, 0.5121, 3.51, 0.109, 222, 55, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1030, 4no9L, 0.5121, 3.51, 0.109, 222, 55, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1031, 4jsqL, 0.5121, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1032, 4bj8I, 0.5121, 3.21, 0.048, 119, 63, ZEBAVIDIN
1033, 4bj8D, 0.5121, 3.23, 0.048, 119, 63, ZEBAVIDIN
1034, 3mg4L, 0.5121, 3.66, 0.107, 222, 56, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1035, 3gptL, 0.5121, 3.69, 0.107, 222, 56, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1036, 3e47Z, 0.5121, 3.69, 0.107, 222, 56, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1037, 6hw8Z, 0.5120, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME IN COMPLEX WITH 39 
1038, 6hw8L, 0.5120, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME IN COMPLEX WITH 39 
1039, 5d16B, 0.5120, 3.17, 0.088, 157, 57, STRUCTURE OF THE C-TERMINAL DOMAIN OF TNSE DOUBLE MUTANT - A453V/D523N
1040, 4qz3L, 0.5120, 3.50, 0.109, 222, 55, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1041, 4jsqZ, 0.5120, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1042, 4eqaD, 0.5120, 2.88, 0.036, 150, 56, CRYSTAL STRUCTURE OF PA1844 IN COMPLEX WITH PA1845 FROM PSEUDOMONAS AERUGINOSA PAO1
1043, 4aznB, 0.5120, 3.72, 0.113, 136, 62, MURINE EPIDERMAL FATTY ACID-BINDING PROTEIN (FABP5) APO FORM POLY-HIS TAG-MEDIATED CRYSTAL PACKING
1044, 5cggL, 0.5119, 3.50, 0.109, 222, 55, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1045, 4ya4L, 0.5119, 3.68, 0.107, 222, 56, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1046, 4qwxZ, 0.5119, 3.51, 0.109, 222, 55, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1047, 4qwlZ, 0.5119, 3.50, 0.109, 222, 55, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1048, 4qwlL, 0.5119, 3.50, 0.109, 222, 55, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1049, 4nnwZ, 0.5119, 3.67, 0.107, 222, 56, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1050, 4nnwL, 0.5119, 3.67, 0.107, 222, 56, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1051, 3sziG, 0.5119, 3.20, 0.117, 119, 60, STRUCTURE OF APO SHWANAVIDIN (P21 FORM)
1052, 3gptZ, 0.5119, 3.69, 0.107, 222, 56, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1053, 6hw6L, 0.5118, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH 20 
1054, 6hubL, 0.5118, 3.68, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 16 
1055, 6htrZ, 0.5118, 3.50, 0.109, 222, 55, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 13 
1056, 6htbL, 0.5118, 3.68, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) 
1057, 5cggZ, 0.5118, 3.50, 0.109, 222, 55, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1058, 4ya9L, 0.5118, 3.50, 0.109, 222, 55, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1059, 4ya4Z, 0.5118, 3.68, 0.107, 222, 56, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1060, 4y8rL, 0.5118, 3.68, 0.107, 222, 56, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1061, 4y8oZ, 0.5118, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1062, 4y8oL, 0.5118, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1063, 4qwxL, 0.5118, 3.51, 0.109, 222, 55, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1064, 4kp5C, 0.5118, 3.45, 0.117, 260, 60, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF HUMAN CARBONIC ANHYDRASE ISOZYME XII WITH 2-CHLORO-4-[(PYRIMIDIN-2-YLSULFANYL) ACETYL]BENZENESULFONAMIDE
1065, 3mg0Z, 0.5118, 3.51, 0.109, 222, 55, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1066, 6hw9Z, 0.5117, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME IN COMPLEX WITH 41B 
1067, 6hw9L, 0.5117, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME IN COMPLEX WITH 41B 
1068, 6hw6Z, 0.5117, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH 20 
1069, 6hubZ, 0.5117, 3.68, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) IN COMPLEX WITH 16 
1070, 6htbZ, 0.5117, 3.68, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA2C (S171G) 
1071, 4ya9Z, 0.5117, 3.50, 0.109, 222, 55, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1072, 4r02Z, 0.5117, 3.68, 0.107, 222, 56, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1073, 4qj0D, 0.5117, 3.37, 0.133, 260, 60, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF HUMAN CARBONIC ANHYDRASE ISOZYME XII WITH INHIBITOR
1074, 4p6vC, 0.5117, 3.23, 0.036, 251, 55, CRYSTAL STRUCTURE OF THE NA+-TRANSLOCATING NADH: UBIQUINONE OXIDOREDUCTASE FROM VIBRIO CHOLERAE
1075, 4bj8A, 0.5117, 3.20, 0.048, 119, 63, ZEBAVIDIN
1076, 3bdmL, 0.5117, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1077, 6hw7Z, 0.5116, 3.50, 0.109, 222, 55, YEAST 20S PROTEASOME IN COMPLEX WITH 29 
1078, 6h39L, 0.5116, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC NON-COVALENT BINDING INHIBITOR RTS-V5 
1079, 4y70Z, 0.5116, 3.50, 0.109, 222, 55, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1080, 4qz2Z, 0.5116, 3.51, 0.109, 222, 55, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1081, 4qz2L, 0.5116, 3.51, 0.109, 222, 55, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1082, 4qwuZ, 0.5116, 3.68, 0.107, 222, 56, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1083, 4qw5Z, 0.5116, 3.50, 0.109, 222, 55, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1084, 4qj0A, 0.5116, 3.41, 0.133, 260, 60, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF HUMAN CARBONIC ANHYDRASE ISOZYME XII WITH INHIBITOR
1085, 4j70L, 0.5116, 3.68, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1086, 3nzjL, 0.5116, 3.67, 0.107, 222, 56, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1087, 3bdmZ, 0.5116, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1088, 2zcyL, 0.5116, 3.68, 0.107, 222, 56, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1089, 6hw7L, 0.5115, 3.50, 0.109, 222, 55, YEAST 20S PROTEASOME IN COMPLEX WITH 29 
1090, 5bvtA, 0.5115, 3.41, 0.049, 134, 61, PALMITATE-BOUND PFABP5
1091, 4qw5L, 0.5115, 3.50, 0.109, 222, 55, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1092, 3sziK, 0.5115, 3.15, 0.102, 117, 59, STRUCTURE OF APO SHWANAVIDIN (P21 FORM)
1093, 2zcyZ, 0.5115, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1094, 1jczB, 0.5115, 3.39, 0.133, 260, 60, CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN CARBONIC ANHYDRASE XII
1095, 6gopZ, 0.5114, 3.68, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1096, 5myqB, 0.5114, 3.34, 0.032, 122, 63, CRYSTAL STRUCTURE OF AVIDIN IN COMPLEX WITH FERROCENE HOMOBIOTIN DERIVATIVE
1097, 4y8rZ, 0.5114, 3.68, 0.107, 222, 56, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1098, 4y81Z, 0.5114, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1099, 4y81L, 0.5114, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1100, 4qwfL, 0.5114, 3.68, 0.107, 222, 56, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1101, 6hweZ, 0.5113, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME BETA2-G45A MUTANT IN COMPLEX WITH CARFILZOMIB 
1102, 6hweL, 0.5113, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME BETA2-G45A MUTANT IN COMPLEX WITH CARFILZOMIB 
1103, 5hi8B, 0.5113, 3.82, 0.016, 136, 62, STRUCTURE OF T-TYPE PHYCOBILIPROTEIN LYASE CPET FROM PROCHLOROCOCCUS PHAGE P-HM1
1104, 5fg7Z, 0.5113, 3.68, 0.107, 222, 56, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1105, 5d17M, 0.5113, 3.52, 0.068, 157, 59, STRUCTURE OF THE C-TERMINAL DOMAIN OF TNSE AT 2.85 RESOLUTION
1106, 4y77Z, 0.5113, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1107, 4y77L, 0.5113, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1108, 4qxjZ, 0.5113, 3.51, 0.109, 222, 55, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1109, 4qxjL, 0.5113, 3.51, 0.109, 222, 55, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1110, 4qwuL, 0.5113, 3.68, 0.107, 222, 56, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1111, 4qwfZ, 0.5113, 3.68, 0.107, 222, 56, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1112, 3nzjZ, 0.5113, 3.67, 0.107, 222, 56, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1113, 6gopL, 0.5112, 3.68, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1114, 5myqD, 0.5112, 3.35, 0.032, 122, 63, CRYSTAL STRUCTURE OF AVIDIN IN COMPLEX WITH FERROCENE HOMOBIOTIN DERIVATIVE
1115, 5hi8A, 0.5112, 3.82, 0.016, 136, 62, STRUCTURE OF T-TYPE PHYCOBILIPROTEIN LYASE CPET FROM PROCHLOROCOCCUS PHAGE P-HM1
1116, 5fgaZ, 0.5112, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1117, 5fgaL, 0.5112, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1118, 5d0wZ, 0.5112, 3.68, 0.107, 222, 56, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1119, 5d0wL, 0.5112, 3.68, 0.107, 222, 56, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1120, 5d0sZ, 0.5112, 3.50, 0.109, 222, 55, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1121, 5d0sL, 0.5112, 3.50, 0.109, 222, 55, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1122, 4x6zM, 0.5112, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1123, 4qv6Z, 0.5112, 3.68, 0.107, 222, 56, YCP BETA5-A49V MUTANT
1124, 4qv6L, 0.5112, 3.68, 0.107, 222, 56, YCP BETA5-A49V MUTANT
1125, 4q0lD, 0.5112, 3.47, 0.117, 260, 60, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF HUMAN CARBONIC ANHYDRASE ISOZYME XII WITH INHIBITOR
1126, 4bj8C, 0.5112, 3.30, 0.048, 119, 63, ZEBAVIDIN
1127, 3p6gA, 0.5112, 3.75, 0.063, 139, 63, HUMAN ADIPOCYTE LIPID-BINDING PROTEIN FABP4 IN COMPLEX WITH (R)- IBUPROFEN
1128, 2lvxA, 0.5112, 3.36, 0.049, 94, 61, MRH DOMAIN OF THE GLUCOSIDASE II BETA SUBUNIT FROM S. POMBE
1129, 6h39Z, 0.5111, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC NON-COVALENT BINDING INHIBITOR RTS-V5 
1130, 5fgiZ, 0.5111, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1131, 5cgfZ, 0.5111, 3.68, 0.107, 222, 56, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1132, 5c0nB, 0.5111, 3.61, 0.097, 131, 62, DEVELOPMENT OF A MONOCLONAL ANTIBODY TARGETING SECRETED AP2 TO TREAT DIABETES AND FATTY LIVER DISEASE
1133, 5ahjL, 0.5111, 3.50, 0.109, 222, 55, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1134, 4y7wZ, 0.5111, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1135, 4qz1Z, 0.5111, 3.51, 0.109, 222, 55, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1136, 4qz1L, 0.5111, 3.51, 0.109, 222, 55, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1137, 4intL, 0.5111, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1138, 4ht2C, 0.5111, 3.48, 0.117, 261, 60, CRYSTAL STRUCTURE OF HUMAN CARBONIC ANHYDRASE ISOZYME XII WITH THE INHIBITOR.
1139, 4bj8G, 0.5111, 3.20, 0.048, 119, 63, ZEBAVIDIN
1140, 4a1yC, 0.5111, 3.66, 0.079, 133, 63, HUMAN MYELIN P2 PROTEIN K65Q MUTANT
1141, 2rtqB, 0.5111, 3.16, 0.113, 123, 62, STREPTAVIDIN-2-IMINOBIOTIN COMPLEX PH 3.25 SPACE GROUP I222 CRYSTALLIZED FROM 4.3 M AMMONIUM SULFATE
1142, 1zguA, 0.5111, 3.25, 0.054, 139, 56, SOLUTION STRUCTURE OF THE HUMAN MMS2-UBIQUITIN COMPLEX
1143, 5fgiL, 0.5110, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1144, 5ahjZ, 0.5110, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1145, 4r02L, 0.5110, 3.67, 0.107, 222, 56, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1146, 4qw7Z, 0.5110, 3.51, 0.109, 222, 55, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1147, 4jt0L, 0.5110, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1148, 3d29L, 0.5110, 3.51, 0.109, 222, 55, PROTEASOME INHIBITION BY FELLUTAMIDE B
1149, 2w2fB, 0.5110, 3.47, 0.065, 175, 62, CRYSTAL STRUCTURE OF SINGLE POINT MUTANT ARG48GLN OF P- COUMARIC ACID DECARBOXYLASE FROM LACTOBACILLUS PLANTARUM STRUCTURAL INSIGHTS INTO THE ACTIVE SITE AND DECARBOXYLATION CATALYTIC MECHANISM
1150, 1ry9B, 0.5110, 3.42, 0.016, 133, 61, SPA15 A TYPE III SECRETION CHAPERONE FROM SHIGELLA FLEXNERI
1151, 6fvwM, 0.5109, 3.84, 0.105, 222, 57, struct.pdbx_descriptor              
1152, 5d0vZ, 0.5109, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1153, 5d0vL, 0.5109, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1154, 5cgfL, 0.5109, 3.68, 0.107, 222, 56, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1155, 4y74Z, 0.5109, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1156, 4y74L, 0.5109, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1157, 4qw7L, 0.5109, 3.51, 0.109, 222, 55, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1158, 4intZ, 0.5109, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1159, 4inrL, 0.5109, 3.68, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1160, 2uz2A, 0.5109, 3.23, 0.048, 115, 63, CRYSTAL STRUCTURE OF XENAVIDIN
1161, 2izdB, 0.5109, 3.17, 0.113, 123, 62, APOSTREPTAVIDIN PH 3.0 I222 COMPLEX
1162, 2gplZ, 0.5109, 3.69, 0.107, 222, 56, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1163, 2gplL, 0.5109, 3.69, 0.107, 222, 56, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1164, 5fgfZ, 0.5108, 3.68, 0.107, 222, 56, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1165, 5fgfL, 0.5108, 3.68, 0.107, 222, 56, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1166, 5fg7L, 0.5108, 3.68, 0.107, 222, 56, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1167, 5cz9L, 0.5108, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1168, 4qzxZ, 0.5108, 3.51, 0.109, 222, 55, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1169, 4qzxL, 0.5108, 3.51, 0.109, 222, 55, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1170, 4qzwZ, 0.5108, 3.51, 0.109, 222, 55, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1171, 4qzwL, 0.5108, 3.51, 0.109, 222, 55, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1172, 4nnsA, 0.5108, 3.69, 0.048, 134, 63, CRYSTAL STRUCTURE OF FABP4 IN COMPLEX WITH NOVEL INHIBITOR
1173, 4gzvE, 0.5108, 3.22, 0.077, 139, 65, CRYSTAL STRUCTURE OF A LIPOCALIN FAMILY PROTEIN (BACOVA_00364) FROM BACTEROIDES OVATUS ATCC 8483 AT 1.95 A RESOLUTION
1174, 3d29Z, 0.5108, 3.52, 0.109, 222, 55, PROTEASOME INHIBITION BY FELLUTAMIDE B
1175, 6hvxZ, 0.5107, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME IN COMPLEX WITH 4 
1176, 6hvxL, 0.5107, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME IN COMPLEX WITH 4 
1177, 5cz9Z, 0.5107, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1178, 4qv9Z, 0.5107, 3.68, 0.107, 222, 56, YCP BETA5-C63F MUTANT
1179, 4qv9L, 0.5107, 3.68, 0.107, 222, 56, YCP BETA5-C63F MUTANT
1180, 4kp8C, 0.5107, 3.49, 0.117, 261, 60, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF HUMAN CARBONIC ANHYDRASE ISOZYME XII WITH 3-[(PYRIMIDIN-2-YLSULFANYL)ACETYL]BENZENESULFONAMIDE
1181, 4jt0Z, 0.5107, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1182, 4bj8L, 0.5107, 3.24, 0.048, 121, 63, ZEBAVIDIN
1183, 1gt5B, 0.5107, 3.33, 0.095, 155, 63, COMPLEXE OF BOVINE ODORANT BINDING PROTEIN WITH BENZOPHENONE
1184, 6ib7A, 0.5106, 3.76, 0.017, 257, 60, STRUCTURE OF WILD TYPE SUHB 
1185, 6hdtB, 0.5106, 3.39, 0.095, 124, 63, CRYSTAL STRUCTURE OF SHORT AFIFAVIDIN - BIOTIN COMPLEX 
1186, 5d0tZ, 0.5106, 3.68, 0.107, 222, 56, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1187, 4y80Z, 0.5106, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1188, 4y80L, 0.5106, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1189, 4qwrZ, 0.5106, 3.50, 0.109, 222, 55, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1190, 4qwrL, 0.5106, 3.50, 0.109, 222, 55, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1191, 3nx2B, 0.5106, 3.43, 0.066, 164, 61, ENTEROBACTER SP. PX6-4 FERULIC ACID DECARBOXYLASE IN COMPLEX WITH SUBSTRATE ANALOGUES
1192, 1gt4B, 0.5106, 3.33, 0.095, 155, 63, COMPLEX OF BOVINE ODORANT BINDING PROTEIN WITH UNDECANAL
1193, 6g7aD, 0.5105, 3.37, 0.133, 261, 60, CRYSTAL STRUCTURE OF HUMAN CARBONIC ANHYDRASE ISOZYME XII 2- (BENZYLAMINO)-4-CHLORO-N-(2-HYDROXYETHYL)-5-SULFAMOYL-BENZAMIDE 
1194, 5ll5D, 0.5105, 3.36, 0.133, 261, 60, CRYSTAL STRUCTURE OF HUMAN CARBONIC ANHYDRASE ISOZYME XII WITH 4-(1H- BENZIMIDAZOL-1-YLACETYL)BENZENESULFONAMIDE
1195, 5fhsZ, 0.5105, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1196, 5fhsL, 0.5105, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1197, 5dkjZ, 0.5105, 3.68, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1198, 5dkjL, 0.5105, 3.68, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1199, 5d8jA, 0.5105, 3.51, 0.097, 133, 62, DEVELOPMENT OF A THERAPEUTIC MONOCLONAL ANTIBODY TARGETING SECRETED AP2 TO TREAT TYPE 2 DIABETES.
1200, 5d0zZ, 0.5105, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1201, 5d0zL, 0.5105, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1202, 5d0tL, 0.5105, 3.68, 0.107, 222, 56, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1203, 5czaL, 0.5105, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1204, 4inrZ, 0.5105, 3.68, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1205, 2uywD, 0.5105, 3.35, 0.048, 119, 63, CRYSTAL STRUCTURE OF XENAVIDIN
1206, 5n7xB, 0.5104, 3.28, 0.048, 121, 63, CRYSTAL STRUCTURE OF STREPTAVIDIN WITH PEPTIDE EWVHPQFEQKAK
1207, 4qwjZ, 0.5104, 3.51, 0.109, 222, 55, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1208, 4qwjL, 0.5104, 3.51, 0.109, 222, 55, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1209, 4hrcZ, 0.5104, 3.69, 0.107, 222, 56, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1210, 4hnpZ, 0.5104, 3.53, 0.109, 222, 55, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1211, 3un8L, 0.5104, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1212, 6fvvM, 0.5103, 3.72, 0.105, 222, 57, struct.pdbx_descriptor              
1213, 4x6z1, 0.5103, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1214, 4qw4Z, 0.5103, 3.51, 0.109, 222, 55, YCP IN COMPLEX WITH CARFILZOMIB
1215, 4qw4L, 0.5103, 3.51, 0.109, 222, 55, YCP IN COMPLEX WITH CARFILZOMIB
1216, 4qvnZ, 0.5103, 3.69, 0.107, 222, 56, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1217, 4qvnL, 0.5103, 3.69, 0.107, 222, 56, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1218, 4bj8E, 0.5103, 3.26, 0.048, 119, 63, ZEBAVIDIN
1219, 6hwcZ, 0.5102, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME BETA2-G45A MUTANT 
1220, 5czaZ, 0.5102, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1221, 4kp5B, 0.5102, 3.53, 0.131, 261, 61, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF HUMAN CARBONIC ANHYDRASE ISOZYME XII WITH 2-CHLORO-4-[(PYRIMIDIN-2-YLSULFANYL) ACETYL]BENZENESULFONAMIDE
1222, 4kp5A, 0.5102, 3.38, 0.133, 261, 60, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF HUMAN CARBONIC ANHYDRASE ISOZYME XII WITH 2-CHLORO-4-[(PYRIMIDIN-2-YLSULFANYL) ACETYL]BENZENESULFONAMIDE
1223, 4inuL, 0.5102, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1224, 3un8Z, 0.5102, 3.67, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1225, 2ju3A, 0.5102, 3.82, 0.062, 127, 65, SOLUTION-STATE NMR STRUCTURES OF APO-LFABP (LIVER FATTY ACID-BINDING PROTEIN)
1226, 6hwcL, 0.5101, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME BETA2-G45A MUTANT 
1227, 5j19B, 0.5101, 3.30, 0.069, 230, 58, PHOSPHO-PON BINDING-INDUCED PLK1 DIMERIZATION
1228, 4y82Z, 0.5101, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1229, 4y82L, 0.5101, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1230, 4qwiZ, 0.5101, 3.51, 0.109, 222, 55, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1231, 4qwiL, 0.5101, 3.51, 0.109, 222, 55, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1232, 5d17B, 0.5100, 3.02, 0.091, 156, 55, STRUCTURE OF THE C-TERMINAL DOMAIN OF TNSE AT 2.85 RESOLUTION
1233, 5bxnZ, 0.5100, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1234, 5bxnL, 0.5100, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1235, 4zjmD, 0.5100, 3.20, 0.138, 109, 58, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS LPQH (RV3763)
1236, 4qvlZ, 0.5100, 3.69, 0.107, 222, 56, YCP IN COMPLEX WITH BORTEZOMIB
1237, 4quyZ, 0.5100, 3.68, 0.107, 222, 56, YCP BETA5-A49S-MUTANT
1238, 4quyL, 0.5100, 3.68, 0.107, 222, 56, YCP BETA5-A49S-MUTANT
1239, 5l64L, 0.5099, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1240, 5l60Z, 0.5099, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1241, 5l5uZ, 0.5099, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1242, 4r17Z, 0.5099, 3.69, 0.107, 222, 56, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1243, 4r17L, 0.5099, 3.69, 0.107, 222, 56, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1244, 4qvpL, 0.5099, 3.69, 0.107, 222, 56, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1245, 4qvlL, 0.5099, 3.69, 0.107, 222, 56, YCP IN COMPLEX WITH BORTEZOMIB
1246, 4inuZ, 0.5099, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1247, 4hrcL, 0.5099, 3.69, 0.107, 222, 56, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1248, 4a1yD, 0.5099, 3.54, 0.081, 133, 62, HUMAN MYELIN P2 PROTEIN K65Q MUTANT
1249, 3ge2A, 0.5099, 3.11, 0.125, 87, 56, CRYSTAL STRUCTURE OF PUTATIVE LIPOPROTEIN SP_0198 FROM STREPTOCOCCUS PNEUMONIAE
1250, 1nbxA, 0.5099, 3.18, 0.113, 120, 62, STREPTAVIDIN MUTANT Y43A AT 1.70A RESOLUTION
1251, 5n4pA, 0.5098, 3.53, 0.065, 133, 62, HUMAN MYELIN P2 MUTANT I52T
1252, 5n4mA, 0.5098, 3.54, 0.081, 133, 62, HUMAN MYELIN PROTEIN P2 MUTANT I43N
1253, 5l5uL, 0.5098, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1254, 4y8kZ, 0.5098, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1255, 4y8kL, 0.5098, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1256, 4qvpZ, 0.5098, 3.69, 0.107, 222, 56, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1257, 4jnjD, 0.5098, 3.19, 0.081, 113, 62, STRUCTURE BASED ENGINEERING OF STREPTAVIDIN MONOMER WITH A REDUCED BIOTIN DISSOCIATION RATE
1258, 2r73C, 0.5098, 3.32, 0.016, 146, 63, CRYSTAL STRUCTURE OF THE POSSUM MILK WHEY LIPOCALIN TRICHOSURIN AT PH 8.2
1259, 1ifbA, 0.5098, 3.73, 0.097, 131, 62, REFINED APOPROTEIN STRUCTURE OF RAT INTESTINAL FATTY ACID BINDING PROTEIN PRODUCED IN ESCHERICHIA COLI
1260, 6hw5Z, 0.5097, 3.68, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH 18 
1261, 6hw5L, 0.5097, 3.68, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH 18 
1262, 5l64Z, 0.5097, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1263, 5l63L, 0.5097, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1264, 5hz6A, 0.5097, 3.72, 0.048, 131, 63, FABP4 IN COMPLEX WITH 6-CHLORO-2-ISOPROPYL-4-(3-ISOPROPYL-PHENYL)- QUINOLINE-3-CARBOXYLIC ACID
1265, 4y78Z, 0.5097, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1266, 4kp5D, 0.5097, 3.38, 0.133, 260, 60, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF HUMAN CARBONIC ANHYDRASE ISOZYME XII WITH 2-CHLORO-4-[(PYRIMIDIN-2-YLSULFANYL) ACETYL]BENZENESULFONAMIDE
1267, 5l63Z, 0.5096, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1268, 5l62Z, 0.5096, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1269, 5l60L, 0.5096, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1270, 5l5tZ, 0.5096, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1271, 4y9yZ, 0.5096, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1272, 4y9yL, 0.5096, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1273, 4y78L, 0.5096, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1274, 4uu3A, 0.5096, 3.44, 0.049, 168, 61, FERULIC ACID DECARBOXYLASE FROM ENTEROBACTER SP.
1275, 4qwkZ, 0.5096, 3.51, 0.109, 222, 55, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1276, 4qwkL, 0.5096, 3.51, 0.109, 222, 55, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1277, 4ht2A, 0.5096, 3.43, 0.133, 261, 60, CRYSTAL STRUCTURE OF HUMAN CARBONIC ANHYDRASE ISOZYME XII WITH THE INHIBITOR.
1278, 4gzvD, 0.5096, 3.22, 0.092, 131, 65, CRYSTAL STRUCTURE OF A LIPOCALIN FAMILY PROTEIN (BACOVA_00364) FROM BACTEROIDES OVATUS ATCC 8483 AT 1.95 A RESOLUTION
1279, 4fzgZ, 0.5096, 3.69, 0.107, 222, 56, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1280, 1kzwA, 0.5096, 3.86, 0.082, 131, 61, SOLUTION STRUCTURE OF HUMAN INTESTINAL FATTY ACID BINDING PROTEIN
1281, 5l61Z, 0.5095, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1282, 5l5oL, 0.5095, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1283, 5cz5Z, 0.5095, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1284, 5cz5L, 0.5095, 3.51, 0.109, 222, 55, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1285, 4y6zL, 0.5095, 3.52, 0.109, 222, 55, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1286, 6hdvC, 0.5094, 3.27, 0.079, 136, 63, THE CRYSTAL STRUCTURE OF INTACT AFIFAVIDIN APO FORM 
1287, 6g8mZ, 0.5094, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH CYSTARGOLIDE B DERIVATIVE 1 
1288, 5l5tL, 0.5094, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1289, 5ixhB, 0.5094, 3.28, 0.063, 161, 63, CRYSTAL STRUCTURE OF BURKHOLDERIA CENOCEPACIA BCNA
1290, 5fgeZ, 0.5094, 3.68, 0.107, 222, 56, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1291, 5fgeL, 0.5094, 3.68, 0.107, 222, 56, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1292, 5d45A, 0.5094, 3.78, 0.048, 135, 63, CRYSTAL STRUCTURE OF FABP4 IN COMPLEX WITH 3-(5-CYCLOPROPYL-23- DIPHENYL-1H-INDOL-1-YL)PROPANOIC ACID
1293, 4z1lZ, 0.5094, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1294, 4z1lL, 0.5094, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1295, 4y6zZ, 0.5094, 3.52, 0.109, 222, 55, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1296, 4qvyL, 0.5094, 3.69, 0.107, 222, 56, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1297, 4fzgL, 0.5094, 3.69, 0.107, 222, 56, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1298, 5l62L, 0.5093, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1299, 5l5oZ, 0.5093, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1300, 5bouZ, 0.5093, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1301, 4qzzZ, 0.5093, 3.69, 0.107, 222, 56, YCP IN COMPLEX WITH OMURALIDE
1302, 4qvyZ, 0.5093, 3.69, 0.107, 222, 56, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1303, 4qv0Z, 0.5093, 3.69, 0.107, 222, 56, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1304, 4qv0L, 0.5093, 3.69, 0.107, 222, 56, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1305, 3wypA, 0.5093, 3.20, 0.113, 120, 62, CRYSTAL STRUCTURE OF WILD-TYPE CORE STREPTAVIDIN IN COMPLEX WITH D- BIOTIN/BIOTIN-D-SULFOXIDE AT 1.3 A RESOLUTION
1306, 3aaeH, 0.5093, 3.04, 0.071, 249, 56, CRYSTAL STRUCTURE OF ACTIN CAPPING PROTEIN IN COMPLEX WITH CARMIL FRAGMENT
1307, 2r09A, 0.5093, 3.00, 0.036, 335, 56, CRYSTAL STRUCTURE OF AUTOINHIBITED FORM OF GRP1 ARF GTPASE EXCHANGE FACTOR
1308, 1zxuA, 0.5093, 3.76, 0.117, 160, 60, X-RAY STRUCTURE OF PROTEIN FROM ARABIDOPSIS THALIANA AT5G01750
1309, 6g8mL, 0.5092, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH CYSTARGOLIDE B DERIVATIVE 1 
1310, 6g7fZ, 0.5092, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH CYSTARGOLIDE B 
1311, 5x3sA, 0.5092, 3.33, 0.068, 223, 59, CRYSTAL STRUCTURE OF MOUSE PLK1-PBD IN COMPLEX WITH PHOSPHOPEPTIDE FROM HEF1 (799-809)
1312, 5lttL, 0.5092, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1313, 5l61L, 0.5092, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1314, 5bouL, 0.5092, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1315, 4qzzL, 0.5092, 3.69, 0.107, 222, 56, YCP IN COMPLEX WITH OMURALIDE
1316, 4qw1Z, 0.5092, 3.69, 0.107, 222, 56, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1317, 4qw1L, 0.5092, 3.69, 0.107, 222, 56, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1318, 3luzB, 0.5092, 3.55, 0.034, 234, 59, CRYSTAL STRUCTURE OF EXTRAGENIC SUPPRESSOR PROTEIN SUHB FROM BARTONELLA HENSELAE VIA COMBINED IODIDE SAD MOLECULAR REPLACEMENT
1319, 3a5pA, 0.5092, 3.36, 0.018, 103, 57, CRYSTAL STRUCTURE OF HEMAGGLUTININ
1320, 2wgqA, 0.5092, 3.48, 0.066, 720, 61, ZINC SUBSTITUTED E COLI COPPER AMINE OXIDASE A MODEL FOR THE PRECURSOR FOR 245-TRIHYDROXYPHENYLALANINEQUINONE FORMATION
1321, 1dk4B, 0.5092, 3.79, 0.067, 252, 60, CRYSTAL STRUCTURE OF MJ0109 GENE PRODUCT INOSITOL MONOPHOSPHATASE
1322, 6g7fL, 0.5091, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH CYSTARGOLIDE B 
1323, 5l65L, 0.5091, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1324, 5fgdZ, 0.5091, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1325, 5fgdL, 0.5091, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1326, 5fg9L, 0.5091, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1327, 2lkkA, 0.5091, 3.81, 0.094, 126, 64, HUMAN L-FABP IN COMPLEX WITH OLEATE
1328, 1ureA, 0.5091, 3.60, 0.078, 131, 64, NMR STRUCTURE OF INTESTINAL FATTY ACID-BINDING PROTEIN COMPLEXED WITH PALMITATE 20 STRUCTURES
1329, 5l5jL, 0.5090, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1330, 5fg9Z, 0.5090, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1331, 5dmbA, 0.5090, 3.53, 0.111, 140, 63, CRYSTAL STRUCTURE OF A TRANSLATIONAL REGULATOR BOUND TO A FLAGELLAR ASSEMBLY FACTOR
1332, 5dkiZ, 0.5090, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1333, 5dkiL, 0.5090, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1334, 4bj8P, 0.5090, 3.25, 0.048, 120, 63, ZEBAVIDIN
1335, 4aloB, 0.5090, 2.97, 0.069, 181, 58, STRUCTURE AND PROPERTIES OF H1 CRUSTACYANIN FROM LOBSTER HOMARUS AMERICANUS
1336, 3aaeF, 0.5090, 3.05, 0.071, 250, 56, CRYSTAL STRUCTURE OF ACTIN CAPPING PROTEIN IN COMPLEX WITH CARMIL FRAGMENT
1337, 3aaeB, 0.5090, 3.05, 0.071, 264, 56, CRYSTAL STRUCTURE OF ACTIN CAPPING PROTEIN IN COMPLEX WITH CARMIL FRAGMENT
1338, 1vwiB, 0.5090, 3.17, 0.113, 123, 62, STREPTAVIDIN-CYCLO-[5-S-VALERAMIDE-HPQGPPC]K-NH2 PH 1.5 I222 COMPLEX
1339, 1swsD, 0.5090, 3.19, 0.097, 112, 62, CORE-STREPTAVIDIN MUTANT D128A AT PH 4.5
1340, 5l5jZ, 0.5089, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1341, 4y7xZ, 0.5089, 3.52, 0.109, 222, 55, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1342, 4y7xL, 0.5089, 3.52, 0.109, 222, 55, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1343, 1libA, 0.5089, 3.54, 0.081, 131, 62, THE ADIPOCYTE LIPID-BINDING PROTEIN AT 1.6 ANGSTROMS RESOLUTION: CRYSTAL STRUCTURES OF THE APOPROTEIN AND WITH BOUND SATURATED AND UNSATURATED FATTY ACIDS
1344, 1gt1B, 0.5089, 3.34, 0.095, 155, 63, COMPLEX OF BOVINE ODORANT BINDING PROTEIN WITH AMINOANTHRACENE AND PYRAZINE
1345, 5l5sL, 0.5088, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1346, 5l5eL, 0.5088, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1347, 4ya1Z, 0.5088, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1348, 2ansA, 0.5088, 3.60, 0.081, 131, 62, ADIPOCYTE LIPID BINDING PROTEIN COMPLEXED WITH 1-ANILINO-8-NAPHTHALENE SULFONATE
1349, 5lajZ, 0.5087, 3.69, 0.107, 222, 56, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1350, 5l68Z, 0.5087, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1351, 5l68L, 0.5087, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1352, 5l65Z, 0.5087, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1353, 4ya1L, 0.5087, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1354, 4y6vL, 0.5087, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1355, 4ww8D, 0.5087, 3.38, 0.133, 260, 60, CRYSTAL STRUCTURE OF HUMAN CARBONIC ANHYDRASE ISOZYME XII WITH 4- PROPYLTHIOBENZENESULFONAMIDE
1356, 4qv8Z, 0.5087, 3.69, 0.107, 222, 56, YCP BETA5-C52F MUTANT
1357, 4qv8L, 0.5087, 3.69, 0.107, 222, 56, YCP BETA5-C52F MUTANT
1358, 5lajL, 0.5086, 3.69, 0.107, 222, 56, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1359, 5l5sZ, 0.5086, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1360, 5cz6L, 0.5086, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1361, 4y8tZ, 0.5086, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1362, 4r00Z, 0.5086, 3.70, 0.107, 222, 56, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1363, 4r00L, 0.5086, 3.70, 0.107, 222, 56, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1364, 3aaeJ, 0.5086, 3.05, 0.071, 249, 56, CRYSTAL STRUCTURE OF ACTIN CAPPING PROTEIN IN COMPLEX WITH CARMIL FRAGMENT
1365, 5n7xM, 0.5085, 3.27, 0.048, 121, 63, CRYSTAL STRUCTURE OF STREPTAVIDIN WITH PEPTIDE EWVHPQFEQKAK
1366, 5laiZ, 0.5085, 3.69, 0.107, 222, 56, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1367, 5laiL, 0.5085, 3.69, 0.107, 222, 56, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1368, 5cz6Z, 0.5085, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1369, 4y8tL, 0.5085, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1370, 4qv1Z, 0.5085, 3.69, 0.107, 222, 56, YCP BETA5-M45A MUTANT
1371, 4qv1L, 0.5085, 3.69, 0.107, 222, 56, YCP BETA5-M45A MUTANT
1372, 2ldkA, 0.5085, 2.63, 0.073, 172, 55, SOLUTION NMR STRUCTURE OF PROTEIN AAUR_3427 FROM ARTHROBACTER AURESCENS NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET AAR96
1373, 6idcA, 0.5084, 2.64, 0.062, 251, 48, LOOP DELETION AND PROLINE INSERTION MUTANT (DELETING SIX RESIDUES AND INSERTED SIX PROLINE RESIDUES) 
1374, 6hv3Z, 0.5084, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) 
1375, 6hv3L, 0.5084, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA2I (1-53) 
1376, 5lttZ, 0.5084, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1377, 5l5zZ, 0.5084, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1378, 5l5rZ, 0.5084, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1379, 5l5pZ, 0.5084, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1380, 5l5eZ, 0.5084, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1381, 4y8uZ, 0.5084, 3.71, 0.107, 222, 56, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1382, 4qwsZ, 0.5084, 3.52, 0.109, 222, 55, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1383, 4qwsL, 0.5084, 3.52, 0.109, 222, 55, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1384, 4qvwZ, 0.5084, 3.69, 0.107, 222, 56, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1385, 4i3dD, 0.5084, 3.67, 0.065, 139, 62, CRYSTAL STRUCTURE OF FLUORESCENT PROTEIN UNAG N57A MUTANT
1386, 5l69Z, 0.5083, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1387, 5l5zL, 0.5083, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1388, 5l5rL, 0.5083, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1389, 5d17E, 0.5083, 3.20, 0.107, 156, 56, STRUCTURE OF THE C-TERMINAL DOMAIN OF TNSE AT 2.85 RESOLUTION
1390, 4y8uL, 0.5083, 3.71, 0.107, 222, 56, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1391, 4y8mZ, 0.5083, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1392, 4y8mL, 0.5083, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1393, 4qvwL, 0.5083, 3.69, 0.107, 222, 56, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1394, 4qvvZ, 0.5083, 3.70, 0.107, 222, 56, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1395, 4qvvL, 0.5083, 3.70, 0.107, 222, 56, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1396, 4bj8M, 0.5083, 3.25, 0.048, 120, 63, ZEBAVIDIN
1397, 5l5iL, 0.5082, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1398, 5l5bZ, 0.5082, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1399, 4y6vZ, 0.5082, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1400, 4r18Z, 0.5082, 3.70, 0.107, 222, 56, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1401, 4qv7Z, 0.5082, 3.69, 0.107, 222, 56, YCP BETA5-A50V MUTANT
1402, 4qv7L, 0.5082, 3.69, 0.107, 222, 56, YCP BETA5-A50V MUTANT
1403, 4bj8H, 0.5082, 3.25, 0.048, 118, 63, ZEBAVIDIN
1404, 5m4yD, 0.5081, 2.18, 0.041, 173, 49, CRYSTAL STRUCTURE OF THE SEC3/SSO2 COMPLEX AT 2.20 ANGSTROM RESOLUTION
1405, 5l5pL, 0.5081, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1406, 5l5dZ, 0.5081, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1407, 4wyoB, 0.5081, 3.17, 0.053, 733, 57, CRYSTAL STRUCTURE OF HUMAN-YEAST CHIMERA ACETYL COA CARBOXYLASE CT DOMAIN BOUND TO COMPOUND 1
1408, 4r18L, 0.5081, 3.70, 0.107, 222, 56, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1409, 4qvmZ, 0.5081, 3.70, 0.107, 222, 56, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1410, 1vwkB, 0.5081, 3.18, 0.113, 123, 62, STREPTAVIDIN-CYCLO-[5-S-VALERAMIDE-HPQGPPC]K-NH2
1411, 5l69L, 0.5080, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1412, 5l5bL, 0.5080, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1413, 5cz7L, 0.5080, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1414, 4ya0Z, 0.5080, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1415, 4y69Z, 0.5080, 3.71, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1416, 4rurZ, 0.5080, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1417, 4rurL, 0.5080, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1418, 4qv3L, 0.5080, 3.69, 0.107, 222, 56, YCP BETA5-M45V MUTANT
1419, 4quxZ, 0.5080, 3.70, 0.107, 222, 56, YCP BETA5-A49T-MUTANT
1420, 4quxL, 0.5080, 3.70, 0.107, 222, 56, YCP BETA5-A49T-MUTANT
1421, 4kc8C, 0.5080, 3.09, 0.085, 443, 59, CRYSTAL STRUCTURE OF ENDO-15-ALPHA-L-ARABINANASE FROM THERMOTOGA PETROPHILA RKU-1 IN COMPLEX WITH TRIS
1422, 4bj8F, 0.5080, 3.26, 0.048, 118, 63, ZEBAVIDIN
1423, 2x45A, 0.5080, 3.11, 0.067, 144, 60, CRYSTAL STRUCTURE OF ARG R 1 IN COMPLEX WITH HISTAMINE
1424, 6hvyZ, 0.5079, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH 5 (7- AND 6-MEMBERED RING) 
1425, 5l6cL, 0.5079, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1426, 5l6bZ, 0.5079, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1427, 5l6bL, 0.5079, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1428, 5h9nA, 0.5079, 3.38, 0.077, 154, 65, CRYSTAL STRUCTURE OF LTBP1 Y114A MUTANT IN COMPLEX WITH LEUKOTRIENE C4
1429, 5f1eA, 0.5079, 3.45, 0.077, 163, 65, APO PROTEIN OF SANDERCYANIN
1430, 5cz4Z, 0.5079, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1431, 4ya0L, 0.5079, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1432, 4y8nZ, 0.5079, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1433, 4y8nL, 0.5079, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1434, 4y69L, 0.5079, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1435, 4qv4Z, 0.5079, 3.70, 0.107, 222, 56, YCP BETA5-M45T MUTANT
1436, 4qv4L, 0.5079, 3.70, 0.107, 222, 56, YCP BETA5-M45T MUTANT
1437, 4qv3Z, 0.5079, 3.69, 0.107, 222, 56, YCP BETA5-M45V MUTANT
1438, 1vdwB, 0.5079, 3.63, 0.068, 248, 59, A HYPOTHETICAL PROTEIN PH1897 FROM PYROCOCCUS HORIKOSHII WITH SIMILARITIES FOR INOSITOL-1 MONOPHOSPHATASE
1439, 1kzxA, 0.5079, 3.86, 0.098, 131, 61, SOLUTION STRUCTURE OF HUMAN INTESTINAL FATTY ACID BINDING PROTEIN WITH A NATURALLY-OCCURRING SINGLE AMINO ACID SUBSTITUTION (A54T)
1440, 6fayA, 0.5078, 3.41, 0.140, 1518, 57, TENEURIN3 MONOMER
1441, 5l5vZ, 0.5078, 3.70, 0.107, 222, 56,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1442, 5l5vL, 0.5078, 3.70, 0.107, 222, 56,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1443, 4wz8B, 0.5078, 3.49, 0.069, 698, 58, CRYSTAL STRUCTURE OF HUMAN-YEAST CHIMERA ACETYL COA CARBOXYLASE CT DOMAIN BOUND TO COMPOUND 6
1444, 4qvmL, 0.5078, 3.70, 0.107, 222, 56, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1445, 4qv5Z, 0.5078, 3.70, 0.107, 222, 56, YCP BETA5-M45I MUTANT
1446, 4qv5L, 0.5078, 3.70, 0.107, 222, 56, YCP BETA5-M45I MUTANT
1447, 5l5iZ, 0.5077, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1448, 5l5dL, 0.5077, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1449, 5fghZ, 0.5077, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1450, 5fghL, 0.5077, 3.69, 0.107, 222, 56, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1451, 5cz7Z, 0.5077, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1452, 4aloA, 0.5077, 3.31, 0.102, 181, 59, STRUCTURE AND PROPERTIES OF H1 CRUSTACYANIN FROM LOBSTER HOMARUS AMERICANUS
1453, 1icnA, 0.5077, 3.74, 0.097, 131, 62, ESCHERICHIA COLI-DERIVED RAT INTESTINAL FATTY ACID BINDING PROTEIN WITH BOUND MYRISTATE AT 1.5 A RESOLUTION AND I- FABPARG106-->GLN WITH BOUND OLEATE AT 1.74 A RESOLUTION
1454, 6hdsD, 0.5076, 3.23, 0.095, 115, 63, CRYSTAL STRUCTURE OF APO SHORT AFIFAVIDIN 
1455, 5l6cZ, 0.5076, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1456, 5l5wZ, 0.5076, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1457, 5l5wL, 0.5076, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1458, 5d0xL, 0.5076, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1459, 5cz4L, 0.5076, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1460, 4z2vA, 0.5076, 3.27, 0.048, 127, 63, CRYSTAL STRUCTURE OF SHORT HOEFAVIDIN-HOEF-PEPTIDE COMPLEX
1461, 3cxjB, 0.5076, 3.45, 0.088, 138, 57, CRYSTAL STRUCTURE OF AN UNCHARACTERIZED PROTEIN FROM METHANOTHERMOBACTER THERMAUTOTROPHICUS
1462, 1jd2S, 0.5076, 3.70, 0.107, 222, 56, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1463, 5l5fZ, 0.5075, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1464, 5l5fL, 0.5075, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1465, 5d0xZ, 0.5075, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1466, 4qw0Z, 0.5075, 3.70, 0.107, 222, 56, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1467, 4qw0L, 0.5075, 3.70, 0.107, 222, 56, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1468, 4qvqZ, 0.5075, 3.53, 0.109, 222, 55, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1469, 4qvqL, 0.5075, 3.53, 0.109, 222, 55, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1470, 4bj8J, 0.5075, 3.27, 0.048, 119, 63, ZEBAVIDIN
1471, 2izcB, 0.5075, 3.19, 0.113, 123, 62, APOSTREPTAVIDIN PH 2.0 I222 COMPLEX
1472, 5l66Z, 0.5074, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1473, 1vwjB, 0.5074, 3.18, 0.113, 123, 62, STREPTAVIDIN-CYCLO-[5-S-VALERAMIDE-HPQGPPC]K-NH2 PH 2.5 I222 COMPLEX
1474, 6iysO, 0.5073, 2.69, 0.062, 245, 48, LOOP DELETION AND PROLINE INSERTION MUTANT (DELETING SIX RESIDUES AND INSERTED THREE PROLINE RESIDUES) 
1475, 5w6zB, 0.5073, 3.09, 0.073, 179, 55, CRYSTAL STRUCTURE OF THE H24W MUTANT OF HSNUDT16 
1476, 5l67L, 0.5073, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1477, 4i3dA, 0.5073, 3.64, 0.065, 139, 62, CRYSTAL STRUCTURE OF FLUORESCENT PROTEIN UNAG N57A MUTANT
1478, 4bj8N, 0.5073, 3.26, 0.048, 118, 63, ZEBAVIDIN
1479, 2rtlA, 0.5073, 3.21, 0.113, 123, 62, STREPTAVIDIN-2-IMINOBIOTIN-SULFATE COMPLEX PH 2.50 SPACE GROUP I4122
1480, 5l66L, 0.5072, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1481, 5l5aL, 0.5072, 3.71, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1482, 5dkyA, 0.5072, 3.20, 0.074, 928, 54, CRYSTAL STRUCTURE OF GLUCOSIDASE II ALPHA SUBUNIT (DNJ-BOUND FROM)
1483, 4qwgZ, 0.5072, 3.53, 0.109, 222, 55, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1484, 4qwgL, 0.5072, 3.53, 0.109, 222, 55, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1485, 3c5oD, 0.5072, 3.41, 0.032, 151, 63, CRYSTAL STRUCTURE OF THE CONSERVED PROTEIN OF UNKNOWN FUNCTION RPA1785 FROM RHODOPSEUDOMONAS PALUSTRIS
1486, 2rtrB, 0.5072, 3.18, 0.113, 123, 62, STREPTAVIDIN-2-IMINOBIOTIN COMPLEX PH 4.0 SPACE GROUP I222
1487, 2gh7A, 0.5072, 3.18, 0.097, 121, 62, EPI-BIOTIN COMPLEX WITH CORE STREPTAVIDIN
1488, 2f01A, 0.5072, 3.18, 0.097, 121, 62, EPI-BIOTIN COMPLEX WITH CORE STREPTAVIDIN
1489, 1swgD, 0.5072, 3.25, 0.049, 113, 61, CIRCULAR PERMUTED STREPTAVIDIN E51/A46 IN COMPLEX WITH BIOTIN
1490, 6hvyL, 0.5071, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH 5 (7- AND 6-MEMBERED RING) 
1491, 5l67Z, 0.5071, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1492, 5l5qL, 0.5071, 3.71, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1493, 4albA, 0.5071, 3.40, 0.082, 158, 61, STRUCTURE OF PHENOLIC ACID DECARBOXYLASE FROM BACILLUS SUBTILIS: TYR19ALA MUTANT IN COMPLEX WITH COUMARIC ACID
1494, 1ik9A, 0.5071, 2.64, 0.060, 207, 50, CRYSTAL STRUCTURE OF A XRCC4-DNA LIGASE IV COMPLEX
1495, 5l5qZ, 0.5070, 3.71, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1496, 5h9lA, 0.5070, 3.49, 0.076, 154, 66, CRYSTAL STRUCTURE OF LTBP1 IN COMPLEX WITH CLEAVED LEUKOTRIENE C4
1497, 4ya5Z, 0.5070, 3.71, 0.107, 222, 56, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1498, 4ya5L, 0.5070, 3.71, 0.107, 222, 56, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1499, 4ya3Z, 0.5070, 3.71, 0.107, 222, 56, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1500, 4ya3L, 0.5070, 3.71, 0.107, 222, 56, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1501, 4gzvA, 0.5070, 3.20, 0.094, 137, 64, CRYSTAL STRUCTURE OF A LIPOCALIN FAMILY PROTEIN (BACOVA_00364) FROM BACTEROIDES OVATUS ATCC 8483 AT 1.95 A RESOLUTION
1502, 1e5pA, 0.5070, 3.41, 0.095, 146, 63, CRYSTAL STRUCTURE OF APHRODISIN A SEX PHEROMONE FROM FEMALE HAMSTER
1503, 5l5xL, 0.5069, 3.53, 0.109, 222, 55, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1504, 5l5aZ, 0.5069, 3.71, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1505, 3lk4E, 0.5069, 3.07, 0.071, 238, 56, CRYSTAL STRUCTURE OF CAPZ BOUND TO THE UNCAPPING MOTIF FROM CD2AP
1506, 1g0hA, 0.5069, 3.76, 0.067, 252, 60, CRYSTAL STRUCTURE OF MJ0109 GENE PRODUCT INOSITOL MONOPHOSPHATASE-FRUCTOSE 16 BISPHOSPHATASE
1507, 3wyqB, 0.5068, 3.20, 0.097, 120, 62, CRYSTAL STRUCTURE OF THE LOW-IMMUNOGENIC CORE STREPTAVIDIN MUTANT LISA-314 (Y22S/Y83S/R84K/E101D/R103K/E116N) AT 1.0 A RESOLUTION
1508, 3lk4K, 0.5068, 3.07, 0.071, 238, 56, CRYSTAL STRUCTURE OF CAPZ BOUND TO THE UNCAPPING MOTIF FROM CD2AP
1509, 6g8nL, 0.5067, 3.71, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH CYSTARGOLIDE B DERIVATIVE 2 
1510, 5l5xZ, 0.5067, 3.53, 0.109, 222, 55, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1511, 5d17I, 0.5067, 3.22, 0.107, 156, 56, STRUCTURE OF THE C-TERMINAL DOMAIN OF TNSE AT 2.85 RESOLUTION
1512, 1icmA, 0.5067, 3.75, 0.081, 131, 62, ESCHERICHIA COLI-DERIVED RAT INTESTINAL FATTY ACID BINDING PROTEIN WITH BOUND MYRISTATE AT 1.5 A RESOLUTION AND I- FABPARG106-->GLN WITH BOUND OLEATE AT 1.74 A RESOLUTION
1513, 6g8nZ, 0.5066, 3.71, 0.107, 222, 56, YEAST 20S PROTEASOME IN COMPLEX WITH CYSTARGOLIDE B DERIVATIVE 2 
1514, 5myqA, 0.5066, 3.36, 0.032, 122, 63, CRYSTAL STRUCTURE OF AVIDIN IN COMPLEX WITH FERROCENE HOMOBIOTIN DERIVATIVE
1515, 4qw3Z, 0.5066, 3.70, 0.107, 222, 56, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1516, 4qw3L, 0.5066, 3.70, 0.107, 222, 56, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1517, 4a1yA, 0.5066, 3.56, 0.081, 133, 62, HUMAN MYELIN P2 PROTEIN K65Q MUTANT
1518, 3lk4Q, 0.5066, 3.07, 0.071, 238, 56, CRYSTAL STRUCTURE OF CAPZ BOUND TO THE UNCAPPING MOTIF FROM CD2AP
1519, 3lk4B, 0.5066, 3.07, 0.071, 238, 56, CRYSTAL STRUCTURE OF CAPZ BOUND TO THE UNCAPPING MOTIF FROM CD2AP
1520, 3lk42, 0.5066, 3.07, 0.071, 238, 56, CRYSTAL STRUCTURE OF CAPZ BOUND TO THE UNCAPPING MOTIF FROM CD2AP
1521, 5myqC, 0.5065, 3.35, 0.032, 122, 63, CRYSTAL STRUCTURE OF AVIDIN IN COMPLEX WITH FERROCENE HOMOBIOTIN DERIVATIVE
1522, 5dkxA, 0.5065, 3.20, 0.074, 925, 54, CRYSTAL STRUCTURE OF GLUCOSIDASE II ALPHA SUBUNIT (TRIS-BOUND FROM)
1523, 3lk4T, 0.5065, 3.07, 0.071, 237, 56, CRYSTAL STRUCTURE OF CAPZ BOUND TO THE UNCAPPING MOTIF FROM CD2AP
1524, 5mpam, 0.5064, 3.78, 0.105, 222, 57, 26S PROTEASOME IN PRESENCE OF ATP (S2)
1525, 5m2bZ, 0.5064, 3.71, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1526, 5m2bL, 0.5064, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1527, 5l6aZ, 0.5064, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1528, 5l6aL, 0.5064, 3.70, 0.107, 222, 56, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1529, 1obpB, 0.5064, 3.35, 0.081, 155, 62, ODORANT-BINDING PROTEIN FROM BOVINE NASAL MUCOSA
1530, 1nc9A, 0.5064, 3.22, 0.113, 120, 62, STREPTAVIDIN MUTANT Y43A WITH IMINOBIOTIN AT 1.8A RESOLUTION
1531, 6hdvB, 0.5063, 3.26, 0.079, 136, 63, THE CRYSTAL STRUCTURE OF INTACT AFIFAVIDIN APO FORM 
1532, 4dneA, 0.5063, 3.20, 0.097, 121, 62, CRYSTAL STRUCTURE OF A TRIPLE-MUTANT OF STREPTAVIDIN IN COMPLEX WITH DESTHIOBIOTIN
1533, 2rtcB, 0.5063, 3.20, 0.113, 123, 62, APOSTREPTAVIDIN PH 3.60 SPACE GROUP I222
1534, 1swcA, 0.5063, 3.22, 0.097, 114, 62, APO-CORE-STREPTAVIDIN AT PH 4.5
1535, 5yvfC, 0.5062, 3.81, 0.138, 318, 65, CRYSTAL STRUCTURE OF BFA1 
1536, 5mu3D, 0.5062, 3.24, 0.071, 185, 56, CRYSTAL STRUCTURE OF CTF19-MCM21 KINETOCHORE ASSEMBLY BOUND WITH CTF19-MCM21 BINDING MOTIF OF CENTRAL KINETOCHORE SUBUNIT OKP1
1537, 3hoeB, 0.5062, 3.48, 0.078, 242, 64, CRYSTAL STRUCTURE OF SURFACE LIPOPROTEIN
1538, 4y6aZ, 0.5061, 3.71, 0.107, 222, 56, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1539, 4y6aL, 0.5061, 3.71, 0.107, 222, 56, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1540, 3aaeD, 0.5061, 3.18, 0.053, 264, 57, CRYSTAL STRUCTURE OF ACTIN CAPPING PROTEIN IN COMPLEX WITH CARMIL FRAGMENT
1541, 2czhB, 0.5061, 3.61, 0.068, 246, 59, CRYSTAL STRUCTURE OF HUMAN MYO-INOSITOL MONOPHOSPHATASE 2 (IMPA2) WITH PHOSPHATE ION (ORTHORHOMBIC FORM)
1542, 1oacA, 0.5061, 3.54, 0.066, 719, 61, CRYSTAL STRUCTURE OF A QUINOENZYME: COPPER AMINE OXIDASE OF ESCHERICHIA COLI AT 2 ANGSTROEMS RESOLUTION
1543, 1kl4D, 0.5061, 3.22, 0.097, 119, 62, AN ENGINEERED STREPTAVIDIN WITH IMPROVED AFFINITY FOR THE STREP-TAG II PEPTIDE : APO-SAM2
1544, 5dkzA, 0.5060, 3.21, 0.074, 921, 54, CRYSTAL STRUCTURE OF GLUCOSIDASE II ALPHA SUBUNIT (ALPHA3-GLC2-BOUND FROM)
1545, 2x45B, 0.5060, 3.09, 0.067, 144, 60, CRYSTAL STRUCTURE OF ARG R 1 IN COMPLEX WITH HISTAMINE
1546, 2qflA, 0.5060, 3.73, 0.017, 262, 60, STRUCTURE OF SUHB: INOSITOL MONOPHOSPHATASE AND EXTRAGENIC SUPPRESSOR FROM E. COLI
1547, 1vwkD, 0.5060, 3.21, 0.113, 121, 62, STREPTAVIDIN-CYCLO-[5-S-VALERAMIDE-HPQGPPC]K-NH2
1548, 1g7nA, 0.5060, 3.56, 0.081, 131, 62, TOWARD CHANGING SPECIFICITY: ADIPOCYTE LIPID BINDING PROTEIN MUTANT APO FORM
1549, 1d6zB, 0.5060, 3.49, 0.066, 719, 61, CRYSTAL STRUCTURE OF THE AEROBICALLY FREEZE TRAPPED RATE-DETERMINING CATALYTIC INTERMEDIATE OF E. COLI COPPER-CONTAINING AMINE OXIDASE.
1550, 5yvfD, 0.5059, 3.52, 0.097, 318, 62, CRYSTAL STRUCTURE OF BFA1 
1551, 5n8eA, 0.5059, 3.47, 0.094, 119, 64, CRYSTAL STRUCTURE OF STREPTAVIDIN WITH PEPTIDE RDPAPAWAHGGG
1552, 3qszB, 0.5059, 3.07, 0.055, 177, 55, CRYSTAL STRUCTURE OF THE STAR-RELATED LIPID TRANSFER PROTEIN (FRAGMENT 25-204) FROM XANTHOMONAS AXONOPODIS AT THE RESOLUTION 2.4A NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET XAR342
1553, 2rtmA, 0.5059, 3.22, 0.113, 123, 62, STREPTAVIDIN-2-IMINOBIOTIN-SULFATE COMPLEX PH 3.50 SPACE GROUP I4122
1554, 2p3nB, 0.5059, 3.66, 0.102, 256, 59, THERMOTOGA MARITIMA IMPASE TM1415
1555, 2cziA, 0.5059, 3.53, 0.052, 259, 58, CRYSTAL STRUCTURE OF HUMAN MYO-INOSITOL MONOPHOSPHATASE 2 (IMPA2) WITH CALCIUM AND PHOSPHATE IONS
1556, 1luqA, 0.5059, 3.18, 0.097, 119, 62, FULL MATRIX ERROR ANALYSIS OF STREPTAVIDIN
1557, 5o68D, 0.5058, 3.86, 0.131, 271, 61, CRYSTAL STRUCTURE OF THE PSEUDOMONAS FUNCTIONAL AMYLOID SECRETION PROTEIN FAPF - R157A MUTANT
1558, 5d17C, 0.5058, 3.23, 0.089, 156, 56, STRUCTURE OF THE C-TERMINAL DOMAIN OF TNSE AT 2.85 RESOLUTION
1559, 2f73D, 0.5058, 3.62, 0.065, 135, 62, CRYSTAL STRUCTURE OF HUMAN FATTY ACID BINDING PROTEIN 1 (FABP1)
1560, 5jqpA, 0.5056, 3.20, 0.074, 918, 54, CRYSTAL STRUCTURE OF ER GLUCOSIDASE II HETERODIMERIC COMPLEX CONSISTING OF CATALYTIC SUBUNIT AND THE BINDING DOMAIN OF REGULATORY SUBUNIT
1561, 1e5pB, 0.5055, 3.41, 0.095, 145, 63, CRYSTAL STRUCTURE OF APHRODISIN A SEX PHEROMONE FROM FEMALE HAMSTER
1562, 1d6yB, 0.5055, 3.50, 0.066, 719, 61, CRYSTAL STRUCTURE OF E. COLI COPPER-CONTAINING AMINE OXIDASE ANAEROBICALLY REDUCED WITH BETA-PHENYLETHYLAMINE AND COMPLEXED WITH NITRIC OXIDE.
1563, 6ieiA, 0.5054, 2.82, 0.062, 250, 48, LOOP DELETION AND PROLINE INSERTION MUTANT (DELETING SIX RESIDUES AND INSERTED FIVE PROLINE RESIDUES) 
1564, 5o68G, 0.5054, 3.83, 0.131, 271, 61, CRYSTAL STRUCTURE OF THE PSEUDOMONAS FUNCTIONAL AMYLOID SECRETION PROTEIN FAPF - R157A MUTANT
1565, 5hjrA, 0.5054, 3.20, 0.055, 855, 55, MURINE ENDOPLASMIC RETICULUM ALPHA-GLUCOSIDASE II WITH BOUND COVALENT INTERMEDIATE
1566, 5d17H, 0.5054, 2.97, 0.073, 154, 55, STRUCTURE OF THE C-TERMINAL DOMAIN OF TNSE AT 2.85 RESOLUTION
1567, 2izhB, 0.5054, 3.19, 0.113, 122, 62, STREPTAVIDIN-BIOTIN PH 10.44 I222 COMPLEX
1568, 1yhpA, 0.5054, 3.30, 0.089, 212, 56, SOLUTION STRUCTURE OF CA2+-FREE DDCAD-1
1569, 5h9oA, 0.5053, 3.18, 0.055, 857, 55, COMPLEX OF MURINE ENDOPLASMIC RETICULUM ALPHA-GLUCOSIDASE II WITH D- GLUCOSE
1570, 4bj8B, 0.5053, 3.24, 0.048, 118, 63, ZEBAVIDIN
1571, 3aa7B, 0.5053, 3.23, 0.053, 243, 57, CRYSTAL STRUCTURE OF ACTIN CAPPING PROTEIN
1572, 2r74A, 0.5053, 2.92, 0.018, 142, 56, CRYSTAL STRUCTURE OF THE POSSUM MILK WHEY LIPOCALIN TRICHOSURIN AT PH 4.6
1573, 2aj7A, 0.5053, 3.57, 0.094, 155, 64, CRYSTAL STRUCTURE OF A PUTATIVE CONTRACTILE PROTEIN (BH3618) FROM BACILLUS HALODURANS AT 1.67 A RESOLUTION
1574, 1y7wA, 0.5053, 3.44, 0.082, 274, 61, CRYSTAL STRUCTURE OF A HALOTOLERANT CARBONIC ANHYDRASE FROM DUNALIELLA SALINA
1575, 2o62B, 0.5052, 3.63, 0.067, 265, 60, CRYSTAL STRUCTURE OF A PROTEIN WITH UNKNOWN FUNCTION FROM DUF3598 FAMILY (NPUN_R4044) FROM NOSTOC PUNCTIFORME PCC 73102 AT 1.75 A RESOLUTION
1576, 6ib8A, 0.5051, 3.76, 0.017, 259, 60, STRUCTURE OF A COMPLEX OF SUHB AND NUSA AR2 DOMAIN 
1577, 5hjoA, 0.5051, 3.19, 0.055, 854, 55, MURINE ENDOPLASMIC RETICULUM ALPHA-GLUCOSIDASE II WITH BOUND SUBSTRATE ANALOGUE
1578, 1swsA, 0.5051, 3.20, 0.097, 114, 62, CORE-STREPTAVIDIN MUTANT D128A AT PH 4.5
1579, 5vy2A, 0.5050, 3.24, 0.071, 179, 56, CRYSTAL STRUCTURE OF THE F36A MUTANT OF HSNUDT16 
1580, 4ghbB, 0.5050, 3.25, 0.130, 254, 54, CRYSTAL STRUCTURE OF A PORIN-LIKE PROTEIN (BACUNI_01323) FROM BACTEROIDES UNIFORMIS ATCC 8492 AT 2.32 A RESOLUTION
1581, 3vg3A, 0.5050, 3.77, 0.094, 129, 64, CADMIUM DERIVATIVE OF HUMAN LFABP
1582, 5l5yZ, 0.5049, 3.54, 0.109, 222, 55, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1583, 5f0eA, 0.5049, 3.19, 0.055, 857, 55, MURINE ENDOPLASMIC RETICULUM ALPHA-GLUCOSIDASE II
1584, 3wznB, 0.5049, 3.19, 0.113, 123, 62, CRYSTAL STRUCTURE OF THE CORE STREPTAVIDIN MUTANT V21 (Y22S/N23D/S27D/Y83S/R84K/E101D/R103K/E116N) COMPLEXED WITH BIOTIN AT 1.3 A RESOLUTION
1585, 2fvzC, 0.5049, 3.60, 0.085, 244, 59, HUMAN INOSITOL MONOPHOSPHOSPHATASE 2
1586, 1vwlD, 0.5049, 3.22, 0.113, 121, 62, STREPTAVIDIN-CYCLO-[5-S-VALERAMIDE-HPQGPPC]K-NH2 PH 3.5 I222 COMPLEX
1587, 1vwiD, 0.5049, 3.22, 0.113, 121, 62, STREPTAVIDIN-CYCLO-[5-S-VALERAMIDE-HPQGPPC]K-NH2 PH 1.5 I222 COMPLEX
1588, 1srhA, 0.5049, 3.20, 0.113, 116, 62, STRUCTURE-BASED DESIGN OF SYNTHETIC AZOBENZENE LIGANDS FOR STREPTAVIDIN
1589, 2rtqD, 0.5048, 3.21, 0.113, 121, 62, STREPTAVIDIN-2-IMINOBIOTIN COMPLEX PH 3.25 SPACE GROUP I222 CRYSTALLIZED FROM 4.3 M AMMONIUM SULFATE
1590, 2czkA, 0.5048, 3.52, 0.052, 253, 58, CRYSTAL STRUCTURE OF HUMAN MYO-INOSITOL MONOPHOSPHATASE 2 (IMPA2) (TRIGONAL FORM)
1591, 5l5yL, 0.5047, 3.54, 0.109, 222, 55, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1592, 5hceC, 0.5047, 3.36, 0.031, 148, 64, TERNARY COMPLEX OF HUMAN COMPLEMENT C5 WITH ORNITHODOROS MOUBATA OMCI AND RHIPICEPHALUS APPENDICULATUS RACI1
1593, 3vpjF, 0.5047, 2.91, 0.036, 147, 56, CRYSTAL STRUCTURE OF TYPE VI EFFECTOR TSE1 FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH IMMUNE PROTEIN TSI1
1594, 3t6fA, 0.5047, 3.19, 0.113, 121, 62, BIOTIN COMPLEX OF Y54F CORE STREPTAVIDIN
1595, 3qszA, 0.5047, 3.31, 0.054, 175, 56, CRYSTAL STRUCTURE OF THE STAR-RELATED LIPID TRANSFER PROTEIN (FRAGMENT 25-204) FROM XANTHOMONAS AXONOPODIS AT THE RESOLUTION 2.4A NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET XAR342
1596, 5cteB, 0.5046, 3.19, 0.053, 728, 57, HUMANIZED YEAST ACC CARBOXYLTRANSFERASE DOMAIN BOUND TO 22- DIMETHYLPROPYL (1S)-1-METHYL-8-[(7-METHYL-1H-INDAZOL-5-YL)CARBONYL]- 28-DIAZASPIRO[4.5]DECANE-2-CARBOXYLATE
1597, 4cphA, 0.5046, 3.22, 0.097, 118, 62, TRANS-DIVALENT STREPTAVIDIN WITH LOVE-HATE LIGAND 4
1598, 3hoeA, 0.5046, 3.48, 0.078, 242, 64, CRYSTAL STRUCTURE OF SURFACE LIPOPROTEIN
1599, 2rtaA, 0.5046, 3.23, 0.113, 121, 62, APOSTREPTAVIDIN PH 2.97 SPACE GROUP I4122
1600, 2izfB, 0.5046, 3.21, 0.113, 123, 62, STREPTAVIDIN-BIOTIN PH 4.0 I222 COMPLEX
1601, 2f73B, 0.5046, 3.59, 0.065, 136, 62, CRYSTAL STRUCTURE OF HUMAN FATTY ACID BINDING PROTEIN 1 (FABP1)
1602, 1vwjD, 0.5046, 3.22, 0.113, 121, 62, STREPTAVIDIN-CYCLO-[5-S-VALERAMIDE-HPQGPPC]K-NH2 PH 2.5 I222 COMPLEX
1603, 6hdtD, 0.5045, 3.27, 0.095, 116, 63, CRYSTAL STRUCTURE OF SHORT AFIFAVIDIN - BIOTIN COMPLEX 
1604, 5o68B, 0.5045, 3.89, 0.148, 274, 61, CRYSTAL STRUCTURE OF THE PSEUDOMONAS FUNCTIONAL AMYLOID SECRETION PROTEIN FAPF - R157A MUTANT
1605, 5hjrC, 0.5045, 3.20, 0.055, 854, 55, MURINE ENDOPLASMIC RETICULUM ALPHA-GLUCOSIDASE II WITH BOUND COVALENT INTERMEDIATE
1606, 5h9oC, 0.5045, 3.18, 0.055, 857, 55, COMPLEX OF MURINE ENDOPLASMIC RETICULUM ALPHA-GLUCOSIDASE II WITH D- GLUCOSE
1607, 4nw4A, 0.5045, 3.10, 0.068, 272, 59, CRYSTAL STRUCTURE OF A DUF4822 FAMILY PROTEIN (EF0375) FROM ENTEROCOCCUS FAECALIS V583 AT 1.85 A RESOLUTION
1608, 4kc7C, 0.5045, 2.99, 0.086, 433, 58, CRYSTAL STRUCTURE OF ENDO-15-ALPHA-L-ARABINANASE FROM THERMOTOGA PETROPHILA RKU-1
1609, 4eqaC, 0.5045, 2.92, 0.036, 150, 56, CRYSTAL STRUCTURE OF PA1844 IN COMPLEX WITH PA1845 FROM PSEUDOMONAS AERUGINOSA PAO1
1610, 5hccC, 0.5044, 3.36, 0.031, 148, 64, TERNARY COMPLEX OF HUMAN COMPLEMENT C5 WITH ORNITHODOROS MOUBATA OMCI AND DERMACENTOR ANDERSONI RACI3.
1611, 4fqbH, 0.5044, 2.96, 0.036, 148, 56, CRYSTAL STRUCTURE OF TOXIC EFFECTOR TSE1 IN COMPLEX WITH IMMUNE PROTEIN TSI1
1612, 2izaA, 0.5044, 3.23, 0.113, 121, 62, APOSTREPTAVIDIN PH 2.00 I4122 STRUCTURE
1613, 6hdtC, 0.5043, 3.26, 0.079, 125, 63, CRYSTAL STRUCTURE OF SHORT AFIFAVIDIN - BIOTIN COMPLEX 
1614, 4xa4A, 0.5042, 2.42, 0.061, 200, 49, CRYSTAL STRUCTURE OF THE COILED-COIL SURROUNDING SKIP 3 OF MYH7
1615, 4i3dB, 0.5042, 3.80, 0.063, 139, 63, CRYSTAL STRUCTURE OF FLUORESCENT PROTEIN UNAG N57A MUTANT
1616, 4bx5A, 0.5042, 3.23, 0.097, 120, 62, CIS-DIVALENT STREPTAVIDIN
1617, 3tvwA, 0.5042, 3.20, 0.053, 711, 57, CRYSTAL STRUCTURE OF THE HUMANIZED CARBOXYLTRANSFERASE DOMAIN OF YEAST ACETYL-COA CAROXYLASE IN COMPLEX WITH COMPOUND 4
1618, 2py1A, 0.5042, 3.80, 0.082, 129, 61, SOLUTION STRUCTURE OF HUMAN LIVER FATTY ACID BINDING PROTEIN
1619, 1swoA, 0.5042, 3.25, 0.097, 120, 62, CORE-STREPTAVIDIN MUTANT W120F AT PH 7.5
1620, 1awbA, 0.5042, 3.58, 0.051, 272, 59, HUMAN MYO-INOSITOL MONOPHOSPHATASE IN COMPLEX WITH D- INOSITOL-1-PHOSPHATE AND CALCIUM
1621, 3tvwB, 0.5041, 3.20, 0.053, 705, 57, CRYSTAL STRUCTURE OF THE HUMANIZED CARBOXYLTRANSFERASE DOMAIN OF YEAST ACETYL-COA CAROXYLASE IN COMPLEX WITH COMPOUND 4
1622, 3pcsA, 0.5041, 3.02, 0.055, 350, 55, STRUCTURE OF ESPG-PAK2 AUTOINHIBITORY IALPHA3 HELIX COMPLEX
1623, 2uywA, 0.5041, 3.36, 0.048, 119, 63, CRYSTAL STRUCTURE OF XENAVIDIN
1624, 4z2oA, 0.5040, 3.30, 0.048, 127, 63, HIGH RESOLUTION CRYSTAL STRUCTURE OF SHORT HOEFAVIDIN-HOEF-PEPTIDE COMPLEX
1625, 4bx7A, 0.5040, 3.32, 0.063, 119, 63, TRANS-DIVALENT STREPTAVIDIN BOUND TO BIOTIN-4-FLUORESCEIN
1626, 3tv5B, 0.5040, 3.20, 0.053, 690, 57, CRYSTAL STRUCTURE OF THE HUMANIZED CARBOXYLTRANSFERASE DOMAIN OF YEAST ACETYL-COA CAROXYLASE IN COMPLEX WITH COMPOUND 1
1627, 3lv0A, 0.5040, 3.56, 0.034, 258, 59, CRYSTAL STRUCTURE OF EXTRAGENIC SUPPRESSOR PROTEIN SUHB FROM BARTONELLA HENSELAE NATIVE
1628, 3bziA, 0.5040, 3.56, 0.051, 223, 59, MOLECULAR AND STRUCTURAL BASIS OF POLO-LIKE KINASE 1 SUBSTRATE RECOGNITION: IMPLICATIONS IN CENTROSOMAL LOCALIZATION
1629, 2p3nA, 0.5040, 3.73, 0.117, 256, 60, THERMOTOGA MARITIMA IMPASE TM1415
1630, 5hcdC, 0.5039, 3.35, 0.031, 148, 64, TERNARY COMPLEX OF HUMAN COMPLEMENT C5 WITH ORNITHODOROS MOUBATA OMCI AND RHIPICEPHALUS MICROPLUS RACI2
1631, 4cpiD, 0.5039, 3.32, 0.048, 120, 63, STREPTAVIDIN A86D MUTANT WITH LOVE-HATE LIGAND 4
1632, 3tv5A, 0.5039, 3.20, 0.053, 696, 57, CRYSTAL STRUCTURE OF THE HUMANIZED CARBOXYLTRANSFERASE DOMAIN OF YEAST ACETYL-COA CAROXYLASE IN COMPLEX WITH COMPOUND 1
1633, 2w0qB, 0.5039, 3.50, 0.066, 719, 61, E. COLI COPPER AMINE OXIDASE IN COMPLEX WITH XENON
1634, 2p3vD, 0.5039, 3.61, 0.119, 254, 59, THERMOTOGA MARITIMA IMPASE TM1415
1635, 2izcD, 0.5039, 3.22, 0.113, 121, 62, APOSTREPTAVIDIN PH 2.0 I222 COMPLEX
1636, 2bjiA, 0.5039, 3.60, 0.051, 274, 59, HIGH RESOLUTION STRUCTURE OF MYO-INOSITOL MONOPHOSPHATASE THE TARGET OF LITHIUM THERAPY
1637, 1jd2L, 0.5039, 3.56, 0.109, 222, 55, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1638, 5yvfA, 0.5038, 3.42, 0.097, 322, 62, CRYSTAL STRUCTURE OF BFA1 
1639, 3ry2A, 0.5038, 3.21, 0.113, 121, 62, WILD-TYPE CORE STREPTAVIDIN-BIOTIN COMPLEX AT ATOMIC RESOLUTION
1640, 1vwdB, 0.5038, 3.23, 0.113, 121, 62, STREPTAVIDIN-CYCLO-AC-[CHPQFC]-NH2 PH 3.0
1641, 1swqC, 0.5038, 3.27, 0.097, 112, 62, CORE-STREPTAVIDIN MUTANT W120A AT PH 7.5
1642, 5o65A, 0.5037, 3.70, 0.153, 270, 59, CRYSTAL STRUCTURE OF THE PSEUDOMONAS FUNCTIONAL AMYLOID SECRETION PROTEIN FAPF
1643, 5jd2B, 0.5037, 3.24, 0.097, 119, 62, SFX STRUCTURE OF CORESTREPTAVIDIN-SELENOBIOTIN COMPLEX
1644, 4a1hA, 0.5037, 3.70, 0.079, 133, 63, HUMAN MYELIN P2 PROTEIN K45S MUTANT
1645, 2fvzB, 0.5037, 3.69, 0.068, 244, 59, HUMAN INOSITOL MONOPHOSPHOSPHATASE 2
1646, 5n7xO, 0.5036, 3.31, 0.048, 122, 63, CRYSTAL STRUCTURE OF STREPTAVIDIN WITH PEPTIDE EWVHPQFEQKAK
1647, 3nadA, 0.5036, 2.98, 0.070, 161, 57, CRYSTAL STRUCTURE OF PHENOLIC ACID DECARBOXYLASE FROM BACILLUS PUMILUS UI-670
1648, 2bc3B, 0.5036, 3.21, 0.097, 141, 62, T7-TAGGED FULL-LENGTH STREPTAVIDIN
1649, 1swkA, 0.5036, 3.22, 0.097, 117, 62, CORE-STREPTAVIDIN MUTANT W79F IN COMPLEX WITH BIOTIN AT PH 4.5
1650, 5x7yC, 0.5035, 3.67, 0.079, 160, 63, CRYSTAL STRUCTURE OF THE DOG LIPOCALIN ALLERGEN CAN F 6
1651, 5lf0b, 0.5035, 3.77, 0.088, 203, 57, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
1652, 5a0qV, 0.5035, 3.71, 0.089, 183, 56, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
1653, 5a0qH, 0.5035, 3.71, 0.089, 183, 56, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
1654, 3vg5A, 0.5035, 3.77, 0.094, 129, 64, BARIUM DERIVATIVE OF HUMAN LFABP
1655, 2x46A, 0.5035, 3.09, 0.068, 141, 59, CRYSTAL STRUCTURE OF SEMET ARG R 1
1656, 2bjiB, 0.5035, 3.61, 0.034, 274, 59, HIGH RESOLUTION STRUCTURE OF MYO-INOSITOL MONOPHOSPHATASE THE TARGET OF LITHIUM THERAPY
1657, 1swqA, 0.5035, 3.21, 0.097, 113, 62, CORE-STREPTAVIDIN MUTANT W120A AT PH 7.5
1658, 5n7xA, 0.5034, 3.22, 0.097, 122, 62, CRYSTAL STRUCTURE OF STREPTAVIDIN WITH PEPTIDE EWVHPQFEQKAK
1659, 5dl0A, 0.5034, 3.22, 0.036, 924, 55, CRYSTAL STRUCTURE OF GLUCOSIDASE II ALPHA SUBUNIT (GLC1MAN2-BOUND FROM)
1660, 4i3dC, 0.5034, 3.67, 0.065, 139, 62, CRYSTAL STRUCTURE OF FLUORESCENT PROTEIN UNAG N57A MUTANT
1661, 4as5A, 0.5034, 3.59, 0.051, 274, 59, STRUCTURE OF MOUSE INOSITOL MONOPHOSPHATASE 1
1662, 3mfbD, 0.5034, 3.83, 0.097, 145, 62, CRYSTAL STRUCTURE OF THE S-TYPE PYOCIN DOMAIN OF ECA1669 PROTEIN FROM ERWINIA CAROTOVORA NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET EWR82C
1663, 3mfbB, 0.5034, 3.83, 0.097, 145, 62, CRYSTAL STRUCTURE OF THE S-TYPE PYOCIN DOMAIN OF ECA1669 PROTEIN FROM ERWINIA CAROTOVORA NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET EWR82C
1664, 1hy2C, 0.5034, 3.23, 0.097, 123, 62, MINIPROTEIN MP-1 COMPLEX WITH STREPTAVIDIN
1665, 5n7xK, 0.5033, 3.22, 0.097, 122, 62, CRYSTAL STRUCTURE OF STREPTAVIDIN WITH PEPTIDE EWVHPQFEQKAK
1666, 4j38A, 0.5033, 3.75, 0.046, 132, 65, STRUCTURE OF BORRELIA BURGDORFERI OUTER SURFACE PROTEIN E IN COMPLEX WITH FACTOR H DOMAINS 19-20
1667, 1swkB, 0.5033, 3.23, 0.097, 117, 62, CORE-STREPTAVIDIN MUTANT W79F IN COMPLEX WITH BIOTIN AT PH 4.5
1668, 1swaA, 0.5033, 3.23, 0.097, 120, 62, APO-CORE-STREPTAVIDIN AT PH 4.5
1669, 3stnA, 0.5032, 3.77, 0.079, 127, 63, STRUCTURE OF HUMAN LFABP (APO-LFABP)
1670, 3lv0B, 0.5032, 3.58, 0.034, 254, 59, CRYSTAL STRUCTURE OF EXTRAGENIC SUPPRESSOR PROTEIN SUHB FROM BARTONELLA HENSELAE NATIVE
1671, 1kl3D, 0.5032, 3.22, 0.097, 119, 62, AN ENGINEERED STREPTAVIDIN WITH IMPROVED AFFINITY FOR THE STREP-TAG II PEPTIDE : SAM1-STREPII
1672, 1d6uB, 0.5032, 3.50, 0.066, 719, 61, CRYSTAL STRUCTURE OF E. COLI AMINE OXIDASE ANAEROBICALLY REDUCED WITH BETA-PHENYLETHYLAMINE
1673, 5nn1A, 0.5031, 3.45, 0.052, 215, 58, THE STRUCTURE OF THE POLO-BOX DOMAIN (PBD) OF POLO-LIKE KINASE 1 (PLK1)
1674, 5hjoC, 0.5031, 3.19, 0.055, 854, 55, MURINE ENDOPLASMIC RETICULUM ALPHA-GLUCOSIDASE II WITH BOUND SUBSTRATE ANALOGUE
1675, 1lczA, 0.5031, 3.19, 0.097, 119, 62, STREPTAVIDIN-BCAP COMPLEX
1676, 5d17K, 0.5030, 3.33, 0.070, 155, 57, STRUCTURE OF THE C-TERMINAL DOMAIN OF TNSE AT 2.85 RESOLUTION
1677, 3mfbC, 0.5030, 3.84, 0.097, 145, 62, CRYSTAL STRUCTURE OF THE S-TYPE PYOCIN DOMAIN OF ECA1669 PROTEIN FROM ERWINIA CAROTOVORA NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET EWR82C
1678, 3mfbA, 0.5030, 3.84, 0.097, 145, 62, CRYSTAL STRUCTURE OF THE S-TYPE PYOCIN DOMAIN OF ECA1669 PROTEIN FROM ERWINIA CAROTOVORA NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET EWR82C
1679, 2f1tC, 0.5030, 3.39, 0.051, 183, 59, OUTER MEMBRANE PROTEIN OMPW
1680, 1yivA, 0.5030, 3.73, 0.095, 131, 63, STRUCTURE OF MYELIN P2 PROTEIN FROM EQUINE SPINAL CORD
1681, 1oacB, 0.5030, 3.70, 0.079, 722, 63, CRYSTAL STRUCTURE OF A QUINOENZYME: COPPER AMINE OXIDASE OF ESCHERICHIA COLI AT 2 ANGSTROEMS RESOLUTION
1682, 5iedA, 0.5029, 3.20, 0.055, 857, 55, MURINE ENDOPLASMIC RETICULUM ALPHA-GLUCOSIDASE II WITH CASTANOSPERMINE
1683, 3wznA, 0.5029, 3.21, 0.113, 124, 62, CRYSTAL STRUCTURE OF THE CORE STREPTAVIDIN MUTANT V21 (Y22S/N23D/S27D/Y83S/R84K/E101D/R103K/E116N) COMPLEXED WITH BIOTIN AT 1.3 A RESOLUTION
1684, 2q4mA, 0.5029, 4.02, 0.098, 160, 61, ENSEMBLE REFINEMENT OF THE CRYSTAL STRUCTURE OF PROTEIN FROM ARABIDOPSIS THALIANA AT5G01750
1685, 2h2yA, 0.5029, 3.08, 0.089, 133, 56, CRYSTAL STRUCTURE OF UBIQUITIN CONJUGATING ENZYME E2 FROM PLASMODIUM FALCIPARUM
1686, 1swoC, 0.5029, 3.25, 0.097, 115, 62, CORE-STREPTAVIDIN MUTANT W120F AT PH 7.5
1687, 1swdA, 0.5029, 3.22, 0.097, 117, 62, APO-CORE-STREPTAVIDIN IN COMPLEX WITH BIOTIN (TWO UNOCCUPIED BINDING SITES) AT PH 4.5
1688, 4jo6D, 0.5028, 3.30, 0.048, 120, 63, STREPTAVIDIN COMPLEX WITH SBP-TAG
1689, 3tvuB, 0.5028, 3.21, 0.053, 690, 57, CRYSTAL STRUCTURE OF THE HUMANIZED CARBOXYLTRANSFERASE DOMAIN OF YEAST ACETYL-COA CAROXYLASE IN COMPLEX WITH COMPOUND 3
1690, 2o3iA, 0.5028, 3.29, 0.123, 366, 57, X-RAY CRYSTAL STRUCTURE OF PROTEIN CV_3147 FROM CHROMOBACTERIUM VIOLACEUM. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET CVR68.
1691, 5ho9A, 0.5027, 3.05, 0.086, 596, 58, STRUCTURE OF TRUNCATED ABNA (DOMAINS 1-3) A GH43 ARABINANASE FROM GEOBACILLLUS STEAROTHERMOPHILUS IN COMPLEX WITH ARABINOOCTAOSE
1692, 2qzqA, 0.5027, 3.17, 0.056, 149, 54, CRYSTAL STRUCTURE OF C-TERMINAL OF AIDA
1693, 6ib8B, 0.5026, 3.81, 0.017, 270, 60, STRUCTURE OF A COMPLEX OF SUHB AND NUSA AR2 DOMAIN 
1694, 4y59A, 0.5026, 3.22, 0.097, 121, 62, CRYSTAL STRUCTURE OF ALIS1-STREPTAVIDIN COMPLEX
1695, 2izkA, 0.5026, 3.24, 0.113, 123, 62, STREPTAVIDIN-GLYCOLURIL PH 2.58 I4122 COMPLEX
1696, 1swaC, 0.5026, 3.25, 0.097, 115, 62, APO-CORE-STREPTAVIDIN AT PH 4.5
1697, 5n8jB, 0.5025, 3.25, 0.065, 120, 62, CRYSTAL STRUCTURE OF STREPTAVIDIN WITH PEPTIDE D-AMINO ACID CONTAINING PEPTIDE GYGLANVDESSG
1698, 5n7xF, 0.5025, 3.37, 0.048, 122, 63, CRYSTAL STRUCTURE OF STREPTAVIDIN WITH PEPTIDE EWVHPQFEQKAK
1699, 5lf4N, 0.5025, 3.78, 0.088, 202, 57, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
1700, 4jnjA, 0.5025, 3.26, 0.102, 115, 59, STRUCTURE BASED ENGINEERING OF STREPTAVIDIN MONOMER WITH A REDUCED BIOTIN DISSOCIATION RATE
1701, 6giuB, 0.5024, 3.59, 0.034, 275, 59, HUMAN IMPASE WITH L-690330 
1702, 5l5hZ, 0.5024, 3.67, 0.109, 222, 55, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1703, 5l5hL, 0.5024, 3.67, 0.109, 222, 55, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1704, 4fmeA, 0.5024, 2.76, 0.093, 351, 54, ESPG-RAB1-ARF6 COMPLEX
1705, 4as5D, 0.5024, 3.59, 0.051, 274, 59, STRUCTURE OF MOUSE INOSITOL MONOPHOSPHATASE 1
1706, 1swcB, 0.5024, 3.19, 0.097, 117, 62, APO-CORE-STREPTAVIDIN AT PH 4.5
1707, 1imcB, 0.5024, 3.71, 0.033, 272, 60, STRUCTURAL STUDIES OF METAL BINDING BY INOSITOL MONOPHOSPHATASE: EVIDENCE FOR TWO-METAL ION CATALYSIS
1708, 1dyuB, 0.5024, 3.52, 0.066, 719, 61, THE ACTIVE SITE BASE CONTROLS COFACTOR REACTIVITY IN ESCHERICHIA COLI AMINE OXIDASE: X-RAY CRYSTALLOGRAPHIC STUDIES WITH MUTATIONAL VARIANTS.
1709, 4whiA, 0.5023, 3.03, 0.017, 102, 59, CRYSTAL STRUCTURE OF C-TERMINAL DOMAIN OF PENICILLIN BINDING PROTEIN RV0907
1710, 4fmeD, 0.5023, 2.76, 0.093, 351, 54, ESPG-RAB1-ARF6 COMPLEX
1711, 2wofB, 0.5023, 3.53, 0.066, 719, 61, EDTA TREATED E. COLI COPPER AMINE OXIDASE
1712, 1imdB, 0.5023, 3.72, 0.033, 272, 60, STRUCTURAL STUDIES OF METAL BINDING BY INOSITOL MONOPHOSPHATASE: EVIDENCE FOR TWO-METAL ION CATALYSIS
1713, 1imbA, 0.5023, 3.61, 0.051, 272, 59, STRUCTURAL ANALYSIS OF INOSITOL MONOPHOSPHATASE COMPLEXES WITH SUBSTRATES
1714, 5n7xH, 0.5022, 3.30, 0.048, 122, 63, CRYSTAL STRUCTURE OF STREPTAVIDIN WITH PEPTIDE EWVHPQFEQKAK
1715, 5h9kA, 0.5022, 3.49, 0.109, 154, 64, CRYSTAL OF A LEUKOTRIENE-BINDING SALIVARY LIPOCALIN
1716, 5ctbB, 0.5022, 3.21, 0.053, 673, 57, HUMANIZED YEAST ACC CARBOXYLTRANSFERASE DOMAIN BOUND TO 67-DIMETHYL- 1 -[(7-METHYL-1H-INDAZOL-5-YL)CARBONYL]SPIRO[CHROMENE-24 - PIPERIDIN]-4(3H)-ONE
1717, 4i3cA, 0.5022, 3.85, 0.063, 139, 63, CRYSTAL STRUCTURE OF FLUORESCENT PROTEIN UNAG N57Q MUTANT
1718, 3wzoD, 0.5022, 3.27, 0.097, 125, 62, CRYSTAL STRUCTURE OF THE CORE STREPTAVIDIN MUTANT V21 (Y22S/N23D/S27D/Y83S/R84K/E101D/R103K/E116N) COMPLEXED WITH BIOTIN LONG TAIL (BTNTAIL) AT 1.5 A RESOLUTION
1719, 3ry1D, 0.5022, 3.21, 0.097, 121, 62, WILD-TYPE CORE STREPTAVIDIN AT ATOMIC RESOLUTION
1720, 1kl4B, 0.5022, 3.24, 0.113, 120, 62, AN ENGINEERED STREPTAVIDIN WITH IMPROVED AFFINITY FOR THE STREP-TAG II PEPTIDE : APO-SAM2
1721, 1awbB, 0.5022, 3.60, 0.034, 272, 59, HUMAN MYO-INOSITOL MONOPHOSPHATASE IN COMPLEX WITH D- INOSITOL-1-PHOSPHATE AND CALCIUM
1722, 5neiA, 0.5021, 3.48, 0.069, 216, 58, THE STRUCTURE OF THE POLO-BOX DOMAIN (PBD) OF POLO-LIKE KINASE 1 (PLK1) IN COMPLEX WITH JES107
1723, 4i3cB, 0.5021, 3.72, 0.081, 139, 62, CRYSTAL STRUCTURE OF FLUORESCENT PROTEIN UNAG N57Q MUTANT
1724, 1swuA, 0.5021, 3.25, 0.097, 120, 62, STREPTAVIDIN MUTANT Y43F
1725, 4as5B, 0.5020, 3.60, 0.051, 274, 59, STRUCTURE OF MOUSE INOSITOL MONOPHOSPHATASE 1
1726, 3js1A, 0.5020, 3.72, 0.082, 130, 61, CRYSTAL STRUCTURE OF ADIPOCYTE FATTY ACID BINDING PROTEIN COVALENTLY MODIFIED WITH 4-HYDROXY-2-NONENAL
1727, 3akmA, 0.5020, 3.71, 0.081, 131, 62, X-RAY STRUCTURE OF IFABP FROM HUMAN AND RAT WITH BOUND FLUORESCENT FATTY ACID ANALOGUE
1728, 2ddkB, 0.5020, 3.48, 0.069, 249, 58, CRYSTAL STRUCTURE OF HUMAN MYO-INOSITOL MONOPHOSPHATASE 2 (IMPA2) (ORTHORHOMBIC FORM)
1729, 1swfB, 0.5020, 3.15, 0.066, 125, 61, CIRCULAR PERMUTED STREPTAVIDIN E51/A46
1730, 1stsB, 0.5020, 3.38, 0.048, 123, 63, STREPTAVIDIN DIMERIZED BY DISULFIDE-BONDED PEPTIDE FCHPQNT- NH2 DIMER
1731, 1ifvB, 0.5020, 3.18, 0.148, 155, 54, CRYSTAL STRUCTURE OF PATHOGENESIS-RELATED PROTEIN LLPR10.1B FROM YELLOW LUPINE
1732, 6gy2A, 0.5019, 3.48, 0.069, 224, 58, CRYSTAL STRUCTURE OF HUMAN PLK1-PBD IN COMPLEX WITH WSSSLATPPTLSSPTVLI PHOSPHOPEPTIDE FROM BRCA2 
1733, 6ezzB, 0.5019, 3.52, 0.066, 720, 61, CRYSTAL STRUCTURE OF ESCHERICHIA COLI AMINE OXIDASE MUTANT E573Q 
1734, 4as5C, 0.5019, 3.59, 0.051, 274, 59, STRUCTURE OF MOUSE INOSITOL MONOPHOSPHATASE 1
1735, 1kl5C, 0.5019, 3.34, 0.048, 120, 63, AN ENGINEERED STREPTAVIDIN WITH IMPROVED AFFINITY FOR THE STREP-TAG II PEPTIDE : SAM2-STREPII
1736, 6gj0A, 0.5018, 3.45, 0.034, 274, 58, HUMAN IMPASE WITH MN 
1737, 6giuA, 0.5018, 3.60, 0.034, 275, 59, HUMAN IMPASE WITH L-690330 
1738, 3re5A, 0.5018, 3.25, 0.129, 125, 62, CRYSTAL STRUCTURE OF R4-6 STREPTAVIDIN
1739, 2izdD, 0.5018, 3.23, 0.097, 121, 62, APOSTREPTAVIDIN PH 3.0 I222 COMPLEX
1740, 1kl5A, 0.5018, 3.31, 0.048, 121, 63, AN ENGINEERED STREPTAVIDIN WITH IMPROVED AFFINITY FOR THE STREP-TAG II PEPTIDE : SAM2-STREPII
1741, 5iegA, 0.5017, 3.25, 0.074, 856, 54, MURINE ENDOPLASMIC RETICULUM ALPHA-GLUCOSIDASE II WITH N-9 - METHOXYNONYL-1-DEOXYNOJIRIMYCIN
1742, 4z6jA, 0.5017, 3.39, 0.048, 133, 63, CRYSTAL STRUCTURE OF APO INTACT HOEFAVIDIN
1743, 4c7pA, 0.5017, 3.29, 0.075, 347, 53, CRYSTAL STRUCTURE OF LEGIONELLA PNEUMOPHILA RALF F255K MUTANT
1744, 3cxjC, 0.5017, 3.25, 0.123, 138, 57, CRYSTAL STRUCTURE OF AN UNCHARACTERIZED PROTEIN FROM METHANOTHERMOBACTER THERMAUTOTROPHICUS
1745, 2rthD, 0.5017, 3.23, 0.113, 121, 62, STREPTAVIDIN-GLYCOLURIL COMPLEX PH 2.50 SPACE GROUP I222
1746, 1kl5B, 0.5017, 3.32, 0.048, 120, 63, AN ENGINEERED STREPTAVIDIN WITH IMPROVED AFFINITY FOR THE STREP-TAG II PEPTIDE : SAM2-STREPII
1747, 1imeB, 0.5017, 3.78, 0.050, 272, 60, STRUCTURAL STUDIES OF METAL BINDING BY INOSITOL MONOPHOSPHATASE: EVIDENCE FOR TWO-METAL ION CATALYSIS
1748, 5eq9B, 0.5016, 3.57, 0.086, 260, 58, CRYSTAL STRUCTURE OF MEDICAGO TRUNCATULA HISTIDINOL-PHOSPHATE PHOSPHATASE (MTHPP) IN COMPLEX WITH L-HISTIDINOL PHOSPHATE AND MG2+
1749, 5b29A, 0.5016, 3.64, 0.081, 132, 62, THE 1.28A STRUCTURE OF HUMAN FABP3 F16V MUTANT COMPLEXED WITH PALMITIC ACID AT ROOM TEMPERATURE
1750, 2p3vA, 0.5016, 3.70, 0.102, 254, 59, THERMOTOGA MARITIMA IMPASE TM1415
1751, 1vwnB, 0.5016, 3.37, 0.048, 121, 63, STREPTAVIDIN-CYCLO-AC-[CHPQFC]-NH2 PH 4.8
1752, 1swlC, 0.5016, 3.27, 0.097, 111, 62, CORE-STREPTAVIDIN MUTANT W108F AT PH 7.0
1753, 1spuB, 0.5016, 3.76, 0.078, 719, 64, STRUCTURE OF OXIDOREDUCTASE
1754, 1kl5D, 0.5016, 3.34, 0.032, 119, 63, AN ENGINEERED STREPTAVIDIN WITH IMPROVED AFFINITY FOR THE STREP-TAG II PEPTIDE : SAM2-STREPII
1755, 1kl4A, 0.5016, 3.25, 0.097, 120, 62, AN ENGINEERED STREPTAVIDIN WITH IMPROVED AFFINITY FOR THE STREP-TAG II PEPTIDE : APO-SAM2
1756, 5d17D, 0.5015, 3.35, 0.070, 155, 57, STRUCTURE OF THE C-TERMINAL DOMAIN OF TNSE AT 2.85 RESOLUTION
1757, 4zjmA, 0.5015, 2.99, 0.125, 107, 56, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS LPQH (RV3763)
1758, 3vg7A, 0.5015, 3.78, 0.094, 129, 64, STRUCTURE OF HUMAN LFABP AT HIGH RESOLUTION FROM S-SAD
1759, 1vwbB, 0.5015, 3.23, 0.113, 123, 62, STREPTAVIDIN-CYCLO-AC-[CHPQFC]-NH2 PH 11.8
1760, 6gy2B, 0.5014, 3.48, 0.069, 224, 58, CRYSTAL STRUCTURE OF HUMAN PLK1-PBD IN COMPLEX WITH WSSSLATPPTLSSPTVLI PHOSPHOPEPTIDE FROM BRCA2 
1761, 5cghZ, 0.5014, 3.66, 0.109, 222, 55, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1762, 5cghL, 0.5014, 3.65, 0.109, 222, 55, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1763, 2rtiD, 0.5014, 3.24, 0.113, 121, 62, STREPTAVIDIN-GLYCOLURIL COMPLEX PH 2.50 SPACE GROUP I222
1764, 1jrqB, 0.5014, 3.52, 0.066, 720, 61, X-RAY STRUCTURE ANALYSIS OF THE ROLE OF THE CONSERVED TYROSINE-369 IN ACTIVE SITE OF E. COLI AMINE OXIDASE
1765, 5xm5B, 0.5013, 3.63, 0.117, 187, 60, CRYSTAL STRUCTURE OF ZINC BINDING PROTEIN ZINT AT 1.49 ANGSTROM FROM E. COLI
1766, 5m4yB, 0.5013, 2.35, 0.040, 173, 50, CRYSTAL STRUCTURE OF THE SEC3/SSO2 COMPLEX AT 2.20 ANGSTROM RESOLUTION
1767, 3akmC, 0.5012, 3.77, 0.113, 131, 62, X-RAY STRUCTURE OF IFABP FROM HUMAN AND RAT WITH BOUND FLUORESCENT FATTY ACID ANALOGUE
1768, 1swhB, 0.5012, 3.24, 0.097, 115, 62, CORE-STREPTAVIDIN MUTANT W79F AT PH 4.5
1769, 6grrB, 0.5011, 3.53, 0.066, 720, 61, CRYSTAL STRUCTURE OF ESCHERICHIA COLI AMINE OXIDASE MUTANT I342F/E573Q 
1770, 5n8jD, 0.5011, 3.31, 0.048, 120, 63, CRYSTAL STRUCTURE OF STREPTAVIDIN WITH PEPTIDE D-AMINO ACID CONTAINING PEPTIDE GYGLANVDESSG
1771, 3wzoB, 0.5011, 3.26, 0.097, 124, 62, CRYSTAL STRUCTURE OF THE CORE STREPTAVIDIN MUTANT V21 (Y22S/N23D/S27D/Y83S/R84K/E101D/R103K/E116N) COMPLEXED WITH BIOTIN LONG TAIL (BTNTAIL) AT 1.5 A RESOLUTION
1772, 1hxzB, 0.5011, 3.27, 0.113, 121, 62, MINIPROTEIN MP-2 COMPLEX WITH STREPTAVIDIN
1773, 1g0u2, 0.5011, 3.82, 0.105, 196, 57, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1774, 3ry1A, 0.5010, 3.26, 0.097, 122, 62, WILD-TYPE CORE STREPTAVIDIN AT ATOMIC RESOLUTION
1775, 2fvzA, 0.5010, 3.67, 0.051, 244, 59, HUMAN INOSITOL MONOPHOSPHOSPHATASE 2
1776, 1slgD, 0.5010, 3.41, 0.048, 121, 63, STREPTAVIDIN PH 5.6 BOUND TO PEPTIDE FCHPQNT
1777, 1kffD, 0.5010, 3.25, 0.097, 119, 62, AN ENGINEERED STREPTAVIDIN WITH IMPROVED AFFINITY FOR THE STREP-TAG II PEPTIDE: APO-SAM1
1778, 1imdA, 0.5010, 3.60, 0.034, 266, 59, STRUCTURAL STUDIES OF METAL BINDING BY INOSITOL MONOPHOSPHATASE: EVIDENCE FOR TWO-METAL ION CATALYSIS
1779, 3unbb, 0.5009, 3.81, 0.105, 202, 57, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1780, 1swkC, 0.5009, 3.26, 0.097, 117, 62, CORE-STREPTAVIDIN MUTANT W79F IN COMPLEX WITH BIOTIN AT PH 4.5
1781, 1srjA, 0.5009, 3.25, 0.113, 118, 62, STRUCTURE-BASED DESIGN OF SYNTHETIC AZOBENZENE LIGANDS FOR STREPTAVIDIN
1782, 1lcwA, 0.5009, 3.21, 0.097, 119, 62, STREPTAVIDIN-HOMOBIOTIN COMPLEX
1783, 5yxcA, 0.5008, 3.62, 0.117, 187, 60, CRYSTAL STRUCTURE OF ZINC BINDING PROTEIN ZINT IN COMPLEX WITH CITRATE FROM E. COLI
1784, 5eq9C, 0.5008, 3.57, 0.086, 258, 58, CRYSTAL STRUCTURE OF MEDICAGO TRUNCATULA HISTIDINOL-PHOSPHATE PHOSPHATASE (MTHPP) IN COMPLEX WITH L-HISTIDINOL PHOSPHATE AND MG2+
1785, 5eq9A, 0.5008, 3.58, 0.086, 254, 58, CRYSTAL STRUCTURE OF MEDICAGO TRUNCATULA HISTIDINOL-PHOSPHATE PHOSPHATASE (MTHPP) IN COMPLEX WITH L-HISTIDINOL PHOSPHATE AND MG2+
1786, 3bs2A, 0.5008, 3.25, 0.067, 146, 60, CRYSTAL STRUCTURE OF MONOMINE
1787, 2o3iB, 0.5008, 3.48, 0.138, 365, 58, X-RAY CRYSTAL STRUCTURE OF PROTEIN CV_3147 FROM CHROMOBACTERIUM VIOLACEUM. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET CVR68.
1788, 1swsB, 0.5008, 3.48, 0.078, 117, 64, CORE-STREPTAVIDIN MUTANT D128A AT PH 4.5
1789, 1swfC, 0.5008, 3.15, 0.066, 125, 61, CIRCULAR PERMUTED STREPTAVIDIN E51/A46
1790, 1swbA, 0.5008, 3.28, 0.097, 120, 62, APO-CORE-STREPTAVIDIN AT PH 7.5
1791, 1kl3B, 0.5008, 3.33, 0.063, 120, 63, AN ENGINEERED STREPTAVIDIN WITH IMPROVED AFFINITY FOR THE STREP-TAG II PEPTIDE : SAM1-STREPII
1792, 1hmtA, 0.5008, 3.78, 0.079, 131, 63, 1.4 ANGSTROMS STRUCTURAL STUDIES ON HUMAN MUSCLE FATTY ACID BINDING PROTEIN: BINDING INTERACTIONS WITH THREE SATURATED AND UNSATURATED C18 FATTY ACIDS
1793, 6j6jD, 0.5007, 3.24, 0.097, 119, 62, BIOTIN-BOUND STREPTAVIDIN 
1794, 6j6jC, 0.5007, 3.24, 0.097, 119, 62, BIOTIN-BOUND STREPTAVIDIN 
1795, 6j6jB, 0.5007, 3.24, 0.097, 119, 62, BIOTIN-BOUND STREPTAVIDIN 
1796, 6j6jA, 0.5007, 3.24, 0.097, 119, 62, BIOTIN-BOUND STREPTAVIDIN 
1797, 5ce4A, 0.5007, 3.77, 0.079, 131, 63, HIGH RESOLUTION X-RAY AND NEUTRON DIFFRACTION STRUCTURE OF H-FABP
1798, 4azoA, 0.5007, 3.56, 0.113, 135, 62, MURINE EPIDERMAL FATTY ACID-BINDING PROTEIN (FABP5) APO FORM POLY-HIS TAG REMOVED
1799, 2yg2B, 0.5007, 3.35, 0.081, 151, 62, STRUCTURE OF APOLIOPROTEIN M IN COMPLEX WITH SPHINGOSINE 1-PHOSPHATE
1800, 1swrB, 0.5007, 3.25, 0.097, 118, 62, CORE-STREPTAVIDIN MUTANT W120A IN COMPLEX WITH BIOTIN AT PH 7.5
1801, 5n7xE, 0.5006, 3.29, 0.048, 122, 63, CRYSTAL STRUCTURE OF STREPTAVIDIN WITH PEPTIDE EWVHPQFEQKAK
1802, 5eq9D, 0.5006, 3.58, 0.086, 254, 58, CRYSTAL STRUCTURE OF MEDICAGO TRUNCATULA HISTIDINOL-PHOSPHATE PHOSPHATASE (MTHPP) IN COMPLEX WITH L-HISTIDINOL PHOSPHATE AND MG2+
1803, 3unbp, 0.5006, 3.79, 0.088, 202, 57, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1804, 3nadB, 0.5006, 2.97, 0.070, 159, 57, CRYSTAL STRUCTURE OF PHENOLIC ACID DECARBOXYLASE FROM BACILLUS PUMILUS UI-670
1805, 3h0sA, 0.5006, 3.32, 0.069, 693, 58, CRYSTAL STRUCTURE OF THE CARBOXYLTRANSFERASE DOMAIN OF ACETYL-COENZYME A CARBOXYLASE IN COMPLEX WITH COMPOUND 7
1806, 1vwcB, 0.5006, 3.25, 0.113, 121, 62, STREPTAVIDIN-CYCLO-AC-[CHPQFC]-NH2 PH 2.0
1807, 1swhA, 0.5006, 3.24, 0.097, 114, 62, CORE-STREPTAVIDIN MUTANT W79F AT PH 4.5
1808, 1nsuA, 0.5006, 3.09, 0.120, 339, 50, CRYSTAL STRUCTURE OF GALACTOSE MUTAROTASE FROM LACTOCOCCUS LACTIS MUTANT H96N COMPLEXED WITH GALACTOSE
1809, 4azpA, 0.5005, 3.55, 0.113, 134, 62, MURINE EPIDERMAL FATTY ACID-BINDING PROTEIN (FABP5) IN COMPLEX WITH THE ENDOCANNABINOID ANANDAMIDE
1810, 4as4A, 0.5005, 3.57, 0.051, 274, 59, STRUCTURE OF HUMAN INOSITOL MONOPHOSPHATASE 1
1811, 1qafB, 0.5005, 3.55, 0.066, 720, 61, THE ACTIVE SITE BASE CONTROLS COFACTOR REACTIVITY IN ESCHERICHIA COLI AMINE OXIDASE : X-RAY CRYSTALLOGRAPHIC STUDIES WITH MUTATIONAL VARIANTS
1812, 1kl3A, 0.5005, 3.32, 0.063, 121, 63, AN ENGINEERED STREPTAVIDIN WITH IMPROVED AFFINITY FOR THE STREP-TAG II PEPTIDE : SAM1-STREPII
1813, 1imaA, 0.5005, 3.63, 0.051, 272, 59, STRUCTURAL ANALYSIS OF INOSITOL MONOPHOSPHATASE COMPLEXES WITH SUBSTRATES
1814, 5ur9H, 0.5004, 3.65, 0.085, 137, 59, ENANTIOMER-SPECIFIC BINDING OF THE POTENT ANTINOCICEPTIVE AGENT SBFI- 26 TO ANANDAMIDE TRANSPORTERS FABP5
1815, 5iefA, 0.5004, 3.18, 0.036, 858, 55, MURINE ENDOPLASMIC RETICULUM ALPHA-GLUCOSIDASE II WITH N-BUTYL-1- DEOXYNOJIRIMYCIN
1816, 3b2lA, 0.5004, 3.77, 0.094, 126, 64, IODIDE DERIVATIVE OF HUMAN LFABP
1817, 1swbB, 0.5004, 3.26, 0.097, 115, 62, APO-CORE-STREPTAVIDIN AT PH 7.5
1818, 1iruV, 0.5004, 3.77, 0.088, 202, 57, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1819, 5ur9F, 0.5003, 3.79, 0.098, 138, 61, ENANTIOMER-SPECIFIC BINDING OF THE POTENT ANTINOCICEPTIVE AGENT SBFI- 26 TO ANANDAMIDE TRANSPORTERS FABP5
1820, 3bu1A, 0.5003, 3.26, 0.067, 144, 60, CRYSTAL STRUCTURE OF MONOMINE-HISTAMINE COMPLEX
1821, 3b2jA, 0.5003, 3.74, 0.079, 130, 63, IODIDE DERIVATIVE OF HUMAN LFABP
1822, 1ns4A, 0.5003, 3.08, 0.120, 339, 50, CRYSTAL STRUCTURE OF GALACTOSE MUTAROTASE FROM LACTOCOCCUS LACTIS MUTANT E304Q COMPLEXED WITH GLUCOSE
1823, 1mmzA, 0.5003, 3.10, 0.120, 339, 50, CRYSTAL STRUCTURE OF GALACTOSE MUTAROTASE FROM LACTOCOCCUS LACTIS COMPLEXED WITH L-ARABINOSE
1824, 5n99G, 0.5002, 3.36, 0.063, 121, 63, CRYSTAL STRUCTURE OF STREPTAVIDIN WITH CYCLIC PEPTIDE NQPWQ
1825, 4y5dD, 0.5002, 3.22, 0.113, 122, 62, CRYSTAL STRUCTURE OF ALIS2-STREPTAVIDIN COMPLEX
1826, 4as4B, 0.5002, 3.58, 0.034, 274, 59, STRUCTURE OF HUMAN INOSITOL MONOPHOSPHATASE 1
1827, 3gd9A, 0.5002, 3.34, 0.070, 362, 57, CRYSTAL STRUCTURE OF LAMINARIPENTAOSE-PRODUCING BETA-13- GLUCANASE IN COMPLEX WITH LAMINARITETRAOSE
1828, 1iruH, 0.5002, 3.77, 0.088, 202, 57, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1829, 1fnta, 0.5002, 3.76, 0.107, 222, 56, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1830, 1swdD, 0.5001, 3.25, 0.097, 118, 62, APO-CORE-STREPTAVIDIN IN COMPLEX WITH BIOTIN (TWO UNOCCUPIED BINDING SITES) AT PH 4.5
1831, 1imfA, 0.5001, 3.62, 0.034, 262, 59, STRUCTURAL STUDIES OF METAL BINDING BY INOSITOL MONOPHOSPHATASE: EVIDENCE FOR TWO-METAL ION CATALYSIS
1832, 1imcA, 0.5001, 3.62, 0.034, 266, 59, STRUCTURAL STUDIES OF METAL BINDING BY INOSITOL MONOPHOSPHATASE: EVIDENCE FOR TWO-METAL ION CATALYSIS
